
<html lang="en"     class="pb-page"  data-request-id="8cf54f54-17ba-4f71-850c-ad39e3e4a57b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-8;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b00265"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor" /></meta><meta name="dc.Creator" content="Fabio  Del Bello" /></meta><meta name="dc.Creator" content="Alessandro  Bonifazi" /></meta><meta name="dc.Creator" content="Gianfabio  Giorgioni" /></meta><meta name="dc.Creator" content="Carlo  Cifani" /></meta><meta name="dc.Creator" content="Maria Vittoria  Micioni Di Bonaventura" /></meta><meta name="dc.Creator" content="Riccardo  Petrelli" /></meta><meta name="dc.Creator" content="Alessandro  Piergentili" /></meta><meta name="dc.Creator" content="Stefano  Fontana" /></meta><meta name="dc.Creator" content="Valerio  Mammoli" /></meta><meta name="dc.Creator" content="Hideaki  Yano" /></meta><meta name="dc.Creator" content="Rosanna  Matucci" /></meta><meta name="dc.Creator" content="Giulio  Vistoli" /></meta><meta name="dc.Creator" content="Wilma  Quaglia" /></meta><meta name="dc.Description" content="In the present article, the M1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D4R selectivity ov..." /></meta><meta name="Description" content="In the present article, the M1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D4R selectivity ov..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 28, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00265" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00265" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00265" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00265" /></link>
        
    
    

<title>1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00265" /></meta><meta property="og:title" content="1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0010.jpeg" /></meta><meta property="og:description" content="In the present article, the M1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D4R selectivity over D2R and D3R and to behave as a D4R antagonist. To better understand the structural features required for the selective interaction with the D4R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain and the piperidine nucleus of 1 were modified, affording compounds 2–14. The 4-benzylpiperidine 9 and the 4-phenylpiperazine 12 showed high D4R affinity and selectivity not only over the other D2-like subtypes, but also over M1–M5 mAChRs. Derivative 12 was also highly selective over some selected off-targets. This compound showed biased behavior, potently and partially activating Gi protein and inhibiting β-arrestin2 recruitment in functional studies. Pharmacokinetic studies demonstrated that it was characterized by a relevant brain penetration. Therefore, 12 might be a useful tool to better clarify the role played by D4R in disorders in which this subtype is involved." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00265"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00265">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00265&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00265&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00265&amp;href=/doi/10.1021/acs.jmedchem.8b00265" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3712-3725</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00232" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00359" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D<sub>4</sub> Receptor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Fabio Del Bello</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Del Bello</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Del+Bello">Fabio Del Bello</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessandro Bonifazi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandro Bonifazi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse−Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Bonifazi">Alessandro Bonifazi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianfabio Giorgioni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianfabio Giorgioni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianfabio++Giorgioni">Gianfabio Giorgioni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlo Cifani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlo Cifani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlo++Cifani">Carlo Cifani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Vittoria Micioni Di Bonaventura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Vittoria Micioni Di Bonaventura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Vittoria++Micioni+Di+Bonaventura">Maria Vittoria Micioni Di Bonaventura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Riccardo Petrelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Riccardo Petrelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Riccardo++Petrelli">Riccardo Petrelli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessandro Piergentili</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandro Piergentili</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +390737402235. Fax: +390737637345. E-mail: <a href="/cdn-cgi/l/email-protection#26474a435555474842544908564f4354414348524f4a4f6653484f45474b084f52"><span class="__cf_email__" data-cfemail="c0a1aca5b3b3a1aea4b2afeeb0a9a5b2a7a5aeb4a9aca980b5aea9a3a1adeea9b4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Piergentili">Alessandro Piergentili</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6135-6826" title="Orcid link">http://orcid.org/0000-0001-6135-6826</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefano Fontana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefano Fontana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery and Development-DMPK, Aptuit, an Evotec Company, Via A. Fleming, 4, 37135 Verona, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Fontana">Stefano Fontana</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valerio Mammoli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valerio Mammoli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery and Development-DMPK, Aptuit, an Evotec Company, Via A. Fleming, 4, 37135 Verona, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valerio++Mammoli">Valerio Mammoli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hideaki Yano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hideaki Yano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse−Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hideaki++Yano">Hideaki Yano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rosanna Matucci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rosanna Matucci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA), Sezione di Farmacologia e Tossicologia, Università degli Studi di Firenze, Viale Pieraccini 6, 50139 Firenze, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rosanna++Matucci">Rosanna Matucci</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giulio Vistoli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giulio Vistoli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milano, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giulio++Vistoli">Giulio Vistoli</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3939-5172" title="Orcid link">http://orcid.org/0000-0002-3939-5172</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Wilma Quaglia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wilma Quaglia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wilma++Quaglia">Wilma Quaglia</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00265&amp;href=/doi/10.1021%2Facs.jmedchem.8b00265" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3712–3725</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 28, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 February 2018</li><li><span class="item_label"><b>Published</b> online</span>28 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00265</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3712%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabio%2BDel%2BBello%252C%2BAlessandro%2BBonifazi%252C%2BGianfabio%2BGiorgioni%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D8%26contentID%3Dacs.jmedchem.8b00265%26title%3D1-%255B3-%25284-Butylpiperidin-1-yl%2529propyl%255D-1%252C2%252C3%252C4-tetrahydroquinolin-2-one%2B%252877-LH-28-1%2529%2Bas%2Ba%2BModel%2Bfor%2Bthe%2BRational%2BDesign%2Bof%2Ba%2BNovel%2BClass%2Bof%2BBrain%2BPenetrant%2BLigands%2Bwith%2BHigh%2BAffinity%2Band%2BSelectivity%2Bfor%2BDopamine%2BD4%2BReceptor%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3725%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00265"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1062</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00265" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Del Bello&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Bonifazi&quot;},{&quot;first_name&quot;:&quot;Gianfabio&quot;,&quot;last_name&quot;:&quot;Giorgioni&quot;},{&quot;first_name&quot;:&quot;Carlo&quot;,&quot;last_name&quot;:&quot;Cifani&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Vittoria Micioni Di Bonaventura&quot;},{&quot;first_name&quot;:&quot;Riccardo&quot;,&quot;last_name&quot;:&quot;Petrelli&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Piergentili&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Fontana&quot;},{&quot;first_name&quot;:&quot;Valerio&quot;,&quot;last_name&quot;:&quot;Mammoli&quot;},{&quot;first_name&quot;:&quot;Hideaki&quot;,&quot;last_name&quot;:&quot;Yano&quot;},{&quot;first_name&quot;:&quot;Rosanna&quot;,&quot;last_name&quot;:&quot;Matucci&quot;},{&quot;first_name&quot;:&quot;Giulio&quot;,&quot;last_name&quot;:&quot;Vistoli&quot;},{&quot;first_name&quot;:&quot;Wilma&quot;,&quot;last_name&quot;:&quot;Quaglia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3712-3725&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00265&quot;},&quot;abstract&quot;:&quot;In the present article, the M1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D4R selectivity over D2R and D3R and to behave as a D4R antagonist. To better understand the structural features required for the selective interaction with the D4R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain and the piperidine nucleus of 1 were modified, affording compounds 2–14. The 4-benzylpiperidine 9 and the 4-phenylpiperazine 12 showed high D4R affinity and selectivity not only over the other D2-like subtypes, but also over M1–M5 mAChRs. Derivative 12 was also highly selective over some selected off-targets. This compound showed biased behavior, potently and partially activating Gi protein and inhibiting β-arrestin2 recruitment in functional studies. Pharmacokinetic studies demonstrated that it was characterized by a relevant brain penetration. Therefore, 12 might be a useful tool to better clar&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00265&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00265" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00265&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00265" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00265&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00265" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00265&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00265&amp;href=/doi/10.1021/acs.jmedchem.8b00265" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00265" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00265" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00265%26sid%3Dliteratum%253Aachs%26pmid%3D29589445%26genre%3Darticle%26aulast%3DDel%2BBello%26date%3D2018%26atitle%3D1-%255B3-%25284-Butylpiperidin-1-yl%2529propyl%255D-1%252C2%252C3%252C4-tetrahydroquinolin-2-one%2B%252877-LH-28-1%2529%2Bas%2Ba%2BModel%2Bfor%2Bthe%2BRational%2BDesign%2Bof%2Ba%2BNovel%2BClass%2Bof%2BBrain%2BPenetrant%2BLigands%2Bwith%2BHigh%2BAffinity%2Band%2BSelectivity%2Bfor%2BDopamine%2BD4%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D8%26spage%3D3712%26epage%3D3725%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/jmcmar.2018.61.issue-8/20180426/jmcmar.2018.61.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the present article, the M<sub>1</sub> mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, <b>1</b>) has been demonstrated to show unexpected D<sub>4</sub>R selectivity over D<sub>2</sub>R and D<sub>3</sub>R and to behave as a D<sub>4</sub>R antagonist. To better understand the structural features required for the selective interaction with the D<sub>4</sub>R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain and the piperidine nucleus of <b>1</b> were modified, affording compounds <b>2</b>–<b>14</b>. The 4-benzylpiperidine <b>9</b> and the 4-phenylpiperazine <b>12</b> showed high D<sub>4</sub>R affinity and selectivity not only over the other D<sub>2</sub>-like subtypes, but also over M<sub>1</sub>–M<sub>5</sub> mAChRs. Derivative <b>12</b> was also highly selective over some selected off-targets. This compound showed biased behavior, potently and partially activating G<sub>i</sub> protein and inhibiting β-arrestin2 recruitment in functional studies. Pharmacokinetic studies demonstrated that it was characterized by a relevant brain penetration. Therefore, <b>12</b> might be a useful tool to better clarify the role played by D<sub>4</sub>R in disorders in which this subtype is involved.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Muscarinic acetylcholine receptors (mAChRs) are G protein-coupled receptors and include five subtypes, namely, M<sub>1</sub>–M<sub>5</sub>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among the five mAChRs, the M<sub>1</sub> subtype is the most abundantly expressed in the brain, including cortex, hippocampus, amygdala, and striatum.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The M<sub>1</sub> subtype is believed to be important for cognition and attention, with potential benefit for the treatment of cognitive symptoms exhibited by those suffering from Alzheimer’s disease (AD) and schizophrenia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The search for a fully selective M<sub>1</sub> agonist has been a pharmaceutical quest for many decades.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Among the several compounds published so far, one of the first was 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1<i>H</i>)-quinolinone, <b>1</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which selectively activates the M<sub>1</sub> subtype over the other four M<sub>2</sub>–M<sub>5</sub> mAChR subtypes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Initially classified as an allosteric agonist, <b>1</b> is now considered as a bitopic agonist, interacting concomitantly with the orthosteric site and part of an allosteric site.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The muscarinic agonist <b>1</b> extends down into the orthosteric site as well as up toward extracellular receptor regions associated with an allosteric site. The piperidine basic center of <b>1</b> interacts with the Asp105 of the third transmembrane (TM) segment in the orthosteric binding site. Mutational data support the requirement of such a residue for the receptor activation by this muscarinic agonist.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, the 3,4-dihydroquinolin-2(1<i>H</i>)-one aromatic group of <b>1</b> has been predicted to occupy space between TM2, TM3, and TM7 domains, near the extracellular loops. In preclinical models of schizophrenia and Alzheimer’s disease, <b>1</b> displayed antipsychotic and cognition-enhancing efficacy.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Unfortunately, its efficacy was limited by nonselective effects on other receptors, including dopamine D<sub>2</sub> receptor subtype (D<sub>2</sub>R).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> D<sub>2</sub>R belongs to the D<sub>2</sub>-like receptor family that also includes D<sub>3</sub> (D<sub>3</sub>R) and D<sub>4</sub> (D<sub>4</sub>R) subtypes, which activate Gα<sub>i/o</sub> to inhibit adenylate cyclase activity and cAMP production.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The Gα<sub>i/o</sub> class of G proteins is inactivated by pertussis toxin-catalyzed ADP-ribosylation. The DR signaling is now widely appreciated to be more complex than simple changes in cAMP levels. Studies have shown that D<sub>2</sub>-like receptors modulate numerous other signaling pathways, including phospholipases, ion channels, mitogen activated protein (MAP) kinases, and the Na<sup>+</sup>/H<sup>+</sup> exchanger.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of 77-LH-28-1 and compounds <b>2</b>–<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several psychiatric and neurological disorders, in particular those involving the D<sub>2</sub>-like subtypes, including Parkinson’s disease, schizophrenia, attention deficit disorder/hyperactivity disorder, Tourette’s disorder, neuroleptic-induced akathisia, post-traumatic stress disorder, drug abuse, bipolar disorder, and restless legs syndrome, have been associated with hypoactivation or hyperactivation of dopamine-releasing neurons.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Furthermore, unmet medical needs involve side effects (motor, metabolic, cardiovascular, and emotional negative potential) associated with medications targeting D<sub>2</sub>-like receptors. This may in part be due to the lack of drugs able to selectively discriminate among the D<sub>2</sub>-like receptor subtypes. D<sub>2</sub>R shares 75% homology in the transmembrane regions with D<sub>3</sub>R and 53% identity with D<sub>4</sub>R.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Moreover, D<sub>2</sub>-like receptors share high homology with other receptor families (muscarinic, adrenergic, serotoninergic receptors), which mediate different physiological processes in distinct brain regions.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Thus, the need for the identification of new ligands with increased D<sub>2</sub>-like subtype selectivity and potentially reduced side effects remains an important challenge in the design of therapeutically useful drugs.</div><div class="NLM_p">Among the D<sub>2</sub>-like receptor subtypes, D<sub>4</sub>R aroused great interest in the early 1990s, when the known atypical antipsychotic agent clozapine demonstrated to bind it with high affinity and showed good selectivity over the other dopamine receptor subtypes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This observation led to the development of novel D<sub>4</sub>R antagonists potentially useful for the treatment of schizophrenia. However, due to the failure of such antagonists in the clinic, D<sub>4</sub>R has lost its interest as a therapeutic target for decades. Recently, D<sub>4</sub>R has garnered a renewed attraction, emerging as a potential therapeutic target for diseases such as cancer, drug addiction, and Parkinson’s disease in which D<sub>4</sub>R antagonists can attenuate <span class="smallcaps smallerCapital">l</span>-DOPA-induced dyskinesias.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Compounds belonging to different chemotypes, including aryl-linked piperazines, amide-linked piperazines, piperidines, morpholines, and imidazolines, have been reported as selective D<sub>4</sub>R ligands (<b>15</b>–<b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Concerning piperidines and piperazines, a general formula deduced from classical D<sub>3</sub>R and D<sub>4</sub>R ligands known in the literature has been proposed. It consists of a lipophilic moiety linked by a spacer to a basic function and an aromatic terminal, which seems to control intrinsic activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> The aromatic terminal can also be fused with the piperidine ring, affording 1,2,3,4-tetrahydroisoquinoline derivatives, acting as potent and selective D<sub>3</sub>R ligands.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Another feature frequently observed in D<sub>2</sub>-like ligands is the presence of an amide function in the lipophilic moiety or in the spacer. Most of the ligands are characterized by the carbonyl function linked to the lipophilic moiety and the NH connected through a spacer to the basic function. However, some D<sub>2</sub>-like ligands bear an inverse amide function.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> While in some benzolactam derivatives the effect of regioisomerism at the amide function on D<sub>2</sub>R and D<sub>3</sub>R affinity has been evaluated,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> concerning D<sub>4</sub>R ligands, the optimal substitution pattern has not been clarified so far. The structure of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) fits the features of the pharmacophore reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, except for the presence of a butyl chain instead of the aromatic terminal. This structurally intriguing difference prompted us to know more about the pharmacological dopaminergic properties of <b>1</b>, which was therefore evaluated for its affinity at D<sub>2</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R subtypes by radioligand binding assays. Encouraged by its interesting affinity profile, according to which <b>1</b> showed high affinity for D<sub>4</sub>R and selectivity over D<sub>2</sub>R and D<sub>3</sub>R subtypes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), to better understand the structural features required for the selective interaction with D<sub>4</sub>R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain of <b>1</b> was variously modified, and the novel compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) were prepared and evaluated by radioligand binding studies at dopamine D<sub>2</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R and at M<sub>1</sub>–M<sub>5</sub> mAChRs. Compounds <b>5</b>–<b>7</b>, already synthesized and evaluated for their affinity at mAChRs,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were included in this study. Furthermore, since it is well-known that not only piperidines but also piperazines are able to bind DRs, the novel compounds <b>11</b>, <b>13</b>, and <b>14</b>, as well as the known compound <b>12</b>, already evaluated for its analgesic activity,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> were prepared and studied (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Compounds <b>1</b>, <b>9</b>, and <b>12</b> were also evaluated by receptor binding assays at some off-targets (α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-adrenoceptor (AR), β<sub>1</sub>- and β<sub>2</sub>-AR, σ<sub>1</sub> receptor, and dopamine and serotonin transporter (DAT and SERT, respectively)). The most relevant D<sub>4</sub>R selective ligands were tested for their functional activities by bioluminescence resonance energy transfer (BRET) assays that detect G protein activation and β-arrestin recruitment with D<sub>4</sub>R, M<sub>1</sub>, and M<sub>4</sub> mAChRs.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative selective D<sub>4</sub>R ligands belonging to different chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) General formula of 1,4-disubstituted piperidines and piperazines deduced from classical dopamine D<sub>3</sub>R and D<sub>4</sub>R drugs. (B) Chemical structure of <b>1</b>, fitting all the features of the pharmacophore except for the aromatic terminal, which is replaced by a butyl chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Affinity Constants, Expressed as p<i>K</i><sub>i</sub>,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> of Compounds <b>1</b>–<b>15</b> for Human Cloned D<sub>2</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R Expressed in HEK293T Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">p<i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>2</sub>R</th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>3</sub>R</th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>4</sub>R</th><th class="colsep0 rowsep0" align="center" char=".">D<sub>4</sub>/D<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>4</sub>/D<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, 77-LH-28-1</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.17 ± 0.16 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">6.21 ± 0.13 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">9.01 ± 0.04 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">691</td><td class="colsep0 rowsep0" align="char" char=".">631</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.35 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.43 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.59 ± 0.18 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.04 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.81 ± 0.06 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.28 ± 0.16 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">174</td><td class="colsep0 rowsep0" align="char" char=".">295</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.28 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.55 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.86 ± 0.15 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">380</td><td class="colsep0 rowsep0" align="char" char=".">204</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char="±">6.18 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.23 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">7.13 ± 0.11 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char="±">5.93 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.17 ± 0.11 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.36 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">269</td><td class="colsep0 rowsep0" align="char" char=".">155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>6</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char="±">6.03 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.02 ± 0.20 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">7.00 ± 0.14 (<i>n</i> = 6)</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.34 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.15 ± 0.16 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.71 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">234</td><td class="colsep0 rowsep0" align="char" char=".">363</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.04 ± 0.06 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.74 ± 0.28 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.90 ± 0.19 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">724</td><td class="colsep0 rowsep0" align="char" char=".">1445</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">6.54 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.39 ± 0.19 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.67 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">135</td><td class="colsep0 rowsep0" align="char" char=".">191</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.29 ± 0.02 (<i>n</i> = 2)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">5.41 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.50 ± 0.26 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.96 ± 0.02 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.88 ± 0.10 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.54 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">380</td><td class="colsep0 rowsep0" align="char" char=".">457</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.42 ± 0.02 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.58 ± 0.18 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">7.70 ± 0.04 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">191</td><td class="colsep0 rowsep0" align="char" char=".">132</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.24 ± 0.01 (<i>n</i> = 2)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">5.40 ± 0.02 (<i>n</i> = 2)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">7.54 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b>, L-745,870</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">5.79 ± 0.09 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">6.42 ± 0.14 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">8.65 ± 0.14 (<i>n</i> = 7)</td><td class="colsep0 rowsep0" align="char" char=".">724</td><td class="colsep0 rowsep0" align="char" char=".">170</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values represent the arithmetic mean ± SEM; <i>n</i> represents the number of experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">When <i>n</i> = 2, <i>K</i><sub>i</sub> > 3 μM and SEM is within ±20%.</p></div></div></div><div class="NLM_p last">Moreover, considering that the lead <b>1</b> has been reported to be CNS penetrant,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the pharmacokinetic profiles of compounds <b>9</b> and <b>12</b> were determined by in vitro and in vivo assays. Finally, docking simulations on the human D<sub>4</sub>R model based on the resolved structure of the human dopamine D<sub>3</sub>R in complex with eticlopride as the template (PDB Id: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> were performed to rationalize the experimental observations and to elucidate the binding mode of the proposed compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The novel derivatives <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b> were prepared according to the procedure reported in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The intermediate 1-(3-bromo-propyl)-3,4-dihydro-1<i>H</i>-quinolin-2-one<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was reacted with suitable amines in the presence of NaH in DMF to yield the desired compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b>. Alcohol derivatives <b>5</b>–<b>7</b> were prepared as reported in the literature.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) suitable amine, NaH, DMF.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Radioligand Binding Assays</h3><div class="NLM_p">The dopaminergic pharmacological profiles of <b>1</b>, its analogues <b>2</b>–<b>14</b>, and the known D<sub>4</sub>R antagonist L-745,870 (<b>15</b>) for cloned human D<sub>2</sub>-like receptor subtypes were evaluated in in vitro binding assays using the antagonist [<sup>3</sup>H]<i>N</i>-methylspiperone to label dopamine receptors, similarly to previously described procedures.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> The affinity values, expressed as p<i>K</i><sub>i</sub>, were calculated according to the Cheng–Prusoff equation<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">The muscarinic pharmacological profiles of the novel compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b> were evaluated by receptor binding assays at human recombinant hM<sub>1</sub>–hM<sub>5</sub> mAChR subtypes stably expressed in Chinese hamster ovary (CHO) cell lines using the labeled antagonist [<sup>3</sup>H]<i>N</i>-methylscopolamine ([<sup>3</sup>H]NMS), following previously described procedures.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> The affinity values, expressed as p<i>K</i><sub>i</sub>, are reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The affinity values of <b>1</b> and <b>5</b>–<b>7</b> at M<sub>1</sub>–M<sub>5</sub> mAChRs, already reported in ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>, are included in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> for useful comparison.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Affinity Constants, Expressed as p<i>K</i><sub>i</sub>,<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> of Compounds <b>1</b>–<b>14</b> for Human Cloned M<sub>1</sub>–M<sub>5</sub> mAChRs, Expressed in CHO Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char="±">p<i>K</i><sub>i</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">hM<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">hM<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">hM<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">hM<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char="±">hM<sub>5</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, 77-LH-28–1</td><td class="colsep0 rowsep0" align="char" char="±">6.50 ± 0.07<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">6.69 ± 0.05<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.92 ± 0.08<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.68 ± 0.11<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.27 ± 0.10<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">4.92 ± 0.01 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.94 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.85 ± 0.09 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.03 ± 0.18 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.62 ± 0.04 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">5.60 ± 0.02 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.72 ± 0.04 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.63 ± 0.11 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.78 ± 0.15 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.71 ± 0.28 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">6.31 ± 0.20 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.25 ± 0.17 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.87 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.24 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.45 ± 0.07 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">5.60 ± 0.12<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.49 ± 0.08<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">4.93 ± 0.10<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.23 ± 0.13<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.84 ± 0.08<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">6.33 ± 0.08<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.22 ± 0.05<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.72 ± 0.10<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.35 ± 0.05<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.34 ± 0.37<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">6.45 ± 0.11<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.68 ± 0.06<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.20 ± 0.06<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.41 ± 0.07<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.51 ± 0.06<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">5.54 ± 0.14 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.62 ± 0.04 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.33 ± 0.20 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.89 ± 0.13 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.69 ± 0.02 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">6.44 ± 0.21 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.10 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.52 ± 0.14 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.14 ± 0.08 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.43 ± 0.25 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">6.58 ± 0.15 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.69 ± 0.10 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.30 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.70 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">6.12 ± 0.12 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">5.57 ± 0.02 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.38 ± 0.15 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.15 ± 0.20 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.50 ± 0.29 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.04 ± 0.21 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">5.37 ± 0.04 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">4.78 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.75 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.03 ± 0.23 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">4.56 ± 0.03 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">5.83 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.32 ± 0.06 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.17 ± 0.16 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.58 ± 0.02 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">5.22 ± 0.24 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">5.64 ± 0.03 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.75 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.18 ± 0.12 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.29 ± 0.15 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char="±">5.10 ± 0.11 (<i>n</i> = 3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values represent the arithmetic mean ± SEM; <i>n</i> represents the number of experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Values were taken from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>.</p></div></div></div><div class="NLM_p">Finally, for the most interesting compounds <b>1</b>, <b>9</b>, and <b>12</b>, the affinity values, expressed as p<i>K</i><sub>i</sub> and reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, were determined by receptor binding assays at some off-targets, namely α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-AR (HEK cells; [<sup>3</sup>H]prazosin), β<sub>1</sub>- and β<sub>2</sub>-AR (HEK cells; [<sup>3</sup>H]CGP12177), σ<sub>1</sub> receptor (guinea pig brain cortices; [<sup>3</sup>H](+)-pentazocine), DAT (rat brain striata; [<sup>3</sup>H]WIN 35,428), and SERT (rat midbrains; [<sup>3</sup>H]citalopram), similarly to previously described procedures.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29−31)</a> The experimental details are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Off-Target Binding Affinities, Expressed as p<i>K</i><sub>i</sub>,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> for the Selected Compounds <b>1</b>, <b>9</b> and <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="left" char="±" /></col><col align="left" char="±" /></col><col align="left" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">p<i>K</i><sub>i</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center" char="±"><b>1</b>, 77-LH-28-1</th><th class="colsep0 rowsep0" align="center" char="±"><b>9</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>12</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>1a</sub>-AR</td><td class="colsep0 rowsep0" align="left" char="±">6.36 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">6.59 ± 0.08 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">7.27 ± 0.12 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>1b</sub>-AR</td><td class="colsep0 rowsep0" align="left" char="±">6.11 ± 0.09 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">6.65 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">7.13 ± 0.08 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>1d</sub>-AR</td><td class="colsep0 rowsep0" align="left" char="±">6.00 ± 0.17 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">6.52 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">7.04 ± 0.19 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β<sub>1</sub>-AR</td><td class="colsep0 rowsep0" align="left" char="±">4.32 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">4.99 ± 0.11 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">4.49 ± 0.26 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β<sub>2</sub>-AR</td><td class="colsep0 rowsep0" align="left" char="±">4.36 ± 0.02 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="left" char="±">5.02 ± 0.01 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="left" char="±">4.45 ± 0.03 (<i>n</i> = 5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<sub>1</sub></td><td class="colsep0 rowsep0" align="left" char="±">8.14 ± 0.06 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">8.00 ± 0.07 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">6.57 ± 0.09 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DAT</td><td class="colsep0 rowsep0" align="left" char="±">5.47 ± 0.02 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">6.35 ± 0.17 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">5.06 ± 0.09 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERT</td><td class="colsep0 rowsep0" align="left" char="±">5.05 ± 0.03 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">7.33 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left" char="±">5.30 ± 0.08 (<i>n</i> = 3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values represent the arithmetic mean ± SEM; <i>n</i> represents the number of experiments. Binding assays are described in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Functional Assays</h3><div class="NLM_p">Based on the radioligand binding results, compounds <b>1</b>, <b>6</b>, <b>9</b>, and <b>12</b> were selected to be evaluated for their functional activities in BRET-based assays at D<sub>4</sub>R. Since compounds <b>1</b> and <b>6</b> had already been evaluated for their functional activities in BRET-based assays at M<sub>1</sub> and M<sub>4</sub> mAChRs,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the activities of compounds <b>9</b> and <b>12</b> were assessed in the same assays, to make useful considerations. The potencies and efficacies, expressed as pEC<sub>50</sub> (−log EC<sub>50</sub>) and <i>E</i><sub>max</sub> (maximum efficacy), respectively, are reported in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> along with those of dopamine (D<sub>4</sub>R full agonist) and carbachol (M<sub>1</sub> and M<sub>4</sub> mAChR full agonist) as references. In parallel, the presence of antagonist as well as allosteric modulatory effects of the tested compounds were studied using a fixed amount of dopamine (1 μM) at D<sub>4</sub>R and carbachol (1 μM) at M<sub>1</sub> and M<sub>4</sub> mAChRs (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, pIC<sub>50</sub> and <i>I</i><sub>max</sub> columns).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency Values (Expressed as pEC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> or pIC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>) and Efficacy Values (%<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>, Normalized to Carbachol <i>E</i><sub>max</sub>) of Compounds <b>1</b>, <b>6</b>, <b>9</b>, <b>12</b>, <b>15</b>, and Dopamine for D<sub>4</sub>R and of Compounds <b>1</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>, <b>6</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>, <b>9</b>, <b>12</b>, Carbachol, and Scopolamine for hM<sub>1</sub> and hM<sub>4</sub> mAChRs Expressed in HEK293T Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" rowspan="2" align="center"> </th><th class="colsep0 rowsep0" colspan="8" align="center">D<sub>4</sub>R</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">G<sub>i</sub> activation</th><th class="rowsep1 colsep0" colspan="4" align="center">βarr2 recruitment</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">7.91 ± 0.19</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.04 ± 0.65</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, 77-LH-28-1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.93 ± 0.15</td><td class="colsep0 rowsep0" align="left">–98</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">8.22 ± 0.31</td><td class="colsep0 rowsep0" align="left">–72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.90 ± 0.18</td><td class="colsep0 rowsep0" align="left">–69</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.82 ± 0.34</td><td class="colsep0 rowsep0" align="left">–70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.77 ± 0.25</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.24 ± 0.19</td><td class="colsep0 rowsep0" align="left">–94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">9.80 ± 0.31</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">8.01 ± 0.31</td><td class="colsep0 rowsep0" align="left">–41</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9.14 ± 0.38</td><td class="colsep0 rowsep0" align="left">–69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b>, L-745,870</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.03 ± 0.30</td><td class="colsep0 rowsep0" align="left">–81</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.37 ± 0.47</td><td class="colsep0 rowsep0" align="left">–60</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="8" align="center">M<sub>1</sub>R</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">G<sub>q</sub> activation</th><th class="rowsep1 colsep0" colspan="4" align="center">βarr2 recruitment</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carbachol</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.02 ± 0.09</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.97 ± 0.07</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">scopolamine</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.66 ± 0.17</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.82 ± 0.34</td><td class="colsep0 rowsep0" align="left">–76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, 77-LH-28-1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.99 ± 0.14<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">57<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.72 ± 0.27<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">+79<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (PAM)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">6.08 ± 0.21<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">32<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.76 ± 0.65<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–27<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.69 ± 0.10<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">53<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.00 ± 0.37<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–31<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">7.54 ± 0.51<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–61<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.73 ± 0.44</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5.58 ± 0.23</td><td class="colsep0 rowsep0" align="left">–44</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">5.92 ± 0.30</td><td class="colsep0 rowsep0" align="left">–71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.19 ± 0.13</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">6.08 ± 0.39</td><td class="colsep0 rowsep0" align="left">–53</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="8" align="center">M<sub>4</sub>R</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">G<sub>i</sub> activation</th><th class="rowsep1 colsep0" colspan="4" align="center">βarr2 recruitment</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>I</i><sub>max</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carbachol</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">7.35 ± 0.10</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.65 ± 0.05</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">scopolamine</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.27 ± 0.14</td><td class="colsep0 rowsep0" align="left">–79</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.24 ± 0.49</td><td class="colsep0 rowsep0" align="left">–73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, 77-LH-28-1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.56 ± 0.45<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">46<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4.32 ± 1.92<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–55<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">5.12 ± 0.24<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–19<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5.70 ± 1.33<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">20<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.48 ± 0.67<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–38<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">5.79 ± 0.06<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–100<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.83 ± 0.60</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5.07 ± 0.23</td><td class="colsep0 rowsep0" align="left">–66</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">5.91 ± 0.33</td><td class="colsep0 rowsep0" align="left">–72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.23 ± 0.55</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">4.92 ± 0.14</td><td class="colsep0 rowsep0" align="left">–74</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The values represent the arithmetic mean ± SEM.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Values were taken from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last"><i>n</i> represents the number of experiments.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">ND = cannot be determined.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">The positive value indicates positive allosteric modulation (PAM) activity with pEC<sub>50</sub> and <i>E</i><sub>max</sub> as opposed to inhibition.</p></div></div></div><div class="NLM_p last">Since functionally selective compounds that exert preferential activation (and/or inactivation) on G protein or β-arrestin are deemed to be therapeutically useful approaches,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> β-arrestin2 recruitment assays at D<sub>4</sub>R and M<sub>1</sub> and M<sub>4</sub> mAChRs were also performed to characterize ligands’ agonist properties (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, β-arrestin2 recruitment, pEC<sub>50</sub> and <i>E</i><sub>max</sub> columns). In parallel, the presence of antagonist and allosteric modulatory effects were assessed using a fixed amount of dopamine (1 μM) at D<sub>4</sub>R and carbachol (1 μM) at M<sub>1</sub> and M<sub>4</sub> mAChRs (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, β-arrestin2 recruitment, pIC<sub>50</sub> and <i>I</i><sub>max</sub> columns).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro and in Vivo Pharmacokinetic Studies</h3><div class="NLM_p">Taking together all the biological results, compounds <b>9</b> and <b>12</b> were selected to be evaluated for their in vitro ADME profile. For both compounds, kinetic solubility at pH 7.4,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> protein binding at human plasma and at mouse plasma and brain tissue binding determined by using equilibrium dialysis,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> hepatic intrinsic clearance determined in mouse liver microsomes,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and permeability studies in MDCKII-Mdr1 cell lines<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were assessed. The results are reported in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. ADME Parameters of Compounds <b>9</b> and <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>12</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">kinetic solubility (pH 7.4)</td><td class="colsep0 rowsep0" align="left">μM</td><td class="colsep0 rowsep0" align="left">477</td><td class="colsep0 rowsep0" align="left">520</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mg/mL</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">protein binding<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">human plasma (fu)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.057</td><td class="colsep0 rowsep0" align="left">0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma (fu)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.097</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse brain (fu)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.051</td><td class="colsep0 rowsep0" align="left">0.086</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">hepatic intrinsic clearance (CLi) in liver microsomes</td><td class="colsep0 rowsep0" align="left">CLi (μL/min/mg protein)</td><td class="colsep0 rowsep0" align="left">396</td><td class="colsep0 rowsep0" align="left">159</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLi (mL/min/g liver)</td><td class="colsep0 rowsep0" align="left">20.80</td><td class="colsep0 rowsep0" align="left">8.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half life (min)</td><td class="colsep0 rowsep0" align="left">3.50</td><td class="colsep0 rowsep0" align="left">8.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">permeability<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Papp A-B (nm/s)</td><td class="colsep0 rowsep0" align="left">109</td><td class="colsep0 rowsep0" align="left">162</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Papp B-A (nm/s)</td><td class="colsep0 rowsep0" align="left">209</td><td class="colsep0 rowsep0" align="left">197</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Papp A-B inhibitor (nm/s)</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Papp B-A inhibitor (nm/s)</td><td class="colsep0 rowsep0" align="left">241</td><td class="colsep0 rowsep0" align="left">229</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">efflux ratio (B-A/A-B)</td><td class="colsep0 rowsep0" align="left">1.92</td><td class="colsep0 rowsep0" align="left">1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Experiment performed at 0.5 and 5 μM in plasma and brain, respectively.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">fu = fraction unbound.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">The P-gp inhibitor used in permeability studies is Elacridar 10 μM. Papp = passive membrane permeability. A-B = apical to basolateral. B-A = basolateral to apical.</p></div></div></div><div class="NLM_p">Moreover, compound <b>12</b> was evaluated for in vivo pharmacokinetic and brain penetration profile following subcutaneous (s.c.) administration in male CD-1 mice at the dose of 3 mg/kg. The results are reported in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of mean concentration with standard deviations of <b>12</b> in plasma and brain after subcutaneous administration (3 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Profile of <b>12</b> after s.c. Administration in Male CD1 Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">brain</th><th class="colsep0 rowsep0" align="center" char=".">plasma</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL or ng/g)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">2046</td><td class="colsep0 rowsep0" align="char" char=".">481</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h·ng/mL)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">2384</td><td class="colsep0 rowsep0" align="char" char=".">518</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half life (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" colspan="2" align="center" char=".">4.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>puu,brain</sub><a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" colspan="2" align="center" char=".">4.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last"><i>C</i><sub>max</sub> = maximum mean concentration.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last"><i>T</i><sub>max</sub> = time corresponding to maximum drug concentration.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">AUC = area under the curve.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>p</sub> = AUC brain/AUC plasma.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last"><i>K</i><sub>puu,brain</sub> AUCu brain/AUCu plasma.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Affinity for Dopamine D<sub>2</sub>-like Receptor Subtypes</h3><div class="NLM_p">The data reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> show that the M<sub>1</sub> bitopic compound <b>1</b> binds with high affinity to D<sub>4</sub>R (p<i>K</i><sub>i</sub> = 9.01), and with significantly lower affinity to the other two D<sub>2</sub>-like receptor subtypes (p<i>K</i><sub>i</sub> D<sub>2</sub>R = 6.17 and p<i>K</i><sub>i</sub> D<sub>3</sub>R = 6.21). Consequently, <b>1</b> is highly selective for D<sub>4</sub>R over D<sub>2</sub>R (selectivity ratio D<sub>4</sub>/D<sub>2</sub> = 691) and D<sub>3</sub>R (selectivity ratio D<sub>4</sub>/D<sub>2</sub> = 631). This selectivity is comparable to those of already known D<sub>4</sub>R selective ligands belonging to different chemotypes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Interestingly, for the first time, it has been demonstrated that the aromatic terminal present in all the known piperidine and piperazine ligands selective for D<sub>4</sub>R can be replaced by a butyl chain (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The D<sub>4</sub>/D<sub>3</sub> selectivity ratio shown by <b>1</b> is about 3.7 times higher than that of the known selective D<sub>4</sub>R antagonist <b>15</b>, tested under the same experimental conditions used for the compounds of the present article.</div><div class="NLM_p">Similarly to <b>1</b>, all its analogues <b>2</b>–<b>14</b> show affinities for D<sub>4</sub>R higher than those for D<sub>2</sub>R and D<sub>3</sub>R, a novel class of D<sub>4</sub>R selective derivatives being obtained. Within this series, <b>1</b> is the most selective compound for D<sub>4</sub>R over D<sub>2</sub>R and D<sub>3</sub>R, together with compound <b>9</b>, which even shows increased selectivity ratios (D<sub>4</sub>/D<sub>2</sub> = 724; D<sub>4</sub>/D<sub>3</sub> = 1445).</div><div class="NLM_p">The butyl chain of <b>1</b> plays an important role in the affinity for all the dopamine D<sub>2</sub>-like receptor subtypes. Its shortening or lengthening, affording <b>3</b> and <b>4</b>, respectively, slightly reduces both affinity and selectivity for D<sub>4</sub>R, while its replacement with a methyl group (compound <b>2</b>) is strongly detrimental. Instead, the introduction of a phenyl ring directly linked to the 4-position of the piperidine nucleus (compound <b>8</b>) or spaced by one or two methylene groups (compounds <b>9</b> and <b>10</b>, respectively) is compatible with high affinity and selectivity for D<sub>4</sub>R. Indeed, compounds <b>8</b>–<b>10</b> show D<sub>4</sub>R affinity values similar to that of <b>1</b>. The benzyl group confers to the ligand the best affinity for D<sub>4</sub>R and selectivity over the other D<sub>2</sub>-like receptor subtypes, as demonstrated by <b>9</b>, which shows selectivity values even higher than those of <b>15</b>.</div><div class="NLM_p">The introduction of a polar hydroxy group in the chain of compounds <b>3</b> and <b>4</b>, affording <b>5</b> and <b>6</b>, respectively, causes a decrease in both affinity and selectivity for D<sub>4</sub>R. However, while the affinity of compound <b>5</b> for D<sub>4</sub>R subtype decreases 14 times compared to <b>3</b>, that of <b>6</b> decreases only three times compared to <b>4</b>. The further elongation of the hydroxyalkyl chain, affording <b>7</b>, is detrimental for D<sub>4</sub>R affinity and selectivity.</div><div class="NLM_p last">The replacement of the piperidine ring of <b>1</b>, <b>9</b>, and <b>10</b> with a piperazine ring, affording <b>11</b>, <b>13</b>, and <b>14</b>, respectively, causes a strong decrease in affinity, especially for D<sub>4</sub>R, suggesting that the introduction of a second basic function is detrimental for D<sub>4</sub>R affinity. However, when the terminal substituent is a phenyl ring, such a modification does not affect D<sub>4</sub>R affinity. Indeed, the piperazine derivative <b>12</b> shows a p<i>K</i><sub>i</sub> value for D<sub>4</sub>R and selectivity over D<sub>2</sub>R and D<sub>3</sub>R comparable to those of its piperidine analog <b>8</b>. The observation that the basicity of N4 of <b>12</b> is lower than that of N1 allows us to hypothesize that probably the N4 does not interfere with the interaction with the corresponding receptor site.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Affinity for hM<sub>1</sub>–hM<sub>5</sub> mAChR Subtypes</h3><div class="NLM_p last">From the results reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, all the tested compounds show micromolar affinities for hM<sub>1</sub>–hM<sub>5</sub> mAChR subtypes. Among the piperidine derivatives, the lowest affinities are those of compound <b>2</b>, bearing a methyl group in the 4-position of the piperidine nucleus, while the highest affinities are shown by compound <b>10</b>, bearing a phenethyl group in the same position. These results suggest that the reduction in the length of the alkyl chain of <b>1</b> (<b>2</b> and <b>3</b>) causes a decrease in affinity, while the presence of a pentyl chain (<b>4</b>) or an aromatic ring (<b>9</b> and <b>10</b>), unless it is directly linked to the piperidine ring (<b>8</b>), results in affinity values for all the hM<sub>1</sub>–hM<sub>5</sub> mAChR subtypes similar to those of <b>1</b>. Compounds <b>4</b>–<b>6</b> and <b>9</b> show selectivity profiles similar to that of <b>1</b>, with higher affinity values for hM<sub>1</sub>, hM<sub>2</sub>, and hM<sub>4</sub> with respect to the other two subtypes. The piperazine derivatives <b>11</b>–<b>14</b> exhibit affinity values for the mAChR subtypes lower than those of the corresponding piperidine analogs <b>1</b> and <b>8</b>–<b>10</b>.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Off-Target Binding Profiles</h3><div class="NLM_p">Due to their interesting affinity and selectivity profiles for D<sub>4</sub>R, compounds <b>1</b>, <b>9</b>, and <b>12</b> were selected to be evaluated for their binding affinities at some off-targets, namely, α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-AR, β<sub>1</sub>- and β<sub>2</sub>-AR, σ<sub>1</sub> receptor, DAT, and SERT. Compared to D<sub>4</sub>R, all the compounds show significantly lower affinities for all the investigated off-targets (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_p last">The observation that the piperidine analogues <b>1</b> and <b>9</b> bind σ<sub>1</sub> receptor with high affinity values (p<i>K</i><sub>i</sub> = 8.14 and 8.00, respectively) is not surprising, considering that the piperidine scaffold characterizes several potent σ<sub>1</sub> receptor ligands<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and numerous dopamine D<sub>4</sub> receptor compounds have been reported to bind σ<sub>1</sub> receptor with high affinity.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Interestingly, compared to <b>1</b> and <b>9</b>, the piperazine derivative <b>12</b> shows significantly lower affinity for σ<sub>1</sub> receptor (p<i>K</i><sub>i</sub> = 6.57), and consequently, its selectivity binding profile for D<sub>4</sub>R is the best among the compounds of this series.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Functional Activities at D<sub>4</sub>R and M<sub>1</sub> and M<sub>4</sub> mAChRs</h3><div class="NLM_p">Due to their higher selectivity for D<sub>4</sub>R over D<sub>2</sub>R and D<sub>3</sub>R subtypes, compounds <b>1</b>, <b>9</b>, and <b>12</b> were selected to be evaluated for their functional activity at D<sub>4</sub>R. Compound <b>6</b> was included in this study because, unlike <b>1</b>, it had previously been demonstrated to behave as a weak M<sub>1</sub> and M<sub>4</sub> mAChR antagonist.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">G<sub>i</sub> protein activation BRET shows that, compounds <b>1</b>, <b>6</b>, and <b>9</b> do not possess a partial agonist property for D<sub>4</sub>R (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). When tested for an antagonist activity in D<sub>4</sub>R-G<sub>i</sub> protein activation with a fixed amount (1 μM) of dopamine, compounds <b>1</b>, <b>6</b>, and <b>9</b> exhibited pIC<sub>50</sub> and <i>I</i><sub>max</sub> values comparable to those of the selective D<sub>4</sub>R antagonist <b>15</b>. On the contrary, compound <b>12</b> behaves as a D<sub>4</sub>R partial agonist (<i>E</i><sub>max</sub> = 48%) with a potency value higher than that of dopamine (pEC<sub>50</sub> = 9.80) and as a partial antagonist (<i>I</i><sub>max</sub> = 41%) when tested in the presence of dopamine (pIC<sub>50</sub> = 8.01).</div><div class="NLM_p">D<sub>4</sub>R β-arrestin2 recruitment result shows that compounds <b>1</b>, <b>6</b>, <b>9</b>, and <b>12</b> have no agonist activity in agreement with the G<sub>i</sub> protein activation. While they all show antagonist activity as expected, <b>1</b> and <b>12</b> have a higher pIC<sub>50</sub> compared to <b>15</b>. Of note, compounds <b>1</b>, <b>6</b>, <b>9</b>, and <b>12</b> show <i>I</i><sub>max</sub> lower than <b>15</b>, indicating good efficacies as antagonists in D<sub>4</sub>R mediated β-arrestin2 recruitment. In summary, for D<sub>4</sub>R activities, compounds <b>1</b>, <b>6</b>, and <b>9</b> behave as antagonists in both G<sub>i</sub> activation and β-arrestin2 recruitment assays, while, interestingly, compound <b>12</b> shows a biased behavior, partially activating G<sub>i</sub> protein and inhibiting β-arrestin2 recruitment.</div><div class="NLM_p last">Compounds <b>1</b> and <b>6</b> had previously been reported to show functionally different behaviors at M<sub>1</sub> and M<sub>4</sub> mAChRs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, the activity profiles of <b>9</b> and <b>12</b> were assessed at the same receptors for useful comparison. For G protein activation, analogously to <b>6</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> compounds <b>9</b> and <b>12</b> show weak partial agonist activities. In the presence of carbachol (1 μM), they behave as partial antagonists. On the contrary, as previously reported,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><b>1</b> behaves as a positive allosteric modulator in M<sub>1</sub> mAChR G<sub>q</sub> activation, while it exhibits partial agonism for M<sub>4</sub> mAChR G<sub>i</sub> activation. In β-arrestin2 recruitment assay, compounds <b>6</b>, <b>9</b>, and <b>12</b> show no agonist activity. In the presence of carbachol, they all show a nearly full to full antagonist activity, albeit a significantly lower potency compared to scopolamine. Therefore, in M<sub>1</sub> and M<sub>4</sub> mAChR activity, <b>6</b>, <b>9</b>, and <b>12</b> are all weak partial agonists with a low potency in G protein activation and antagonists with a low potency in β-arrestin2 recruitment.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vitro ADME and in Vivo Pharmacokinetic Studies</h3><div class="NLM_p">Compounds <b>9</b> and <b>12</b>, selected for an in vitro ADME characterization, showed similar ADME profiles (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Both compounds are characterized by high kinetic solubility at pH 7.4 (477 and 520 μM for <b>9</b> and <b>12</b>, respectively), moderate protein binding either in mouse plasma or in mouse brain tissue homogenates, and high apparent permeability without relevant efflux ratios (1.92 and 1.22 for <b>9</b> and <b>12</b>, respectively) when tested in MDCKII-Mdr1 cell lines, therefore resulting in no P-gp substrates.</div><div class="NLM_p">Based on the overall results from the ADME in vitro assays and due to its interesting D<sub>4</sub> selectivity profile, compound <b>12</b> was selected to investigate its brain penetration and systemic exposure following s.c. administration at 3 mg/kg in male CD-1 mice. From the results reported in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, it emerges that compound <b>12</b> shows a relevant brain penetration (<i>K</i><sub>p</sub> = 4.35) and that, based on a <i>K</i><sub>puu,brain</sub> of 4.05, there is no impact of efflux transporters but an even potential for active brain influx.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> After 0.25 h from the treatment, exposures reach the mean maximum concentration either in plasma or brain (481 ng/mL and 2046 ng/g, respectively) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The exposures (AUC<sub>last</sub>) obtained were 518 and 2384 h·ng/mL in plasma and brain, respectively. Free concentration exposures (AUC<sub>ulast</sub>), calculated by correcting total concentration (AUC<sub>last</sub>) for the free fraction in plasma or brain, resulted in 50.5 and 204 h·ng/mL, respectively.</div><div class="NLM_p last">To rationalize the high clearance of the tested compound, a similarity-based predictive analysis was performed as recently published.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Briefly, the method is based on the MetaQSAR resource, which is a curated database of xenobiotic metabolism reactions collected by a meta-analysis of the recent specialized literature. The possible metabolites for <b>12</b> were then derived by considering the reported metabolites for the three most similar compounds included in the database: prilocaine (Tanimoto distance = 0.7), imipramine (0.67), and lidocaine (0.67). From their metabolic profile, three putative metabolic reactions can be figured out for <b>12</b>: (a) hydroxylation of a Csp<sup>3</sup> atom carrying a heteroatom; (b) oxidation of aryl moieties; and (c) <i>N</i>-glucuronidation of cyclic amines. Even though prilocaine and lidocaine include the metabolites deriving from the hydrolysis of their amide function, the quinolinone ring should be stable since lactams larger than four-membered rings are resistant to metabolic hydrolysis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Molecular Modeling</h3><div class="NLM_p">To rationalize the observed results, docking studies were performed using a D<sub>4</sub>R homology model based on the structure of the human dopamine D<sub>3</sub>R in complex with eticlopride as the template. Though a novel D<sub>2</sub> structure in complex with risperidone has been recently released (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6c38">6c38</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> the here-used D<sub>3</sub> structure in complex with eticlopride still remains the more suitable template to generate the D<sub>4</sub> homology model both for the markedly greater identity (78.39% vs 55.22% for D<sub>3</sub>/D<sub>4</sub> and D<sub>2</sub>/D<sub>4</sub> alignments, respectively) and for the more extended coverage (100% vs 91% for D<sub>3</sub>/D<sub>4</sub> and D<sub>2</sub>/D<sub>4</sub> alignments, respectively).</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A shows the key interactions stabilizing the putative complex between D<sub>4</sub>R and <b>1</b>, which is vastly dominated by the pivotal ion-pair that the charged ammonium head elicits with Asp115 reinforced by the H-bond with Tyr438. Again, the quinolinone ring elicits H-bonds with Cys119, Ser196, and Ser200 plus π–π stacking with Phe410, Phe411,and His414 as well as apolar contacts with Val116, Leu187, and Val193, which also contact the linker between the piperazine and quinolinone rings. The carbon skeleton of the piperazine ring and the alkyl tail stabilize an extended set of hydrophobic contacts with surrounding apolar residues such as Leu90, Phe91, Leu111, and Met112. The reported interactions can clearly rationalize the observed affinity values. In detail, the beneficial role of the alkyl chain is easily understood when considering the surrounding apolar residues, which are also well-suited to accommodate aromatic moieties as exemplified by <b>9</b>, the benzyl group of which elicits a clear π–π stacking with Phe91 (see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). The crucial role of these hydrophobic interactions is further confirmed by the negative effect exerted by the introduction of a hydroxyl function. Even though the binding site reveals some accessible H-bonding residues that might contact the hydroxyl function, such a polar contact would hamper the proper approach of the tail to the mentioned apolar residues with an overall negative impact. For example, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C shows that the hydroxyl function of <b>5</b> approaches Thr434 while inducing the complete loss of the mentioned apolar contacts. This finding emphasizes that the addition of a polar group can be deleterious, regardless of the elicited contacts, if it destabilizes a set of hydrophobic contacts involving extended lipophilic regions of the ligands.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Main interactions stabilizing the putative complexes between the D<sub>4</sub>R homology model and <b>1</b> (A), <b>9</b> (B), <b>5</b> (C), and <b>12</b> (D). Panels B–D are focused on the contacts elicited by the apolar tail and underline (B) the extended set of apolar contacts stabilized by the benzyl moiety of <b>9</b>, (C) the detrimental role exerted by polar functions of <b>5</b>, and (D) the involvement of the residues located in ECL2, which contact the phenyl ring of <b>12</b>, whose backbone is colored in lime.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a view to explaining the different affinity of the piperazine derivatives, the mentioned PM7-based semiempirical calculations were utilized to calculate the p<i>K</i><sub>a</sub> values of the two nitrogen atoms by using a specific script included in VEGA. The obtained results reveal that in the alkyl derivative <b>11</b> the N4 atom is clearly more basic than the N1 atom [9.22 (N1) vs 10.22 (N4)], while the two nitrogen atoms possess comparable basicity in benzyl and phenethyl analogues [10.38 (N1) vs 10.55(N4) and 10.17 (N1) vs 10.11 (N4) for <b>13</b> and <b>14</b>, respectively]. These results may indicate that the N4 protonated species is the one only involved in receptor recognition for <b>11</b>, while both protonated forms can be involved for the benzyl and phenethyl analogues <b>13</b> and <b>14</b>. What is more, docking results reveal that the shift of the protonated center on the N4 atom is detrimental for binding since it worsens the interactions involving the protonated N4 atom and impacts the pose of the quinolinone ring, thus destabilizing the key contacts involving it (results not shown). Thus, these results can rationalize the marked drop in affinity of <b>11</b> and the less pronounced decrease in affinity of <b>13</b> and <b>14</b> due to the possible simultaneous involvement of both protonated forms. Similar semiempirical calculations confirmed the vastly greater basicity of the N1 atom of <b>12</b> [10.19 (N1) vs 7.35 (N4)], while docking simulations reveal that the <i>N</i>-phenyl tail of <b>12</b> approaches some key residues in ECL2 such as Cys185 and Arg186 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Even though other simulated ligands can also contact such residues, one may argue that the greater rigidity of the 4-phenylpiperazine moiety of <b>12</b> has a greater impact on the local folding of ECL2 explaining its biased behavior due to the role of the extracellular loop ECL2 in influencing the coupling with the signaling proteins as already reviewed.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">To explain the observed selectivity of these derivatives toward D<sub>4</sub>R, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> reports the complex between D<sub>4</sub>R and <b>1</b> (as seen in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) in which the interacting residues are colored by conservation degree as derived from multiple alignments of D<sub>2</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R computed by Clustal X.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The greatest differences among the three subtypes are detected in the region of TM3 surrounding the key and conserved aspartate residues. In detail, a key role should be played by the Leu111 and Met112 residues, which are replaced by Phe and Val residues in D<sub>2</sub>R and D<sub>3</sub>R. (i.e., Phe110 and Val111 as well as Phe106 and Val107 in D<sub>2</sub>R and D<sub>3</sub>R, respectively). Another relevant difference is seen in Leu90, which is replaced by a tryptophan residue in both D<sub>2</sub>R (Trp90) and D<sub>3</sub>R (Trp85). Collectively, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> underlines that the subpockets contacting the charged moieties and the quinolinone ring are highly conserved, while that harboring the apolar tail shows relevant differences among the monitored subtypes. In detail, these different residues should render the subpocket accommodating the alkyl tail in D<sub>2</sub>R and D<sub>3</sub>R narrower and more rigid compared to the corresponding D<sub>4</sub>R cavity and so unable to conveniently harbor bulky apolar groups, which, instead, beneficially contribute to the D<sub>4</sub>R affinity as before discussed. These findings can explain why the selectivity is roughly proportional to the steric hindrance of this hydrophobic tail and why the D<sub>2</sub>R vs D<sub>3</sub>R selectivity is almost always close to 1.0 since the relevant residues are conserved in these two subtypes.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Main interactions stabilizing the putative complex for <b>1</b> within the D<sub>4</sub>R homology model, whose residues are colored according to the conservation degree as derived by the sequence alignment of D<sub>4</sub>R with D<sub>2</sub>R and D<sub>3</sub>R (light green = conserved residues; orange = nonconserved residues).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a view to corroborating the obtained docking results, a correlative study was performed by using the docking scores computed by ReScore+ as well as a small set of representative physicochemical descriptors. For each ligand, the score averages as computed by considering all the 10 generated poses were utilized in order to account for the possible role of multiple binding modes as recently proposed.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The so-obtained best equation (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>) emphasizes the role of an optimal balance between lipophilic and polar moieties as encoded by lipole and the relevance of ionic contacts exerted by the protonated group as parametrized by the electrostatic scores (elect_mean).<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_m001.gif" alt="" id="_i21" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_m002.gif" alt="" id="_i22" /></img></span></div><div class="NLM_p last">Notably, the score averages perform better than the corresponding best values, thus suggesting that for rather flexible ligands such as those involved in the study the possibility of assuming slightly different binding modes beneficially contributes to the observed affinity reasonably due to positive entropic effects.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, the bitopic M<sub>1</sub> mAChR agonist <b>1</b> shows unexpectedly high D<sub>4</sub>R affinity and selectivity over D<sub>2</sub>R and D<sub>3</sub>R and behaves as an antagonist in both G<sub>i</sub> activation and β-arrestin2 recruitment assays for D<sub>4</sub>R. Interestingly, the structure of <b>1</b> differs from those of other known selective D<sub>4</sub>R ligands, which are characterized by the presence of a properly substituted aromatic group at the 4-position of the piperidine ring (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). On the contrary, <b>1</b> bears a butyl aliphatic chain, indicating that not only π–π interactions but also hydrophobic interactions might be favorable for D<sub>4</sub>R affinity. The aliphatic chain of <b>1</b> can be successfully replaced by an aryl or alkylaryl chain (<b>8</b>–<b>10</b>) without affecting high D<sub>4</sub>R affinity and selectivity over D<sub>2</sub>R and D<sub>3</sub>R subtypes. From functional studies, it emerges that <b>9</b> behaves as a D<sub>4</sub>R antagonist and, unlike <b>1</b>, is a weak partial antagonist at M<sub>1</sub> mAChR. Compound <b>9</b> shows high D<sub>4</sub>R affinity and selectivity not only over the other D<sub>2</sub>-like subtypes but also over M<sub>1</sub>–M<sub>5</sub> mAChRs. The substitution of the piperidine nucleus with a piperazine ring causes a sharp decrease in affinity, except for compound <b>12</b>, which shows affinity for D<sub>4</sub>R and selectivity over D<sub>2</sub>R and D<sub>3</sub>R comparable to its piperidine analog <b>8</b>. Compound <b>12</b> also displays high selectivity over M<sub>1</sub>–M<sub>5</sub> mAChRs and other selected off-targets, namely, α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-AR, β<sub>1</sub>- and β<sub>2</sub>-AR, σ<sub>1</sub> receptor, DAT, and SERT. Interestingly, in in vivo pharmacokinetic studies, a relevant brain penetration characterizes this compound. From functional studies, it shows a biased behavior, potently and partially activating G<sub>i</sub> protein and inhibiting β-arrestin2 recruitment. Future studies with <b>12</b> might reveal mechanistically related behaviors and the interplay between G-protein- and β-arrestin-mediated signaling in D<sub>4</sub>R-related physiological effects.</div><div class="NLM_p">Docking simulations clearly confirm the key role of hydrophobic interactions, elicited by the alkyl chain, which are also responsible for the observed D<sub>4</sub>R selectivity. Moreover, they suggest that an affinitive ligand should possess an optimal balance between hydrophobic and hydrophilic portions as also confirmed by correlative studies. Finally, the biased behavior of <b>12</b>, which contacts Cys185 and Arg186, emphasizes the role of the extracellular loop ECL2 in modulating the receptor activation.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p last">Considering the renewed interest garnered by D<sub>4</sub>R, recently emerged as a potential therapeutic target for diseases such as cancer, drug addiction, and Parkinson’s disease in which D<sub>4</sub>R antagonists can attenuate <span class="smallcaps smallerCapital">l</span>-DOPA-induced dyskinesias,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the selective D<sub>4</sub>R compounds <b>9</b> and especially <b>12</b> might help to better clarify the role played by this subtype in the above disorders and are good candidates for further evaluation in in vivo animal models for D<sub>4</sub>R-mediated pathologies.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General</h4><div class="NLM_p last">Melting points were taken in glass capillary tubes on a Büchi SMP-20 apparatus and are uncorrected. IR and NMR spectra were recorded on PerkinElmer 297 and Varian Mercury AS400 instruments, respectively. Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS), and spin multiplicities are given as s (singlet), d (doublet), dd (double doublet), t (triplet), or m (multiplet). IR spectral data (not shown because of the lack of unusual features) were obtained for all compounds reported and are consistent with the assigned structures. Mass spectra were obtained using a Hewlett-Packard 1100 MSD instrument utilizing electron-spray ionization (ESI). The microanalyses were recorded on FLASH 2000 instrument (ThermoFisher Scientific). The elemental composition of the compounds agreed to within ±0.4% of the calculated value. Chromatographic separations were performed on silica gel columns (Kieselgel 40, 0.040–0.063 mm, Merck) by flash chromatography. Compounds were named following IUPAC rules as applied by ChemBioDraw Ultra (version 11.0) software for systematically naming organic chemicals. The purity of the novel compounds was determined by combustion analysis and was ≥95%.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure to Synthesize Compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b></h4><div class="NLM_p">NaH (0.018 mol) was added portionwise to a solution of amine (0.005 mol) in DMF (20 mL) at 0 °C. After the solution was stirred for 15 min, 1-(3-bromo-propyl)-3,4-dihydro-1<i>H</i>-quinolin-2-one<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (0.005 mol) was added portionwise. The reaction was stirred overnight at room temperature. The mixture was diluted with water and extracted with EtOAc. The organic layer was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to afford colorless oils that were purified by column chromatography eluting with EtOAc/MeOH (8:2).</div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 1-(3-(4-Methylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>2</b>)</h5><div class="NLM_p last">This was prepared starting from 4-methylpiperidine: 53% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.98 (d, <i>J</i> = 6.3 Hz, 3H), 1.45–2.44 (m, 9H), 2.60 (m, 2H), 2.79 (m, 2H), 2.88 (m, 2H), 3.24 (m, 2H), 3.99 (t, <i>J</i> = 7.2 Hz, 2H), 7.00 (t, <i>J</i> = 7.3 Hz, 1H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.15 (d, <i>J</i> = 7.3 Hz, 1H), 7.26 (m, 1H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 138–139 °C, ESI/MS <i>m</i>/<i>z</i> 287.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 1-(3-(4-Propylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>3</b>)</h5><div class="NLM_p last">This was prepared starting from 4-propylpiperidine: 46% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.87 (t, <i>J</i> = 7.1 Hz, 3H), 1.06–2.09 (m, 13H), 2.50 (m, 2H), 2.63 (m, 2H), 2.88 (m, 2H), 3.01 (m, 2H), 3.97 (t, <i>J</i> = 7.5 Hz, 2H), 6.99 (t, <i>J</i> = 7.5 Hz, 1H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 7.24 (m, 1H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 142–143 °C, ESI/MS <i>m</i>/<i>z</i> 315.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>20</sub>H<sub>30</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 1-(3-(4-Pentylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>4</b>)</h5><div class="NLM_p last">This was prepared starting from 4-pentylpiperidine: 43% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.90 (t, <i>J</i> = 7.2 Hz, 3H), 1.16–2.02 (m, 17H), 2.45 (m, 2H), 2.63 (m, 2H), 2.88 (m, 2H), 2.95 (m, 2H), 3.96 (t, <i>J</i> = 7.5 Hz, 2H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 7.23 (m, 1H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 118–119 °C, ESI/MS <i>m</i>/<i>z</i> 343.3 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>22</sub>H<sub>34</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 1-(3-(4-Phenylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>8</b>)</h5><div class="NLM_p last">This was prepared starting from 4-phenylpiperidine: 47% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.59 (m, 2H), 1.99 (m, 2H), 2.40 (m, 2H), 2.56–2.79 (m, 5H), 2.90 (m, 2H), 3.08 (m, 2H), 3.65 (m, 2H), 4.05 (t, <i>J</i> = 6.9 Hz, 2H), 7.03 (t, <i>J</i> = 7.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 7.28 (m, 6H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 150–151 °C, ESI/MS <i>m</i>/<i>z</i> 349.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>23</sub>H<sub>28</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 1-(3-(4-Benzylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>9</b>)</h5><div class="NLM_p last">This was prepared starting from 4-benzylpiperidine: 44% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.31–2.03 (m, 9H), 2.45 (m, 2H), 2.53 (d, <i>J</i> = 6.9 Hz, 2H), 2.61 (m, 2H), 2.87 (m, 2H), 2.95 (m, 2H), 3.95 (t, <i>J</i> = 7.4 Hz, 2H), 6.98 (t, <i>J</i> = 7.5 Hz, 1H), 7.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.09–7.30 (m, 7H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 164–166 °C, ESI/MS <i>m</i>/<i>z</i> 363.2 (M + H<sup>+</sup>), 385.1 (M + Na<sup>+</sup>). Anal. Calcd. (C<sub>24</sub>H<sub>30</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 1-(3-(4-Phenethylpiperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>10</b>)</h5><div class="NLM_p last">This was prepared starting from 4-phenethylpiperidine: 42% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.21–1.97 (m, 11H), 2.40 (m, 2H), 2.63 (m, 4H), 2.89 (m, 4H), 3.97 (t, <i>J</i> = 7.4 Hz, 2H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.12–7.32 (m, 7H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 140–142 °C, ESI/MS <i>m</i>/<i>z</i> 377.3 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>25</sub>H<sub>32</sub>N<sub>2</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 1-(3-(4-Butylpiperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>11</b>)</h5><div class="NLM_p last">This was prepared starting from 4-butylpiperazine: 55% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.90 (t, <i>J</i> = 7.1 Hz, 3H), 1.17–1.83 (m, 6H), 2.21 (m, 2H), 2.62 (m, 2H), 2.84 (m, 2H), 3.02 (m, 2H), 3.19 (m, 2H), 3.48–3.94 (m, 6H), 4.07 (t, <i>J</i> = 7.4 Hz, 2H), 6.97–7.22 (m, 4H). The free base was transformed into the oxalate salt, which was crystallized from EtOH: mp 225–226 °C, ESI/MS <i>m</i>/<i>z</i> 330.2 (M + H<sup>+</sup>), 352.2 (M + Na<sup>+</sup>). Anal. Calcd. (C<sub>20</sub>H<sub>31</sub>N<sub>3</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 1-(3-(4-Phenylpiperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>12</b>)</h5><div class="NLM_p last">This was prepared starting from 4-phenylpiperazine: 59% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.99 (m, 2H), 2.58–2.93 (m, 10H), 3.30 (m, 4H), 4.02 (t, <i>J</i> = 7.4 Hz, 2H), 6.98–7.29 (m, 9H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 212–213 °C, ESI/MS <i>m</i>/<i>z</i> 350.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 1-(3-(4-Benzylpiperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>13</b>)</h5><div class="NLM_p last">This was prepared starting from 4-benzylpiperazine: 57% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.92 (m, 2H), 2.40–2.75 (m, 12H), 2.87 (m, 2H), 3.57 (s, 2H), 3.98 (t, <i>J</i> = 7.5 Hz, 2H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 7.06 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 7.19–7.37 (m, 6H). The free base was transformed into the oxalate salt, which was crystallized from 2-PrOH: mp 222–223 °C, ESI/MS <i>m</i>/<i>z</i> 364.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>23</sub>H<sub>29</sub>N<sub>3</sub>O.H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 1-(3-(4-Phenethylpiperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>14</b>)</h5><div class="NLM_p last">This was prepared starting from 4-phenethylpiperazine: 50% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.90 (m, 2H), 2.36–2.87 (m, 18H), 3.97 (t, <i>J</i> = 7.5 Hz, 2H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 7.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.14–7.35 (m, 7H). The free base was transformed into the hydrochloride salt, which was crystallized from 2-PrOH: ESI/MS <i>m</i>/<i>z</i> 378.2 (M + H<sup>+</sup>). Anal. Calcd. (C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O.HCl) C, H, N.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Biology</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> D<sub>2</sub>-like Radioligand Binding Assays</h4><div class="NLM_p">Membranes were prepared from HEK293 cells stably expressing human D<sub>2</sub>, D<sub>3</sub>, or D<sub>4</sub>, grown in a 50:50 mix of DMEM and Ham’s F12 culture media, supplemented with 20 mM HEPES, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 0.1 mM nonessential amino acids, 1× antibiotic/antimycotic, 10% heat-inactivated fetal bovine serum, and 200 μg/mL hygromycin (Life Technologies, Grand Island, NY), and kept in an incubator at 37 °C and 5% CO<sub>2</sub>. Upon reaching 80–90% confluence, cells were harvested using premixed Earle’s Balanced Salt Solution (EBSS) with 5 mM EDTA (Life Technologies) and centrifuged at 3000 rpm for 10 min at 21 °C. The supernatant was removed, and the pellet was resuspended in 10 mL of hypotonic lysis buffer (5 mM MgCl<sub>2</sub>, 5 mM Tris, pH 7.4 at 4 °C) and centrifuged at 20,000 rpm for 30 min at 4 °C. The pellet was then resuspended in fresh EBSS buffer made from 8.7 g/L Earle’s Balanced Salts without phenol red (US Biological, Salem, MA) and 2.2 g/L sodium bicarbonate, pH to 7.4. A Bradford protein assay (Bio-Rad, Hercules, CA) was used to determine the protein concentration, and membranes were diluted to 500 μg/mL and stored at −80 °C for later use.</div><div class="NLM_p last">Radioligand competition binding experiments were conducted using thawed membranes. Test compounds were freshly dissolved in 30% DMSO and 70% H<sub>2</sub>O to a stock concentration of 10 mM or 100 μM. Each test compound was then diluted into 10 half-log serial dilutions using 30% DMSO vehicle. Previously frozen membranes were diluted in fresh EBSS to a 200 μg/mL (for D<sub>2</sub> or D<sub>3</sub>) or 300 μg/mL (D<sub>4</sub>) stock for binding. Radioligand competition experiments were conducted in 96-well plates containing 300 μL of fresh EBSS buffer, 50 μL of diluted test compound, 100 μL of membranes (20 μg total protein for D<sub>2</sub> or D<sub>3</sub>, 30 μg total protein for D<sub>4</sub>), and 50 μL of [<sup>3</sup>H]<i>N</i>-methylspiperone (0.4 nM final concentration; PerkinElmer). Nonspecific binding was determined using 10 μM (+)-butaclamol (Sigma-Aldrich, St. Louis, MO), and total binding was determined with 30% DMSO vehicle. All compound dilutions were tested in duplicate, and the reaction was incubated for 1 h at room temperature. The reaction was terminated by filtration through a PerkinElmer Uni-Filter-96 GF/B, presoaked for 60 min in 0.5% polyethylenimine, using a Brandel 96-well plate Harvester manifold (Brandel Instruments, Gaithersburg, MD). The filters were washed three times with 3 mL (3 × 1 mL/well) of ice-cold binding buffer. Then 65 μL of PerkinElmer MicroScint 20 scintillation cocktail was added to each well, and filters were counted using a PerkinElmer MicroBeta microplate counter (calculated efficiency: 56%). IC<sub>50</sub> values for each compound were determined from dose–response curves, and <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff equation; <i>K</i><sub>d</sub> values for [<sup>3</sup>H]<i>N</i>-methylspiperone were determined via separate homologous competitive binding experiments. These analyses were performed using GraphPad Prism version 6.00 for Macintosh (GraphPad Software, San Diego, CA). <i>K</i><sub>i</sub> values were determined from at least three independent experiments and are reported as mean ± SEM.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Muscarinic Radioligand Binding Assays</h4><div class="NLM_p">CHO cells stably transfected with the human muscarinic receptors (hM<sub>1–5</sub>) were grown in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum and 100 units/mL each of penicillin G and streptomycin (Sigma–Aldrich, Milano, Italy), 4 mM glutamine (Sigma–Aldrich, Milano, Italy), nonessential amino acid solution 100× (Sigma–Aldrich, Milano, Italy), and 50 μg/mL of G-418 (Gibco, Grand Iland, NY) at 37 °C under 5% CO<sub>2</sub>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Cells were grown to confluence, trypsinized, and harvested with PBS buffer (25 mM sodium phosphate, containing 5 mM MgCl<sub>2</sub> at pH 7.4). Cells were suspended in ice-cold PBS buffer and homogenized for 30 s using an Ultra-Turrax (setting 5) (IKA-Werke GmbH & Co. KG, Staufen, Germany). The homogenate was then pelleted by centrifugation (17,000<i>g</i> for 15 min at 4 °C), and the membranes were resuspended in the same buffer, rehomogenized in PBS with Ultra-Turrax, and stored at 80 °C. The protein content was measured according to the method of Bradford<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> using the Bio-Rad protein assay reagent (Bio-Rad Laboratories, Munchen, Germany).</div><div class="NLM_p last">All binding assays were conducted in a 250 μL mixture of binding buffer (25 mM sodium phosphate pH 7.4 containing 5 mM MgCl<sub>2</sub>) in a 96-well plate (Sarstedt, Verona, Italy) and thawed membranes (25–70 μg/mL).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In ligand inhibition binding assays, 0.2 nM [<sup>3</sup>H]<i>N</i>-methylscopolamine chloride ([<sup>3</sup>H]NMS, PerkinElmer Life and Analytical Science, Monza, Italy) and the test ligands (concentrations ranging from 0.1 nM to 1 mM) were used. The samples were incubated for 2 h at room temperature. Nonspecific binding was determined in the presence of 10 μM atropine. In all assays, the total binding was always less than 10% of the total counts added. Incubation was terminated by rapid filtration through UniFilter GF/B plates (PerkinElmer Life and Analytical Science, Monza, Italy) using a FilterMate Cell Harvester (PerkinElmer Life and Analytical Science, Monza, Italy). Filters were than washed with ice-cold water and dried before the addition of 25 μL of scintillation liquid Microscint 20 (PerkinElmer Life and Analytical Science, Monza, Italy). The quantity of membrane-bound radioligand was measured by TopCount NXT Microplate Scintillation Counter (PerkinElmer Life and Analytical Science, Monza, Italy). Stock solutions of tested compounds were made in DMSO, and dilutions were usually made in the incubation buffer. DMSO at the highest concentration used (10%) had no effect on binding. Data (specific counts per minute) were analyzed using a four-parameter logistic equation in GraphPad Prism 5.02 (GraphPad Software, San Diego, CA). <i>K</i><sub>d</sub> values for [<sup>3</sup>H]NMS were determined via separate saturation binding experiments, and the affinity estimates for test compounds (p<i>K</i><sub>I</sub>) were calculated from the IC<sub>50</sub> values using the Cheng and Prusoff correction. Data are presented as mean ± SEM of at least three experiments, each one performed in duplicate.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> BRET Assays</h4><div class="NLM_p last">BRET assays were performed in transiently transfected HEK293T cells with the constructs described later. For G protein activation assays, a pair between RLuc8 (renilla luciferase variant, donor) fused Gα subunit–mVenus (yellow fluorescent protein variant, acceptor) fused Gγ subunit was used as described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> For β-arrestin engagement assays, a pair between RLuc8 fused receptor and mVenus fused effector was used as described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Briefly, a constant amount of plasmid cDNA (15 μg total) was transfected into HEK293T cells using polyethylenimine (PEI) (Sigma-Aldrich) in a 1:2 ratio (30 μg PEI) in 10 cm dishes. Cells were maintained in culture with DMEM supplemented with 10% FBS. Experiments were performed ∼48 h post-transfection. Cells were harvested, washed, and resuspended in PBS. Approximately 200,000 cells/well were distributed in 96-well plates, and 5 μM coelenterazine H was added to each well. Two min after the addition of luciferase, substrate ligands were added to each well. Typically, in antagonist mode, a ligand was added 15 min before the addition of agonist. The fluorescence (excitation at 500 nm and emission at 540 nm for 1 s recording in BRET) and luminescence (no filters, 1 s recording) were quantified 2 min after a ligand was added (Mithras LB 940, Berthold). In parallel, the BRET signal from the same batch of cells was determined by quantifying and calculating the ratio of the light emitted by mVenus (510–540 nm) over that emitted by RLuc8 (485 nm). The net BRET values were obtained by subtracting the background determined in cells expressing RLuc8 alone. Results are expressed as the BRET change produced by the corresponding drug. Data and statistical analyses were performed with Prism 5.01 (GraphPad Software). For Gi activation assays, receptor, Gαi1–RLuc8 (RLuc8 inserted at 91st amino acid), β1, and γ2–mVenus (mVenus fused at Nterminus) constructs were transfected. For Gq activation assays, receptor, Gαq–Rluc8 (RLuc8 inserted at 97th amino acid), β1, γ2–mVenus, and Ric8A constructs were transfected. For β-arrestin engagement assays, receptor and β-arrestin2–mVenus (mVenus fused at N-terminus) constructs were transfected. The cDNAs for human D<sub>4</sub>R, M<sub>1</sub>, and M<sub>4</sub> mAChRs were obtained from <a href="http://www.cdna.org" class="extLink">www.cdna.org</a> and tagged with signal peptide (SP),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> followed by a Myc epitope tag (SM hereafter) for surface receptor expression detection. SM receptor constructs were used for the engagement assays. For the receptor–Rluc8 fusion constructs, RLuc8 cDNA sequence was fused to frame the C-terminus of D<sub>4</sub>R, M<sub>1</sub>, and M<sub>4</sub> mAChRs.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Pharmacokinetic Studies</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> In Vivo Pharmacokinetic Profile Assays</h4><div class="NLM_p">All studies described in this article per using mice were done in compliance with national legislation, with Aptuit policy on the Care and Use of Animals, and with related codes of practice. The pharmacokinetic parameters of <b>12</b> were determined following s.c. (bolus) administration in male CD-1 mice of 3 mg free base/kg. Blood and brain samples (<i>n</i> = 3) were withdrawn after 0.083, 0.25, 0.5, 1, 2, 4, and 6 h from administration. The blood was withdrawn in animals anaesthetized by isofluorane, by cardiac puncture; K2EDTA was used as an anticoagulant and stored in wet ice. Within 30 min from withdrawal, blood samples were centrifuged (3000<i>g</i>, 10 min, 4 °C), and two aliquots of 50 μL were diluted with 150 μL of HEPES 0.1 N. The samples were stored at −20 °C up to the day of analysis.</div><div class="NLM_p">Brain samples were collected after decapitation of anaesthetized animals and removal from skull. The samples were stored at −20 °C up to the day of analysis. After defrosting, each brain was weighed, diluted 1:5 with HEPES 0.1 N, and homogenized with Precellys 24 homogenizer, Bertin Instruments (two homogenizations at 6100 rpm for 30″ with 15″ of pause).</div><div class="NLM_p">The calibration curves were prepared the same day of study using a blank matrix from naïve mice. The working solution, obtained by serial dilutions of 50% acetonitrile in water from a stock solution in DMSO and spiking in matrix, were performed by Hamilton Microlab STARlet. The calibration curves were stored at −20 °C up to the day of analysis.</div><div class="NLM_p">The samples were prepared by protein precipitation (two volumes of acetonitrile with 20 ng/mL of Rolipram used as internal standard (IS)) and vortex-mixed for 5 min. After centrifugation (3000<i>g</i>, 10 min, 4 °C), the supernatant were transferred and diluted (1:1.8) with water using Hamilton Microlab STARlet.</div><div class="NLM_p last">The chromatography was performed by using UPLC (ACQUITY UPLC I-Class System-Waters) on a Acquity UPLC BEH C18 1.7 μm (2.1 × 30 mm) using a fast chromatography gradient (1.5 min; phase A 0.1% of formic acid in water, phase B 0.1% of formic acid in acetonitrile; gradient from 95% to 5% A). The mass spectrometer was an AB Sciex triple quadrupole, API4000. The analytes were monitored in MRM using as quantifier channels 350.2/160.2 and 276.1/208.2 for <b>12</b> and IS, respectively. The calibration standard and quality control report for both matrixes are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Computational Details</h3><div class="NLM_p last">The primary sequence of the human D<sub>4</sub>R was retrieved from Uniprot (Id: P21917, DRD4_HUMAN). The corresponding homology model was built by using Modeller9.12<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> based on the resolved structure of the human dopamine D<sub>3</sub> receptor in complex with eticlopride as the template (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>). Among the 10 generated structures, the best models were selected accordingly to both the scores computed by Modeller9.12 (i.e., DOPE and GA341 scores) and the percentages of residues falling in the allowed regions of the Ramachandran plot. The so-selected model was then minimized by keeping fixed the backbone atoms to preserve the predicted folding and underwent a set of structural checks to avoid the occurrence of wrong configurations, unpredicted gaps, <i>cis</i>-peptide bonds, and colliding residues. The so-refined model reveals a percentage of residues falling in the allowed regions of the Ramachandran plot equal to 98.8% (90.3% within the core regions), while the residues within the allowed regions of the chi space correspond to 95.1%. The ligands were simulated in the protonated state and their conformational space was explored by MonteCarlo simulations, which generated 1000 minimized conformers for each ligand. The so-obtained lowest energy structure was then optimized by PM7 semiempirical calculations<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and finally underwent docking simulations. Docking simulations were performed by PLANTS<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> focusing the search on a 13 Å radius sphere around Asp115, which is involved in a key ion-pair with the protonated ligand. For each simulated molecule, 10 poses were generated and ranked by the ChemPLP scoring function with a speed equal to 1. All computed results were minimized and rescored by using ReScore+ as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00265" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00265" class="ext-link">10.1021/acs.jmedchem.8b00265</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Elemental analysis results for compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b>. Experimental details of radioligand binding assays at α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-AR, β<sub>1</sub>- and β<sub>2</sub>-AR, σ<sub>1</sub> receptor, DAT, and SERT. Calibration standard and quality control report for <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf">jm8b00265_si_001.pdf (2.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_002.csv">jm8b00265_si_002.csv (3.52 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00265" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Piergentili</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6135-6826" title="Orcid link">http://orcid.org/0000-0001-6135-6826</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#47262b223434262923352869372e2235202229332e2b2e0732292e24262a692e33"><span class="__cf_email__" data-cfemail="4b2a272e38382a252f3924653b222e392c2e253f2227220b3e2522282a2665223f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Del Bello</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Bonifazi</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse−Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianfabio Giorgioni</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlo Cifani</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Vittoria Micioni Di Bonaventura</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Riccardo Petrelli</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Fontana</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery and Development-DMPK, Aptuit, an Evotec Company, Via A. Fleming, 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerio Mammoli</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery and Development-DMPK, Aptuit, an Evotec Company, Via A. Fleming, 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideaki Yano</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse−Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosanna Matucci</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino
(NEUROFARBA), Sezione di Farmacologia e Tossicologia, Università degli Studi di Firenze, Viale Pieraccini 6, 50139 Firenze, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giulio Vistoli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Farmaceutiche, Università
degli Studi di Milano, Via Mangiagalli 25, 20133 Milano, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3939-5172" title="Orcid link">http://orcid.org/0000-0002-3939-5172</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wilma Quaglia</span> - <span class="hlFld-Affiliation affiliation">Scuola
di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d52e7098-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the University of Camerino (Fondo di Ateneo per la Ricerca 2014-2015) and by the Intramural Research Program of the National Institute on Drug Abuse (NIDA-IRP) (to A.B. and H.Y.). We express our gratitude to Dr. Amy H. Newman and Prof. Mario Giannella for their suggestions and comments for this manuscript, to Michael P. Ellenberger and Adrian M. Guerrero for their technical assistance in the radioligand binding studies, and to Aptuit and the staff that performed the pharmacokinetic assays.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS USED</td></tr><tr><td class="NLM_term">mAChRs</td><td class="NLM_def"><p class="first last">muscarinic acetylcholine receptors</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mitogen activated protein</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">NMS</td><td class="NLM_def"><p class="first last"><i>N</i>-methylscopolamine</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">EBSS</td><td class="NLM_def"><p class="first last">Earle’s Balanced Salt Solution</p></td></tr><tr><td class="NLM_term">CLi</td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum mean concentration</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">IS</td><td class="NLM_def"><p class="first last">internal standard</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span> <span> </span><span class="NLM_article-title">Molecular properties of muscarinic acetylcholine receptors</span>. <i>Proc. Jpn. Acad., Ser. B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.2183/pjab.89.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2183%2Fpjab.89.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WisbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=226-256&author=T.+Haga&title=Molecular+properties+of+muscarinic+acetylcholine+receptors&doi=10.2183%2Fpjab.89.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of muscarinic acetylcholine receptors</span></div><div class="casAuthors">Haga, Tatsuya</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Japan Academy, Series B: Physical and Biological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">226-256</span>CODEN:
                <span class="NLM_cas:coden">PJABDW</span>;
        ISSN:<span class="NLM_cas:issn">0386-2208</span>.
    
            (<span class="NLM_cas:orgname">Nippon Gakushiin</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors, which comprise five subtypes (M1-M5 receptors), are expressed in both the CNS and PNS (particularly the target organs of parasympathetic neurons).  M1-M5 receptors are integral membrane proteins with seven trans-membrane segments, bind with acetylcholine (ACh) in the extracellular phase, and thereafter interact with and activate GTP-binding regulatory proteins (G proteins) in the intracellular phase: M1, M3, and M5 receptors interact with Gq-type G proteins, and M2 and M4 receptors with Gi/Go-type G proteins.  Activated G proteins initiate a no. of intracellular signal transduction systems.  Agonist-bound muscarinic receptors are phosphorylated by G protein-coupled receptor kinases, which initiate their desensitization through uncoupling from G proteins, receptor internalization, and receptor breakdown (down regulation).  Recently the crystal structures of M2 and M3 receptors were detd. and are expected to contribute to the development of drugs targeted to muscarinic receptors.  This paper summarizes the mol. properties of muscarinic receptors with ref. to the historical background and bias to studies performed in our labs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNsRsNbN65t7Vg90H21EOLACvtfcHk0ljEqE6rHgZ8ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WisbnF&md5=a794b04e33ebb4562699767c1776ddc1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2183%2Fpjab.89.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2183%252Fpjab.89.226%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DT.%26atitle%3DMolecular%2520properties%2520of%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DProc.%2520Jpn.%2520Acad.%252C%2520Ser.%2520B%26date%3D2013%26volume%3D89%26spage%3D226%26epage%3D256%26doi%3D10.2183%2Fpjab.89.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonds, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, M. R.</span></span> <span> </span><span class="NLM_article-title">Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3218</span>– <span class="NLM_lpage">3226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1523%2FJNEUROSCI.11-10-03218.1991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1941081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK3MXmsVymu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=3218-3226&author=A.+I.+Leveyauthor=C.+A.+Kittauthor=W.+F.+Simondsauthor=D.+L.+Priceauthor=M.+R.+Brann&title=Identification+and+localization+of+muscarinic+acetylcholine+receptor+proteins+in+brain+with+subtype-specific+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies</span></div><div class="casAuthors">Levey, Allan I.; Kitt, Cheryl A.; Simonds, William F.; Price, Donald L.; Brann, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3218-26</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">The mRNAs encoding 5 genetically distinct muscarinic acetylcholine receptors are present in the central nervous system.  Because of their pharmacol. similarities, it has not been possible to detect the individual encoded proteins; thus, their physiol. functions are not well defined.  To characterize the family of proteins, a panel of subtype-selective antibodies was generated against recombinant muscarinic receptor proteins and shown to bind specifically to each of the cloned receptors.  Using immunopptn., 3 receptor proteins (m1, m2, and m4) accounted for the vast majority of the total solubilized muscarinic binding sites in rat brain.  These receptor subtypes had marked differences in regional and cellular localization as shown by immunocytochem.  The m1-protein was present in cortex and striatum and was localized to cell bodies and neurites, consistent with its role as a major postsynaptic muscarinic receptor.  The m2-receptor protein was abundant in basal forebrain, scattered striatal neurons, mesopontine tegmentum, and cranial motor nuclei; this distribution is similar to that of cholinergic neurons and suggests that m2 is an autoreceptor.  However, m2 was also present in noncholinergic cortical and subcortical structures, providing evidence that this subtype may presynaptically modulate release of other neurotransmitters and/or function postsynaptically.  The m4-receptor was enriched in neostriatum, olfactory tubercle, and islands of Calleja, indicating an important role in extrapyramidal function.  These results clarify the roles of these genetically defined receptor proteins in cholinergic transmission in brain.  Since the nonselective muscarinic drugs used in the treatment of patients with neurol. disease produce many side effects, the characterization of receptor subtypes, including cellular and subcellular localization, will be of great value in defining the targets for the development of more effective and specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGmj58pI1WrVg90H21EOLACvtfcHk0lht4GMQB0A2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsVymu7k%253D&md5=88088860361c6ad23d6ff64730997f68</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.11-10-03218.1991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.11-10-03218.1991%26sid%3Dliteratum%253Aachs%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DKitt%26aufirst%3DC.%2BA.%26aulast%3DSimonds%26aufirst%3DW.%2BF.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DIdentification%2520and%2520localization%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520proteins%2520in%2520brain%2520with%2520subtype-specific%2520antibodies%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26spage%3D3218%26epage%3D3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span> <span> </span><span class="NLM_article-title">Activation of M<sub>1</sub> and M<sub>4</sub> muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia</span>. <i>Neuropsychiatr. Dis. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.2147/NDT.S55104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2147%2FNDT.S55104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=24511233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=183-191&author=D.+J.+Fosterauthor=D.+L.+Choiauthor=P.+J.+Connauthor=J.+M.+Rook&title=Activation+of+M1+and+M4+muscarinic+receptors+as+potential+treatments+for+Alzheimer%E2%80%99s+disease+and+schizophrenia&doi=10.2147%2FNDT.S55104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Foster, Daniel J.; Choi, Derrick L.; Conn, P. Jeffrey; Rook, Jerri M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-191, 9</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and schizophrenia (SZ) are neurol. disorders with overlapping symptomatol., including both cognitive deficits and behavioral disturbances.  Current clin. treatments for both disorders have limited efficacy accompanied by dose-limiting side effects, and ultimately fail to adequately address the broad range of symptoms obsd.  Novel therapeutic options for AD and SZ are needed to better manage the spectrum of symptoms with reduced adverse-effect liability.  Substantial evidence suggests that activation of muscarinic acetylcholine receptors (mAChRs) has the potential to treat both cognitive and psychosis-related symptoms assocd. with numerous central nervous system (CNS) disorders.  However, use of nonselective modulators of mAChRs is hampered by dose-limiting peripheral side effects that limit their clin. utility.  In order to maintain the clin. efficacy without the adverse-effect liability, efforts have been focused on the discovery of compds. that selectively modulate the centrally located M1 and M4 mAChR subtypes.  Previous drug discovery attempts have been thwarted by the highly conserved nature of the acetylcholine site across mAChR subtypes.  However, current efforts by our lab. and others have now focused on modulators that bind to allosteric sites on mAChRs, allowing these compds. to display unprecedented subtype selectivity.  Over the past couple of decades, the discovery of small mols. capable of selectively targeting the M1 or M4 mAChR subtypes has allowed researchers to elucidate the roles of these receptors in regulating cognitive and behavioral disturbances in preclin. animal models.  Here, we provide an overview of these promising preclin. and clin. studies, which suggest that M1- and M4-selective modulators represent viable novel targets with the potential to successfully address a broad range of symptoms obsd. in patients with AD and SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1huQLY2kYMrVg90H21EOLACvtfcHk0lht4GMQB0A2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL&md5=cb4b539ecd830e56559b11ad18358622</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2147%2FNDT.S55104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S55104%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520as%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520schizophrenia%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2014%26volume%3D10%26spage%3D183%26epage%3D191%26doi%3D10.2147%2FNDT.S55104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">M<sub>1</sub> muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer’s disease</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1039/c2md20025b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1039%2Fc2md20025b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=752-762&author=M.+Deckerauthor=U.+Holzgrabe&title=M1+muscarinic+acetylcholine+receptor+allosteric+modulators+as+potential+therapeutic+opportunities+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc2md20025b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2Fc2md20025b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20025b%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DM1%2520muscarinic%2520acetylcholine%2520receptor%2520allosteric%2520modulators%2520as%2520potential%2520therapeutic%2520opportunities%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D752%26epage%3D762%26doi%3D10.1039%2Fc2md20025b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeggo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kew, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melarange, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roopun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teriakidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M<sub>1</sub> muscarinic receptor agonist, 77-LH-28-1</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28-1&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lhcJ4ATx1U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28-1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of bitopic ligand engagement with the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">23817</span>– <span class="NLM_lpage">23837</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.582874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1074%2Fjbc.M114.582874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=25006252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=23817-23837&author=P.+Keovauthor=L.+L%C3%B3pezauthor=S.+M.+Devineauthor=C.+Valantauthor=J.+R.+Laneauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Molecular+mechanisms+of+bitopic+ligand+engagement+with+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.582874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Keov, Peter; Lopez, Laura; Devine, Shane M.; Valant, Celine; Lane, J. Robert; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">23817-23837</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TBPB and 77-LH-28-1 are selective agonists of the M1 muscarinic acetylcholine receptor (mAChR) that may gain their selectivity through a bitopic mechanism, interacting concomitantly with the orthosteric site and part of an allosteric site.  The current study combined site-directed mutagenesis, anal. pharmacol., and mol. modeling to gain further insights into the structural basis underlying binding and signaling by these agonists.  Mutations within the orthosteric binding site caused similar redns. in affinity and signaling efficacy for both selective and prototypical orthosteric ligands.  In contrast, the mutation of residues within transmembrane helix (TM) 2 and the second extracellular loop (ECL2) discriminated between the different classes of ligand.  In particular, ECL2 appears to be involved in the selective binding of bitopic ligands and in coordinating biased agonism between intracellular calcium mobilization and ERK1/2 phosphorylation.  Mol. modeling of the interaction between TBPB and the M1 mAChR revealed a binding pose predicted to extend from the orthosteric site up toward a putative allosteric site bordered by TM2, TM3, and TM7, thus consistent with a bitopic mode of binding.  Overall, these findings provide valuable structural and mechanistic insights into bitopic ligand actions and receptor activation and support a role for ECL2 in dictating the active states that can be adopted by a G protein-coupled receptor.  This may enable greater selective ligand design and development for mAChRs and facilitate improved identification of bitopic ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK1wgCftEmorVg90H21EOLACvtfcHk0lhcJ4ATx1U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSms7rK&md5=4bd6dfe1cf3d516746e579e97b181f29</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.582874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.582874%26sid%3Dliteratum%253Aachs%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520mechanisms%2520of%2520bitopic%2520ligand%2520engagement%2520with%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D23817%26epage%3D23837%26doi%3D10.1074%2Fjbc.M114.582874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, E. C.</span></span> <span> </span><span class="NLM_article-title">Mutagenic mapping suggests a novel binding mode for selective agonists of M<sub>1</sub> muscarinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1124/mol.108.050963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fmol.108.050963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=331-341&author=G.+Lebonauthor=C.+J.+Langmeadauthor=B.+G.+Tehanauthor=E.+C.+Hulme&title=Mutagenic+mapping+suggests+a+novel+binding+mode+for+selective+agonists+of+M1+muscarinic+acetylcholine+receptors&doi=10.1124%2Fmol.108.050963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.050963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.050963%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DHulme%26aufirst%3DE.%2BC.%26atitle%3DMutagenic%2520mapping%2520suggests%2520a%2520novel%2520binding%2520mode%2520for%2520selective%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D331%26epage%3D341%26doi%3D10.1124%2Fmol.108.050963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M<sub>1</sub>-preferring receptor agonists</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>605</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2008.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejphar.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19168056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=605&publication_year=2009&pages=53-56&author=J.+N.+Heinrichauthor=J.+A.+Buteraauthor=T.+Carrickauthor=A.+Kramerauthor=D.+Kowalauthor=T.+Lockauthor=K.+L.+Marquisauthor=M.+H.+Pauschauthor=M.+Popiolekauthor=S.+C.+Sunauthor=E.+Tsengauthor=A.+J.+Uvegesauthor=S.+C.+Mayer&title=Pharmacological+comparison+of+muscarinic+ligands%3A+historical+versus+more+recent+muscarinic+M1-preferring+receptor+agonists&doi=10.1016%2Fj.ejphar.2008.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists</span></div><div class="casAuthors">Heinrich, Julia N.; Butera, John A.; Carrick, Tikva; Kramer, Angela; Kowal, Dianne; Lock, Tim; Marquis, Karen L.; Pausch, Mark H.; Popiolek, Mike; Sun, Shaiu-Ching; Tseng, Eugene; Uveges, Albert J.; Mayer, Scott C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">605</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">53-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In functional assay assessments using the five muscarinic receptor subtypes, a second generation of muscarinic M1-preferring receptor agonists [AC-42 (1), AC-260584 (2), 77-LH-28-1 (3) and LY-593039 (4)] was shown to have higher selectivity for muscarinic M1 over M3 receptor as compared to historical agonists [talsaclidine (8), sabcomeline (10), xanomeline (11), WAY-132983 (12), cevimeline (9) and NGX-267 (6)].  Another striking difference of these more recent compds. is their affinities for the dopamine D2 and 5-HT2B receptors.  Taken together, these results suggest that the newer compds. may have a greater clin. safety profile, esp. with regard to muscarinic M3 receptor-mediated events, than the historical agonists, but their affinities for other receptors may still compromise their use to validate the therapeutic potential of muscarinic M1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmMFFxEgbLVg90H21EOLACvtfcHk0lhH8wJJ0hg1Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D&md5=6654ccca50a1db7447e949f5028093dd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DCarrick%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BC.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26atitle%3DPharmacological%2520comparison%2520of%2520muscarinic%2520ligands%253A%2520historical%2520versus%2520more%2520recent%2520muscarinic%2520M1-preferring%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D605%26spage%3D53%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2008.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhH8wJJ0hg1Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajiness, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, L. V.</span></span> <span> </span><span class="NLM_article-title">Signal transduction pathways modulated by D<sub>2</sub>-like dopamine receptors</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/S1054-3589(08)60786-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2FS1054-3589%2808%2960786-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=454-457&author=R.+M.+Huffauthor=C.+L.+Chioauthor=M.+E.+Lajinessauthor=L.+V.+Goodman&title=Signal+transduction+pathways+modulated+by+D2-like+dopamine+receptors&doi=10.1016%2FS1054-3589%2808%2960786-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1054-3589%2808%2960786-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1054-3589%252808%252960786-3%26sid%3Dliteratum%253Aachs%26aulast%3DHuff%26aufirst%3DR.%2BM.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DLajiness%26aufirst%3DM.%2BE.%26aulast%3DGoodman%26aufirst%3DL.%2BV.%26atitle%3DSignal%2520transduction%2520pathways%2520modulated%2520by%2520D2-like%2520dopamine%2520receptors%26jtitle%3DAdv.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D454%26epage%3D457%26doi%3D10.1016%2FS1054-3589%2808%2960786-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehne, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andree, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, J. N.</span></span> <span> </span><span class="NLM_article-title">D<sub>2</sub> receptor partial agonists: treatment of CNS disorders of dopamine function</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.2174/156802608785161394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2174%2F156802608785161394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=18691133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1068-1088&author=J.+H.+Kehneauthor=T.+H.+Andreeauthor=J.+N.+Heinrich&title=D2+receptor+partial+agonists%3A+treatment+of+CNS+disorders+of+dopamine+function&doi=10.2174%2F156802608785161394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">D2 receptor partial agonists: treatment of CNS disorders of dopamine function</span></div><div class="casAuthors">Kehne, John H.; Andree, Terrance H.; Heinrich, Julia N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1068-1088</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A remarkable diversity of psychiatric and neurol. disorders have been assocd. with dysfunction of dopamine (DA)-contg. neurons, including schizophrenia, bipolar disorder (BD), Parkinson's disease (PD), and restless legs syndrome (RLS).  In such disorders, transmission in discrete DA pathways may range from hypoactivation to hyperactivation of DA receptors, particularly those of the D2 subtype, providing the rationale for treatment approaches that activate or block D2 receptors, resp.  However, full agonists or pure D2 receptor antagonists may not be optimal therapeutic approaches for their resp. disorders for a no. of reasons, including an inability to restore the aberrant DA pathways to a normal level of basal tone.  D2 receptor partial agonists (D2PAs) are proposed to stabilize activity in DA pathways by dampening excessive (and/or by restoring deficient) D2 receptor stimulation thereby shepherding DA neurons back to a desired level of basal activity.  Stabilizing aberrant DA activity without disrupting non-dysfunctional DA neurons may provide a potentially improved approach for treating DA disorders.  The status of DA D2PAs and their potential application to schizophrenia, BD, PD, and RLS is reviewed.  Preclin. and clin. evidence supports the idea that dysfunctions of D2 receptors contribute to these CNS disorders.  Diseases in which both hyper- and hypofunction of DA pathways are present may be particularly promising, and challenging, targets for D2PAs.  Furthermore, different DA disorders may respond optimally to D2PAs with differing levels of intrinsic activity, with "DA deficiency" diseases responding more effectively to higher intrinsic activity D2PAs than "DA hyperactivation" diseases.  Overall, current evidence supports the conclusion that D2PAs have significant potential as improved CNS therapies relative to classic full agonists and antagonists at D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXnz0ClAI_LVg90H21EOLACvtfcHk0ljTJgogvuXDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtbw%253D&md5=e2501665b430e96d34941f0101b98190</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802608785161394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161394%26sid%3Dliteratum%253Aachs%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26atitle%3DD2%2520receptor%2520partial%2520agonists%253A%2520treatment%2520of%2520CNS%2520disorders%2520of%2520dopamine%2520function%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1068%26epage%3D1088%26doi%3D10.2174%2F156802608785161394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. H. F.</span>; <span class="NLM_string-name">Wong, A. H. C.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptor genetics in neuropsychiatric disorders</span>. In  <i>The Dopamine Receptors</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, K. A.</span></span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">632</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1007%2F978-1-60327-333-6_19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=585-632&author=F.+H.+F.+Lee&author=A.+H.+C.+Wongauthor=K.+A.+Neve&title=The+Dopamine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-333-6_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-60327-333-6_19%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DF.%2BH.%2BF.%26atitle%3DDopamine%2520receptor%2520genetics%2520in%2520neuropsychiatric%2520disorders%26btitle%3DThe%2520Dopamine%2520Receptors%26aulast%3DNeve%26aufirst%3DK.%2BA.%26pub%3DHumana%2520Press%26date%3D2010%26spage%3D585%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enna, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Challenges in the search for drugs to treat central nervous system disorders</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.143420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fjpet.108.143420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19182069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Omuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=404-411&author=S.+J.+Ennaauthor=M.+Williams&title=Challenges+in+the+search+for+drugs+to+treat+central+nervous+system+disorders&doi=10.1124%2Fjpet.108.143420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the search for drugs to treat central nervous system disorders</span></div><div class="casAuthors">Enna, S. J.; Williams, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-411</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The history of drug discovery spans approx. 200,000 years.  For much of this time, the identification of therapeutic agents was empirical, with the shift to a more hypothesis-driven approach occurring in the late 19th century.  Since then, the objective has changed from identifying an active drug and its mechanism of action to detg. therapeutic potential only after identifying drug-like compds. that interact with a target site.  Although the emphasis on target identification, or targephilia, has yielded novel drugs, overall it appears to have slowed the drug discovery process, esp. for compds. used in treating central nervous system (CNS) disorders.  This is because the targephilic approach requires a good understanding of target physiol. and its integration with the target organ, with a hierarchical integration from in vitro cellular and functional tissue studies to animal models that reasonably predict human responses.  Because the majority of CNS drugs were discovered empirically, drug discovery in this area appears less amenable to target-based approaches than it seems for other types of therapeutics.  Improving the success rate in CNS drug discovery requires a more pharmacometric-based approach, with a renewed emphasis on defining basic CNS function in intact animals and a more systematic in vivo screening of novel structures.  Efforts must also be directed toward defining the sites of action of existing CNS drugs to aid in the design of second-generation agents with improved efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE5W5Q6hNLP7Vg90H21EOLACvtfcHk0ljTJgogvuXDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Omuro%253D&md5=3b19e9402d08d3e722e6a445b4714d57</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143420%26sid%3Dliteratum%253Aachs%26aulast%3DEnna%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DChallenges%2520in%2520the%2520search%2520for%2520drugs%2520to%2520treat%2520central%2520nervous%2520system%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D404%26epage%3D411%26doi%3D10.1124%2Fjpet.108.143420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Tol, H. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D<sub>4</sub> receptor with high affinity for the antipsychotic clozapine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/350610a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+M.+Van%0ATolauthor=J.+R.+Bunzowauthor=H.-C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine&doi=10.1038%2F350610a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0lgqW1A7c9TtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614%26doi%3D10.1038%2F350610a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span> <span> </span><span class="NLM_article-title">The return of D<sub>4</sub> dopamine receptor antagonists in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7233</span>– <span class="NLM_lpage">7243</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7233-7243&author=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=The+return+of+D4+dopamine+receptor+antagonists+in+drug+discovery&doi=10.1021%2Facs.jmedchem.7b00151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00151%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DThe%2520return%2520of%2520D4%2520dopamine%2520receptor%2520antagonists%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7233%26epage%3D7243%26doi%3D10.1021%2Facs.jmedchem.7b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the search for D<sub>3</sub>- and D<sub>4</sub>-selective drugs: probes, models and candidates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2eZrJoXDojTDQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeyer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">PR123</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1021/cr300113a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300113a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR123-178&author=N.+Yeauthor=J.+L.+Neumeyerauthor=R.+J.+Baldessariniauthor=X.+Zhenauthor=A.+Zhang&title=Update+1+of%3A+Recent+progress+in+development+of+dopamine+receptor+subtype-selective+agents%3A+potential+therapeutics+for+neurological+and+psychiatric+disorders&doi=10.1021%2Fcr300113a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300113a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DZhen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DUpdate%25201%2520of%253A%2520Recent%2520progress%2520in%2520development%2520of%2520dopamine%2520receptor%2520subtype-selective%2520agents%253A%2520potential%2520therapeutics%2520for%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR123%26epage%3D178%26doi%3D10.1021%2Fcr300113a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackling, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D<sub>3</sub> receptor ligands</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1002/cbic.200300784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbic.200300784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=15185375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1OmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=508-518&author=U.+R.+Machauthor=A.+E.+Hacklingauthor=S.+Perachonauthor=S.+Ferryauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=P.+Sokoloffauthor=H.+Stark&title=Development+of+novel+1%2C2%2C3%2C4-tetrahydroisoquinoline+derivatives+and+closely+related+compounds+as+potent+and+selective+dopamine+D3+receptor+ligands&doi=10.1002%2Fcbic.200300784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands</span></div><div class="casAuthors">Mach, Ulrich R.; Hackling, Anneke E.; Perachon, Sylvie; Ferry, Sandrine; Wermuth, Camille G.; Schwartz, Jean-Charles; Sokoloff, Pierre; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Based on N-alkylated 1,2,3,4-tetrahydroisoquinoline derivs. which are structurally related to the partial agonist BP 897, a series of novel, selective dopamine D3 receptor antagonists has been synthesized.  Derivatization included changes in the arylamide moiety and the tetrahydroisoquinoline substructure leading to compds. with markedly improved selectivities and affinities in the low nanomolar concn. range.  From the 55 structures presented here, (E)-3-(4-iodophenyl)-N-(4-(1,2,3,4-tetrahydroisoquinolin-2-yl)butyl)acrylamide (51) has high affinity (Ki(hD3) = 12 nM) and a 123-fold preference for the D3 receptor relative to the D2 receptor subtype.  Its pharmacol. profile offers the prospect of a novel radioligand as a tool for various dopamine D3-receptor-related in vitro and in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg7zhWvn6mRLVg90H21EOLACvtfcHk0livu2OyOWI_Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1OmtLg%253D&md5=580665e16ce2e75a349d1c301e1916ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300784%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DU.%2BR.%26aulast%3DHackling%26aufirst%3DA.%2BE.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520novel%25201%252C2%252C3%252C4-tetrahydroisoquinoline%2520derivatives%2520and%2520closely%2520related%2520compounds%2520as%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D508%26epage%3D518%26doi%3D10.1002%2Fcbic.200300784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Areias, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D<sub>2</sub> and D<sub>3</sub> receptors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcmdc.201000101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1300-1317&author=L.+L%C3%B3pezauthor=J.+Selentauthor=R.+Ortegaauthor=C.+F.+Masaguerauthor=E.+Dom%C3%ADnguezauthor=F.+Areiasauthor=J.+Breaauthor=M.+I.+Lozaauthor=F.+Sanzauthor=M.+Pastor&title=Synthesis%2C+3D-QSAR%2C+and+structural+modeling+of+benzolactam+derivatives+with+binding+affinity+for+the+D2+and+D3+receptors&doi=10.1002%2Fcmdc.201000101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000101%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DR.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DE.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DPastor%26aufirst%3DM.%26atitle%3DSynthesis%252C%25203D-QSAR%252C%2520and%2520structural%2520modeling%2520of%2520benzolactam%2520derivatives%2520with%2520binding%2520affinity%2520for%2520the%2520D2%2520and%2520D3%2520receptors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1300%26epage%3D1317%26doi%3D10.1002%2Fcmdc.201000101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1–[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9065</span>– <span class="NLM_lpage">9077</span>, <span class="refDoi"> DOI: 10.1021/jm501173q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501173q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9065-9077&author=A.+Bonifaziauthor=H.+Yanoauthor=F.+Del+Belloauthor=A.+Farandeauthor=W.+Quagliaauthor=R.+Petrelliauthor=R.+Matucciauthor=M.+Nesiauthor=G.+Vistoliauthor=S.+Ferr%C3%A9author=A.+Piergentili&title=Synthesis+and+biological+evaluation+of+a+novel+series+of+heterobivalent+muscarinic+ligands+based+on+xanomeline+and+1%E2%80%93%5B3-%284-butylpiperidin-1-yl%29propyl%5D-1%2C2%2C3%2C4-tetrahydroquinolin-2-one+%2877-LH-28-1%29&doi=10.1021%2Fjm501173q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501173q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501173q%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DA.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DPiergentili%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520heterobivalent%2520muscarinic%2520ligands%2520based%2520on%2520xanomeline%2520and%25201%25E2%2580%2593%255B3-%25284-butylpiperidin-1-yl%2529propyl%255D-1%252C2%252C3%252C4-tetrahydroquinolin-2-one%2520%252877-LH-28-1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9065%26epage%3D9077%26doi%3D10.1021%2Fjm501173q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havera, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDyke, J. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancilio, L. F.</span></span> <span> </span><span class="NLM_article-title">Analgetic activity of cyclized basic anilides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm00304a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00304a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=580-583&author=H.+J.+Haveraauthor=J.+W.+VanDykeauthor=T.+M.+Liuauthor=L.+F.+Sancilio&title=Analgetic+activity+of+cyclized+basic+anilides&doi=10.1021%2Fjm00304a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00304a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00304a004%26sid%3Dliteratum%253Aachs%26aulast%3DHavera%26aufirst%3DH.%2BJ.%26aulast%3DVanDyke%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DT.%2BM.%26aulast%3DSancilio%26aufirst%3DL.%2BF.%26atitle%3DAnalgetic%2520activity%2520of%2520cyclized%2520basic%2520anilides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D580%26epage%3D583%26doi%3D10.1021%2Fjm00304a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+T.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lgvjjTss7W7OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sams, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plath, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M<sub>1</sub> receptor agonist with unprecedented selectivity and procognitive potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6386</span>– <span class="NLM_lpage">6397</span>, <span class="refDoi"> DOI: 10.1021/jm100697g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100697g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6386-6397&author=A.+G.+Samsauthor=M.+Hentzerauthor=G.+K.+Mikkelsenauthor=K.+Larsenauthor=C.+Bundgaardauthor=N.+Plathauthor=C.+T.+Christoffersenauthor=B.+Bang-Andersen&title=Discovery+of+N-%7B1-%5B3-%283-oxo-2%2C3-dihydrobenzo%5B1%2C4%5Doxazin-4-yl%29propyl%5Dpiperidin-4-yl%7D-2-phenylacetamide+%28Lu+AE51090%29%3A+an+allosteric+muscarinic+M1+receptor+agonist+with+unprecedented+selectivity+and+procognitive+potential&doi=10.1021%2Fjm100697g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm100697g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100697g%26sid%3Dliteratum%253Aachs%26aulast%3DSams%26aufirst%3DA.%2BG.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DLarsen%26aufirst%3DK.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DPlath%26aufirst%3DN.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520N-%257B1-%255B3-%25283-oxo-2%252C3-dihydrobenzo%255B1%252C4%255Doxazin-4-yl%2529propyl%255Dpiperidin-4-yl%257D-2-phenylacetamide%2520%2528Lu%2520AE51090%2529%253A%2520an%2520allosteric%2520muscarinic%2520M1%2520receptor%2520agonist%2520with%2520unprecedented%2520selectivity%2520and%2520procognitive%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6386%26epage%3D6397%26doi%3D10.1021%2Fjm100697g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micioni Di Bonaventura, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggesi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">The replacement of the 2-methoxy substituent of <i>N</i>-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT<sub>1A</sub> receptor over α<sub>1</sub>-adrenoceptor and D<sub>2</sub>-like receptor subtypes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejmech.2016.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27662034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGrt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=233-244&author=F.+Del%0ABelloauthor=A.+Bonifaziauthor=M.+Giannellaauthor=G.+Giorgioniauthor=A.+Piergentiliauthor=R.+Petrelliauthor=C.+Cifaniauthor=M.+V.+Micioni+Di+Bonaventuraauthor=T.+M.+Keckauthor=A.+Mazzolariauthor=G.+Vistoliauthor=A.+Ciliaauthor=E.+Poggesiauthor=R.+Matucciauthor=W.+Quaglia&title=The+replacement+of+the+2-methoxy+substituent+of+N-%28%286%2C6-diphenyl-1%2C4-dioxan-2-yl%29methyl%29-2-%282-methoxyphenoxy%29ethan-1-amine+improves+the+selectivity+for+5-HT1A+receptor+over+%CE%B11-adrenoceptor+and+D2-like+receptor+subtypes&doi=10.1016%2Fj.ejmech.2016.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes</span></div><div class="casAuthors">Del Bello, Fabio; Bonifazi, Alessandro; Giannella, Mario; Giorgioni, Gianfabio; Piergentili, Alessandro; Petrelli, Riccardo; Cifani, Carlo; Micioni Di Bonaventura, Maria Vittoria; Keck, Thomas M.; Mazzolari, Angelica; Vistoli, Giulio; Cilia, Antonio; Poggesi, Elena; Matucci, Rosanna; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine (I) is a potent 5-HT1A receptor and α1d-adrenoceptor (α1d-AR) ligand.  Analogs II [X = CH, R = Cl, Me, NO2, OH, OCH2OMe; X = N, R = H] were rationally designed and prepd. to evaluate whether electronic and/or lipophilic properties of substituents in the ortho position of its phenoxy moiety exert any favorable effects on the affinity/activity at 5-HT1A receptor and improve selectivity over α1-ARs.  To rationalize the exptl. observations and derive information about receptor-ligand interactions of the reported ligands, docking studies, using 5-HT1A and α1d-AR models generated by homol. techniques, and a retrospective computational study were performed.  The results highlighted that proper substituents in position 2 of the phenoxy moiety of 3 selectively address the ligands toward 5-HT1A receptor with respect to α1-ARs and D2-like receptor subtypes.  Methoxymethylenoxy deriv. II [X = CH, R = OCH2OMe] showed the best 5-HT1A selectivity profile and the highest potency at 5-HT1A receptor, behaving as a partial agonist.  Finally, II [X = CH, R = OCH2OMe], tested in light/dark exploration test in mice, significantly reduced anxiety-linked behaviors.  Therefore, it may be considered a lead for the design of partial agonists potentially useful in the treatment of disorders in which 5-HT1A receptor is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE3SWsDcqoKLVg90H21EOLACvtfcHk0lgkejwCZt61gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGrt7jN&md5=d0d0c386b3f910521042565ed32ba839</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMicioni%2BDi%2BBonaventura%26aufirst%3DM.%2BV.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DCilia%26aufirst%3DA.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DThe%2520replacement%2520of%2520the%25202-methoxy%2520substituent%2520of%2520N-%2528%25286%252C6-diphenyl-1%252C4-dioxan-2-yl%2529methyl%2529-2-%25282-methoxyphenoxy%2529ethan-1-amine%2520improves%2520the%2520selectivity%2520for%25205-HT1A%2520receptor%2520over%2520%25CE%25B11-adrenoceptor%2520and%2520D2-like%2520receptor%2520subtypes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D233%26epage%3D244%26doi%3D10.1016%2Fj.ejmech.2016.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Ben, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Soto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span> <span> </span><span class="NLM_article-title">A novel class of dopamine D<sub>4</sub> receptor ligands bearing an imidazoline nucleus</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcmdc.201600022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=26990230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1819-1828&author=V.+Mammoliauthor=A.+Bonifaziauthor=D.+Dal+Benauthor=M.+Giannellaauthor=G.+Giorgioniauthor=A.+Piergentiliauthor=M.+Piginiauthor=W.+Quagliaauthor=A.+Thomasauthor=A.+H.+Newmanauthor=S.+Ferr%C3%A9author=M.+Sanchez-Sotoauthor=T.+M.+Keckauthor=F.+Del+Bello&title=A+novel+class+of+dopamine+D4+receptor+ligands+bearing+an+imidazoline+nucleus&doi=10.1002%2Fcmdc.201600022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus</span></div><div class="casAuthors">Mammoli, Valerio; Bonifazi, Alessandro; Dal Ben, Diego; Giannella, Mario; Giorgioni, Gianfabio; Piergentili, Alessandro; Pigini, Maria; Quaglia, Wilma; Thomas, Ajiroghene; Newman, Amy H.; Ferre, Sergi; Sanchez-Soto, Marta; Keck, Thomas M.; Del Bello, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1819-1828</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Over the years, the 2-substituted imidazoline nucleus has been demonstrated to be a bioversatile structural motif.  In this study, novel imidazoline derivs. bearing a 3- and/or 4-hydroxy- or methoxy-substituted Ph ring, linked by an ethylene bridge to position 2 of an N-benzyl- or N-phenethyl-substituted imidazoline nucleus, were prepd. and studied against D2-like receptor subtypes.  Binding studies highlighted that a set of N-phenethylimidazoline compds. are selective for D4 over D2 and D3 receptors.  In functional assays, the 3-methoxy-substituted deriv., endowed with the highest D4 affinity value, and its 3-hydroxy analog behaved as partial agonists with low intrinsic efficacy and as competitive D4 antagonists when tested in the presence of the D2-like receptor agonist quinpirole.  Mol. docking anal., performed using a homol. model of the human D4 receptor developed using the X-ray crystal structure of the antagonist-bound human D3 receptor as a template, was in accordance with the binding results and provided useful information for the design of novel imidazoline D4 receptor ligands based on this new scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWnSDaWqXh7Vg90H21EOLACvtfcHk0lgkejwCZt61gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlKlsLo%253D&md5=ff32a504bf4e28810262bfad7e87a9cb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600022%26sid%3Dliteratum%253Aachs%26aulast%3DMammoli%26aufirst%3DV.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DSanchez-Soto%26aufirst%3DM.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DDel%2BBello%26aufirst%3DF.%26atitle%3DA%2520novel%2520class%2520of%2520dopamine%2520D4%2520receptor%2520ligands%2520bearing%2520an%2520imidazoline%2520nucleus%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1819%26epage%3D1828%26doi%3D10.1002%2Fcmdc.201600022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (I<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgkejwCZt61gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcicchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span> <span> </span><span class="NLM_article-title">Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejmech.2017.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=28609709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=327-337&author=F.+Del%0ABelloauthor=A.+Bonifaziauthor=G.+Giorgioniauthor=R.+Petrelliauthor=W.+Quagliaauthor=A.+Altomareauthor=A.+Falcicchioauthor=R.+Matucciauthor=G.+Vistoliauthor=A.+Piergentili&title=Novel+muscarinic+acetylcholine+receptor+hybrid+ligands+embedding+quinuclidine+and+1%2C4-dioxane+fragments&doi=10.1016%2Fj.ejmech.2017.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments</span></div><div class="casAuthors">Del Bello, Fabio; Bonifazi, Alessandro; Giorgioni, Gianfabio; Petrelli, Riccardo; Quaglia, Wilma; Altomare, Angela; Falcicchio, Aurelia; Matucci, Rosanna; Vistoli, Giulio; Piergentili, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-337</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To obtain novel muscarinic acetylcholine receptor (mAChR) antagonists, the enantiomers of the hybrid compds. (I (R = H, Me), II), in which the quinuclidin-3-yloxy fragment of solifenacin and the 6,6-diphenyl-1,4-dioxane-2-yl moiety linked by an ester or ether spacer were embedded in the same chem. entity, were prepd. and evaluated for their affinity at the five mAChR subtypes (M1-M5).  Stereochem. and the nature of the linker between the quinuclidine moiety and the 1,4-dioxane nucleus play an important role on the affinities of the compds.  The presence of an ether bridge confers higher affinities for all mAChR subtypes to the ligand.  Interestingly, the ether enantiomer (R,S)-II shows the highest affinity at all mAChR subtypes with pKi values similar to that of solifenacin at M3 and higher at the other subtypes.  Unlike solifenacin, it shows a preference for M1 mAChR subtype with respect to the other subtypes.  This compd., lacking a permanent pos. charge on the nitrogen atom, can be a useful tool for the pharmacol. study of mAChRs in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOfeZ1yf6kuLVg90H21EOLACvtfcHk0lgg9wD_9OE9bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjur3P&md5=31008476052c3ff0a6ac7a01621ae8e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DFalcicchio%26aufirst%3DA.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26atitle%3DNovel%2520muscarinic%2520acetylcholine%2520receptor%2520hybrid%2520ligands%2520embedding%2520quinuclidine%2520and%25201%252C4-dioxane%2520fragments%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D137%26spage%3D327%26epage%3D337%26doi%3D10.1016%2Fj.ejmech.2017.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guandalini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanelli, M. N.</span></span> <span> </span><span class="NLM_article-title">Carbachol dimers as homobivalent modulators of muscarinic receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.bcp.2016.03.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=90-101&author=R.+Matucciauthor=M.+Nesiauthor=M.+V.+Martinoauthor=C.+Bellucciauthor=D.+Manettiauthor=E.+Ciutiauthor=A.+Mazzolariauthor=S.+Deiauthor=L.+Guandaliniauthor=E.+Teodoriauthor=G.+Vistoliauthor=M.+N.+Romanelli&title=Carbachol+dimers+as+homobivalent+modulators+of+muscarinic+receptors&doi=10.1016%2Fj.bcp.2016.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DMartino%26aufirst%3DM.%2BV.%26aulast%3DBellucci%26aufirst%3DC.%26aulast%3DManetti%26aufirst%3DD.%26aulast%3DCiuti%26aufirst%3DE.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26atitle%3DCarbachol%2520dimers%2520as%2520homobivalent%2520modulators%2520of%2520muscarinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D108%26spage%3D90%26epage%3D101%26doi%3D10.1016%2Fj.bcp.2016.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farfariello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggesi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships in 1,4-benzodioxan-related compounds. 11. Reversed enantioselectivity of 1,4-dioxane derivatives in α<sub>1</sub>-adrenergic and 5-HT<sub>1A</sub> receptor binding sites recognition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1021/jm301525w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301525w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKhurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=584-588&author=A.+Bonifaziauthor=A.+Piergentiliauthor=F.+Del+Belloauthor=Y.+Farandeauthor=M.+Giannellaauthor=M.+Piginiauthor=C.+Amantiniauthor=M.+Nabissiauthor=V.+Farfarielloauthor=G.+Santoniauthor=E.+Poggesiauthor=A.+Leonardiauthor=S.+Menegonauthor=W.+Quaglia&title=Structure%E2%80%93activity+relationships+in+1%2C4-benzodioxan-related+compounds.+11.+Reversed+enantioselectivity+of+1%2C4-dioxane+derivatives+in+%CE%B11-adrenergic+and+5-HT1A+receptor+binding+sites+recognition&doi=10.1021%2Fjm301525w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11. Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1-Adrenergic and 5-HT1A Receptor Binding Sites Recognition</span></div><div class="casAuthors">Bonifazi, Alessandro; Piergentili, Alessandro; Del Bello, Fabio; Farande, Yogita; Giannella, Mario; Pigini, Maria; Amantini, Consuelo; Nabissi, Massimo; Farfariello, Valerio; Santoni, Giorgio; Poggesi, Elena; Leonardi, Amedeo; Menegon, Sergio; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">584-588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-HT1A receptor and α1-adrenoreceptor (α1-AR) binding sites recognized by the 1,4-dioxanes 2-4 display reversed stereochem. requirements. (S)-2 proved to be a potent 5-HT1A receptor agonist highly selective over α1-AR subtypes.  Chirality influenced the anticancer activity of 3 and 4 in human prostate cancer cells (PC-3): (R)-4, eutomer at the α1d-AR subtype, was the most potent.  The decreased effect of 4 and (R)-4 in α1d-AR silenced PC-3 cells confirmed that their anticancer activity was α1d-AR-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Q-LN9OxlA7Vg90H21EOLACvtfcHk0lgg9wD_9OE9bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKhurjJ&md5=1ddde77a863997976e8b1f1380c3afc0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301525w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301525w%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DY.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DFarfariello%26aufirst%3DV.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%25201%252C4-benzodioxan-related%2520compounds.%252011.%2520Reversed%2520enantioselectivity%2520of%25201%252C4-dioxane%2520derivatives%2520in%2520%25CE%25B11-adrenergic%2520and%25205-HT1A%2520receptor%2520binding%2520sites%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D584%26epage%3D588%26doi%3D10.1021%2Fjm301525w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barocelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flammini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Novel potent <i>N</i>-methyl-D-aspartate (NMDA) receptor antagonists or σ<sub>1</sub> receptor ligands based on properly substituted 1,4-dioxane ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8601</span>– <span class="NLM_lpage">8615</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01214</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01214" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8601-8615&author=A.+Bonifaziauthor=F.+Del+Belloauthor=V.+Mammoliauthor=A.+Piergentiliauthor=R.+Petrelliauthor=C.+Cimarelliauthor=M.+Pelleiauthor=D.+Schepmannauthor=B.+W%C3%BCnschauthor=E.+Barocelliauthor=S.+Bertoniauthor=L.+Flamminiauthor=C.+Amantiniauthor=M.+Nabissiauthor=G.+Santoniauthor=G.+Vistoliauthor=W.+Quaglia&title=Novel+potent+N-methyl-D-aspartate+%28NMDA%29+receptor+antagonists+or+%CF%831+receptor+ligands+based+on+properly+substituted+1%2C4-dioxane+ring&doi=10.1021%2Facs.jmedchem.5b01214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Potent N-Methyl-D-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring</span></div><div class="casAuthors">Bonifazi, Alessandro; Del Bello, Fabio; Mammoli, Valerio; Piergentili, Alessandro; Petrelli, Riccardo; Cimarelli, Cristina; Pellei, Maura; Schepmann, Dirk; Wunsch, Bernhard; Barocelli, Elisabetta; Bertoni, Simona; Flammini, Lisa; Amantini, Consuelo; Nabissi, Massimo; Santoni, Giorgio; Vistoli, Giulio; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8601-8615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepd. to interact either with the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA) receptor or with σ1 receptors, resp.  The biol. profiles of the novel compds. were assessed using radioligand binding assays, and the compds. with the highest affinities were investigated for their functional activity.  The results were in line with the available pharmacophore models and highlighted that the 1,4-dioxane scaffold is compatible with potent antagonist activity at NMDA receptor or high affinity for σ1 receptors.  The primary amines I [R = C6H11, trans] and I [R = Ph] bearing a cyclohexyl and a Ph ring or two Ph rings in position 6, resp., were the most potent noncompetitive antagonists at the NMDA receptor with IC50 values similar to those of the dissociative anesthetic (S)-(+)-ketamine.  The 5,5-di-Ph substitution assocd. with a benzylaminomethyl moiety in position 2, as in II, favored the interaction with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom9Lw-lUtPSLVg90H21EOLACvtfcHk0lhAWmC0B5hUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slsb%252FN&md5=0c053c67bc8f4f3449c1af2a3470df2e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01214%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DMammoli%26aufirst%3DV.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DCimarelli%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26aulast%3DBarocelli%26aufirst%3DE.%26aulast%3DBertoni%26aufirst%3DS.%26aulast%3DFlammini%26aufirst%3DL.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DNovel%2520potent%2520N-methyl-D-aspartate%2520%2528NMDA%2529%2520receptor%2520antagonists%2520or%2520%25CF%25831%2520receptor%2520ligands%2520based%2520on%2520properly%2520substituted%25201%252C4-dioxane%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8601%26epage%3D8615%26doi%3D10.1021%2Facs.jmedchem.5b01214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and high affinity 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10676</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10676-10691&author=J.+Caoauthor=R.+D.+Slackauthor=O.+M.+Bakareauthor=C.+Burzynskiauthor=R.+Raisauthor=B.+S.+Slusherauthor=T.+Kopajticauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=H.+Yanoauthor=Y.+Heauthor=G.-H.+Biauthor=Z.-X.+Xiauthor=C.+J.+Lolandauthor=A.+H.+Newman&title=Novel+and+high+affinity+2-%5B%28diphenylmethyl%29sulfinyl%5Dacetamide+%28modafinil%29+analogues+as+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.6b01373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Cao, Jianjing; Slack, Rachel D.; Bakare, Oluyomi M.; Burzynski, Caitlin; Rais, Rana; Slusher, Barbara S.; Kopajtic, Theresa; Bonifazi, Alessandro; Ellenberger, Michael P.; Yano, Hideaki; He, Yi; Bi, Guo-Hua; Xi, Zheng-Xiong; Loland, Claus J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10676-10691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT).  The atypical DAT inhibitors have received attention due to their promising pharmacol. profiles in animal models of cocaine and methamphetamine abuse.  Herein the authors report a series of modafinil analogs that have an atypical DAT inhibitor profile.  The authors extended SAR by chem. manipulating the oxidn. states of the sulfoxide and the amide functional groups, halogenating the Ph rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 1-(4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (compd. 11b), which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine.  These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimulant abuse medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0BwESHNuRbVg90H21EOLACvtfcHk0lhAWmC0B5hUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP&md5=e912f256c764249ad606d83ac9c570fb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520high%2520affinity%25202-%255B%2528diphenylmethyl%2529sulfinyl%255Dacetamide%2520%2528modafinil%2529%2520analogues%2520as%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10676%26epage%3D10691%26doi%3D10.1021%2Facs.jmedchem.6b01373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.173948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling&doi=10.1124%2Fjpet.110.173948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0lhAWmC0B5hUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302%26doi%3D10.1124%2Fjpet.110.173948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benicchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signalling pathway</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5725</span>– <span class="NLM_lpage">5733</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.bmc.2015.07.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5725-5733&author=F.+Del%0ABelloauthor=A.+Farandeauthor=M.+Giannellaauthor=A.+Piergentiliauthor=W.+Quagliaauthor=T.+Benicchiauthor=F.+Cappelliauthor=A.+Nenciniauthor=M.+Salernoauthor=R.+J.+Thomasauthor=M.+Travagliauthor=M.+Varrone&title=Identification+of+2-aminopyrimidine+derivatives+as+inhibitors+of+the+canonical+Wnt+signalling+pathway&doi=10.1016%2Fj.bmc.2015.07.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DA.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DBenicchi%26aufirst%3DT.%26aulast%3DCappelli%26aufirst%3DF.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DSalerno%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26atitle%3DIdentification%2520of%25202-aminopyrimidine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520canonical%2520Wnt%2520signalling%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5725%26epage%3D5733%26doi%3D10.1016%2Fj.bmc.2015.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">In vitro prediction of brain penetration – a case for free thinking?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1517/17460441.1.6.595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1517%2F17460441.1.6.595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=595-560&author=S.+G.+Summerfieldauthor=P.+Jeffrey&title=In+vitro+prediction+of+brain+penetration+%E2%80%93+a+case+for+free+thinking%3F&doi=10.1517%2F17460441.1.6.595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17460441.1.6.595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.1.6.595%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520prediction%2520of%2520brain%2520penetration%2520%25E2%2580%2593%2520a%2520case%2520for%2520free%2520thinking%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2006%26volume%3D6%26spage%3D595%26epage%3D560%26doi%3D10.1517%2F17460441.1.6.595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelletti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Cin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehanne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajbaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchió, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliosi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdonà, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomelleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolyl 5-azaspiro[2.4]heptanes: lead identification and early lead optimization of a new series of potent and selective dopamine D3 receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8576</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8549-8576&author=F.+Micheliauthor=A.+Bacchiauthor=S.+Braggioauthor=L.+Castellettiauthor=P.+Cavalliniauthor=P.+Cavanniauthor=S.+Cremonesiauthor=M.+Dal+Cinauthor=A.+Ferianiauthor=S.+Gehanneauthor=M.+Kajbafauthor=L.+Marchi%C3%B3author=S.+Nolaauthor=B.+Oliosiauthor=A.+Pellacaniauthor=E.+Perdon%C3%A0author=A.+Savaauthor=T.+Semeraroauthor=L.+Tarsiauthor=S.+Tomelleriauthor=A.+Wongauthor=F.+Visentiniauthor=L.+Zonziniauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+5-azaspiro%5B2.4%5Dheptanes%3A+lead+identification+and+early+lead+optimization+of+a+new+series+of+potent+and+selective+dopamine+D3+receptor+antagonists&doi=10.1021%2Facs.jmedchem.6b00972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio, Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdona, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8549-8576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described.  Some of these compds. also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases.  A few derivs. with overall favorable developability characteristics were selected for further late lead optimization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKMOaVTpugrVg90H21EOLACvtfcHk0lippBARw9yWjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN&md5=9588db3bf4e320c6d082b4318a8143a4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCastelletti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDal%2BCin%26aufirst%3DM.%26aulast%3DFeriani%26aufirst%3DA.%26aulast%3DGehanne%26aufirst%3DS.%26aulast%3DKajbaf%26aufirst%3DM.%26aulast%3DMarchi%25C3%25B3%26aufirst%3DL.%26aulast%3DNola%26aufirst%3DS.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DPerdon%25C3%25A0%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTomelleri%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%25205-azaspiro%255B2.4%255Dheptanes%253A%2520lead%2520identification%2520and%2520early%2520lead%2520optimization%2520of%2520a%2520new%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8549%26epage%3D8576%26doi%3D10.1021%2Facs.jmedchem.6b00972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laydbak, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span> <span> </span><span class="NLM_article-title">Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6342</span>– <span class="NLM_lpage">6451</span>, <span class="refDoi"> DOI: 10.1021/jm300303e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6342-6451&author=S.+Shibataauthor=J.+R.+Gillespieauthor=R.+M.+Ranadeauthor=C.+Y.+Kohauthor=J.+E.+Kimauthor=J.+U.+Laydbakauthor=F.+H.+Zuckerauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=F.+S.+Bucknerauthor=E.+Fan&title=Urea-based+inhibitors+of+Trypanosoma+brucei+methionyl-tRNA+synthetase%3A+selectivity+and+in+vivo+characterization&doi=10.1021%2Fjm300303e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Based Inhibitors of Trypanosoma brucei Methionyl-tRNA Synthetase: Selectivity and in Vivo Characterization</span></div><div class="casAuthors">Shibata, Sayaka; Gillespie, J. Robert; Ranade, Ranae M.; Koh, Cho Yeow; Kim, Jessica E.; Laydbak, Joy U.; Zucker, Frank H.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Fan, Erkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6342-6351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based methionyl-tRNA synthetase inhibitors were designed, synthesized, and evaluated for their potential toward treating human African trypanosomiasis (HAT).  With the aid of a homol. model and a structure-activity-relationship approach, low nM inhibitors were discovered that show high selectivity toward the parasite enzyme over the closest human homolog.  These compds. inhibit parasite growth with EC50 values as low as 0.15 μM while having low toxicity to mammalian cells.  Two compds. (2 and 26) showed excellent membrane permeation in the MDR1-MDCKII model and encouraging oral pharmacokinetic properties in mice.  Compd. 2 (I) was confirmed to enter the CNS in mice.  Compd. 26 had modest suppressive activity against Trpanosoma brucei rhodesiense in the mouse model, suggesting that more potent analogs or compds. with higher exposures need to be developed.  The urea-based inhibitors are thus a promising starting point for further optimization toward the discovery of orally available and CNS active drugs to treat HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobDMlz2d57bLVg90H21EOLACvtfcHk0lhVQ21nyWfFMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D&md5=a7029357bdc79d52992a4b6eeff53e80</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300303e%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DKoh%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLaydbak%26aufirst%3DJ.%2BU.%26aulast%3DZucker%26aufirst%3DF.%2BH.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DFan%26aufirst%3DE.%26atitle%3DUrea-based%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520methionyl-tRNA%2520synthetase%253A%2520selectivity%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6342%26epage%3D6451%26doi%3D10.1021%2Fjm300303e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perfumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Novel highly potent and selective σ<sub>1</sub> receptor antagonists related to spipethiane</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1021/jm901542q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901542q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Wktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1261-1269&author=A.+Piergentiliauthor=C.+Amantiniauthor=F.+Del+Belloauthor=M.+Giannellaauthor=L.+Mattioliauthor=M.+Palmeryauthor=M.+Perfumiauthor=M.+Piginiauthor=G.+Santoniauthor=P.+Tucciauthor=M.+Zottiauthor=W.+Quaglia&title=Novel+highly+potent+and+selective+%CF%831+receptor+antagonists+related+to+spipethiane&doi=10.1021%2Fjm901542q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane</span></div><div class="casAuthors">Piergentili, Alessandro; Amantini, Consuelo; Del Bello, Fabio; Giannella, Mario; Mattioli, Laura; Palmery, Maura; Perfumi, Marina; Pigini, Maria; Santoni, Giorgio; Tucci, Paolo; Zotti, Margherita; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conservative chem. modifications of the core structure of the lead spipethiane (1) afforded novel potent σ1 ligands. σ1 affinity and σ1/σ2 selectivity proved to be favored by the introduction of polar functions (oxygen atom or carbonyl group) in position 3 or 4 (4-6) or by the elongation of the distance between the two hydrophobic portions of the mol. with the simultaneous presence of a carbonyl group in position 4 (8 and 9).  The obsd. cytostatic effect against the human breast cancer cell line MCF-7/ADR, highly expressing σ1 receptors, and not against MCF-7, as well as the enhancement of morphine analgesia highlighted the σ1 antagonist profile of this series of compds.  In particular, due to its high σ1 affinity (pKi = 10.28) and σ1/σ2 selectivity ratio (29510), compd. 9 (I) might be a novel valuable tool for σ receptor characterization and a suitable template for the rational design of potential therapeutically useful σ1 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JWhD2T1LHrVg90H21EOLACvtfcHk0lhVQ21nyWfFMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Wktg%253D%253D&md5=ab40c7eaaf8f259f9796d38d48af96a8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901542q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901542q%26sid%3Dliteratum%253Aachs%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DMattioli%26aufirst%3DL.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DPerfumi%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DTucci%26aufirst%3DP.%26aulast%3DZotti%26aufirst%3DM.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DNovel%2520highly%2520potent%2520and%2520selective%2520%25CF%25831%2520receptor%2520antagonists%2520related%2520to%2520spipethiane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1261%26epage%3D1269%26doi%3D10.1021%2Fjm901542q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schetz, J. A.</span></span> <span> </span><span class="NLM_article-title">An unambiguous assay for the cloned human sigma<sub>1</sub> receptor reveals high affinity interactions with dopamine D<sub>4</sub> receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>578</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2007.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejphar.2007.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=17961544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=578&publication_year=2008&pages=123-136&author=I.+T.+Leeauthor=S.+Chenauthor=J.+A.+Schetz&title=An+unambiguous+assay+for+the+cloned+human+sigma1+receptor+reveals+high+affinity+interactions+with+dopamine+D4+receptor+selective+compounds+and+a+distinct+structure-affinity+relationship+for+butyrophenones&doi=10.1016%2Fj.ejphar.2007.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span></div><div class="casAuthors">Lee, Ivan T.; Chen, Shiuhwei; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">578</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of the sigma1 receptor to interact with a huge range of drug structural classes coupled with its wide distribution in the body has contributed to it being implicated as a possible therapeutic target for a broad array of disorders ranging from substance abuse to depression to Alzheimer's disease.  Surprisingly, the reported affinity values for some sigma1 receptor ligands vary more than 50-fold.  The potential of the sigma1 receptor as a pharmacotherapeutic target prompted us to develop an unambiguous assay system for measuring the affinity of ligands to the cloned human sigma1 receptor.  In the course of characterizing this system and detg. the true affinity values for almost three dozen compds., it was discovered that some dopamine D4 receptor selective compds. bind sigma1 receptors with high affinity.  A systematic anal. of haloperidol-like compds. revealed a clear structure-affinity relationship amongst clin. relevant butyrophenones.  The antidepressant fluvoxamine, the drug of abuse methamphetamine, and the neurosteroid progesterone were amongst the many ligands whose interactions with the sigma1 receptor were confirmed with the screening assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6V71Qpygx17Vg90H21EOLACvtfcHk0lhVQ21nyWfFMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D&md5=a5f025cd9d7c3f130544afb4e3140f56</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BT.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520unambiguous%2520assay%2520for%2520the%2520cloned%2520human%2520sigma1%2520receptor%2520reveals%2520high%2520affinity%2520interactions%2520with%2520dopamine%2520D4%2520receptor%2520selective%2520compounds%2520and%2520a%2520distinct%2520structure-affinity%2520relationship%2520for%2520butyrophenones%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D578%26spage%3D123%26epage%3D136%26doi%3D10.1016%2Fj.ejphar.2007.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span> <span> </span><span class="NLM_article-title">Assessing brain free fraction in early drug discovery</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1517/17425250903559873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1517%2F17425250903559873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=20102287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=337-344&author=K.+D.+Readauthor=S.+Braggio&title=Assessing+brain+free+fraction+in+early+drug+discovery&doi=10.1517%2F17425250903559873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing brain free fraction in early drug discovery</span></div><div class="casAuthors">Read, Kevin D.; Braggio, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The incorporation of brain tissue binding routinely in CNS drug discovery screening strategies has markedly changed the way CNS drug discovery is performed and is proving to be a valuable tool in identifying new therapies for CNS diseases.  For many years emphasis has been placed on the magnitude of the brain to blood ratio, the bigger the better, even though, in many cases, brain total concn. (Cbrain) has no or, at best, poor correlation with receptor occupancy/pharmacodynamic readout.  Today, Cbrain values measured during in vivo expts. are cor. for the fraction unbound measured through in vitro expts. using brain tissue homogenate or brain tissue slice to obtain an est. of the brain unbound concn. (Cu,brain), and this has been demonstrated across a range of CNS targets to give a much better correlation with receptor occupancy/pharmacodynamic readout.  This apparently simple change in CNS lead optimization strategy has de facto revolutionized the vision of the brain penetration concepts.Areas covered in this review: This review will provide an overview of the use and applications of assessing brain free fraction to det. Cu,brain.Take home message: Assessing brain free fraction to det. Cu,brain in CNS lead optimization strategies is the surrogate of choice for rapidly assessing biophase concn. for the majority of CNS targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9c99W0CmXPbVg90H21EOLACvtfcHk0lgTXd484CGuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D&md5=f989ca92c918d40fc01ba01835942ded</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1517%2F17425250903559873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903559873%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DBraggio%26aufirst%3DS.%26atitle%3DAssessing%2520brain%2520free%2520fraction%2520in%2520early%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D337%26epage%3D344%26doi%3D10.1517%2F17425250903559873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, A.</span></span> <span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2030</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200900103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbdv.200900103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19937839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+basics+and+implications+of+the+evolving+new+concept&doi=10.1002%2Fcbdv.200900103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept</span></div><div class="casAuthors">Reichel, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2030-2049</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A review.  Despite enormous efforts, achieving a safe and efficacious concn. profile in the brain remains one of the big challenges in central nervous system (CNS) drug discovery and development.  Although there are multiple reasons, many failures are due to underestimating the complexity of the brain, also in terms of pharmacokinetics (PK).  To this day, PK support of CNS drug discovery heavily relies on improving the blood-brain barrier (BBB) permeability in vitro and/or the brain/plasma ratio (Kp) in vivo, even though neither parameter can be reliably linked to pharmacodynamic (PD) and efficacy readouts.  While increasing BBB permeability may shorten the onset of drug action, an increase in the total amt. in brain may not necessarily increase the relevant drug concn. at the pharmacol. target.  Since the traditional Kp ratio is based on a crude homogenization of brain tissue, it ignores the compartmentalization of the brain and an increase favors non-specific binding to brain lipids rather than free drug levels.  To better link exposure/PK to efficacy/PD and to delineate key parameters, an integrated approach to CNS drug discovery is emerging which distinguishes total from unbound brain concns.  As the complex nature of the brain requires different compartments to be considered when trying to understand and improve new compds., several complementary parameters need to be measured in vitro and in vivo, and integrated into a coherent model of brain penetration and distribution.  The new paradigm thus concs. on finding drug candidates with the right balance between free fraction in plasma and brain, and between rate and extent of CNS penetration.  Integrating this data into a coherent model of CNS distribution which can be linked to efficacy will allow it to design compds. with an optimal mix in physicochem., pharmacol., and pharmacokinetic properties, ultimately mitigating the risk for failures in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprtDCziki1f7Vg90H21EOLACvtfcHk0lgTXd484CGuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSrtL3F&md5=d1b7b08605319178cfececbfa59da39a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200900103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200900103%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049%26doi%3D10.1002%2Fcbdv.200900103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span> <span> </span><span class="NLM_article-title">MetaQSAR: an integrated database engine to manage and analyze metabolic data</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01473</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01473" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1019-1030&author=A.+Pedrettiauthor=A.+Mazzolariauthor=G.+Vistoliauthor=B.+Testa&title=MetaQSAR%3A+an+integrated+database+engine+to+manage+and+analyze+metabolic+data&doi=10.1021%2Facs.jmedchem.7b01473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data</span></div><div class="casAuthors">Pedretti, Alessandro; Mazzolari, Angelica; Vistoli, Giulio; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-1030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The study describes the MetaQSAR tool, a new database engine specifically tailored to collect and analyze metabolic data.  This is a plug-in embedded in the VEGA suite of programs (freely downloadable at www.vegazz.net) and takes advantage from all cheminformatics features implemented in the software with addnl. tools aimed to perform statistical analyses, similarity searches and physicochem. profiling of the stored mols.  MetaQSAR also implements a novel metab. classification, which groups the metabolic reactions in 101 classes and can find numerous applications in metabolic analyses.  The potentials of MetaQSAR are here assessed by using it to store and analyze an extended database focused on metab. of xenobiotics, which was collected by manually curated meta-anal. of the recent literature.  The database includes 1890 substrates taken from about 1500 original papers in the years 2004-2015.  The database was utilized in both physicochem. analyses and similarity searches, so evidencing the notable potentialities of MetaQSAR, which can find particularly fruitful applications in developing targeted predictive approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5F-P_xq-qbbVg90H21EOLACvtfcHk0lgTXd484CGuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gs7fI&md5=945cc6a583728bf0c192b760f1a2a8d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01473%26sid%3Dliteratum%253Aachs%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMetaQSAR%253A%2520an%2520integrated%2520database%2520engine%2520to%2520manage%2520and%2520analyze%2520metabolic%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1019%26epage%3D1030%26doi%3D10.1021%2Facs.jmedchem.7b01473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, S. D.</span></span> <span> </span><span class="NLM_article-title">The biochemistry of drug metabolism - an introduction: part 3. Reactions of hydrolysis and their enzymes</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2031</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200790169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbdv.200790169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=2031-2122&author=B.+Testaauthor=S.+D.+Kr%C3%A4mer&title=The+biochemistry+of+drug+metabolism+-+an+introduction%3A+part+3.+Reactions+of+hydrolysis+and+their+enzymes&doi=10.1002%2Fcbdv.200790169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790169%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DS.%2BD.%26atitle%3DThe%2520biochemistry%2520of%2520drug%2520metabolism%2520-%2520an%2520introduction%253A%2520part%25203.%2520Reactions%2520of%2520hydrolysis%2520and%2520their%2520enzymes%26jtitle%3DChem.%2520Biodiversity%26date%3D2007%26volume%3D4%26spage%3D2031%26epage%3D2122%26doi%3D10.1002%2Fcbdv.200790169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0ljyKRgfeOluug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conner, A. C.</span></span> <span> </span><span class="NLM_article-title">Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.mce.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27899324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2017&pages=3-11&author=M.+J.+Woolleyauthor=A.+C.+Conner&title=Understanding+the+common+themes+and+diverse+roles+of+the+second+extracellular+loop+%28ECL2%29+of+the+GPCR+super-family&doi=10.1016%2Fj.mce.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family</span></div><div class="casAuthors">Woolley, Michael J.; Conner, Alex C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular loops (ECLs) of G protein-coupled receptors (GPCRs) can bind directly to docked orthosteric or allosteric ligands, they can contain transient contact points for ligand entry into the transmembrane (TM) bundle and they can regulate the activation of the receptor signalling pathways.  Of the three ECLs, ECL2 is the largest and most structurally diverse reflecting its functional importance.  This has been shown through biochem. techniques and has been supported by the many subsequent crystal structures of GPCRs bound to both agonists and antagonists.  ECL2 shares common structural features between (and sometimes across) receptor sub-families and can facilitate ligand entry to the TM core or act directly as a surface of the ligand-binding pocket.  Structural similarities seem to underpin common binding mechanisms; however, where these exist, variations in primary sequence ensure ligand-binding specificity.  This review will compare current understanding of the structural themes and main functional roles of ECL2 in ligand binding, activation and regulation of the major families of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uQpFUSHnlLVg90H21EOLACvtfcHk0ljyKRgfeOluug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnt7vM&md5=072c61b1b81aff3ee686e9820e99fedc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BJ.%26aulast%3DConner%26aufirst%3DA.%2BC.%26atitle%3DUnderstanding%2520the%2520common%2520themes%2520and%2520diverse%2520roles%2520of%2520the%2520second%2520extracellular%2520loop%2520%2528ECL2%2529%2520of%2520the%2520GPCR%2520super-family%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2017%26volume%3D449%26spage%3D3%26epage%3D11%26doi%3D10.1016%2Fj.mce.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackshields, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettigan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWilliam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, D. G.</span></span> <span> </span><span class="NLM_article-title">Clustal W and Clustal X version 2.0</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2947</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btm404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1093%2Fbioinformatics%2Fbtm404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=17846036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlaqsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=2947-2948&author=M.+A.+Larkinauthor=G.+Blackshieldsauthor=N.+P.+Brownauthor=R.+Chennaauthor=P.+A.+McGettiganauthor=H.+McWilliamauthor=F.+Valentinauthor=I.+M.+Wallaceauthor=A.+Wilmauthor=R.+Lopezauthor=J.+D.+Thompsonauthor=T.+J.+Gibsonauthor=D.+G.+Higgins&title=Clustal+W+and+Clustal+X+version+2.0&doi=10.1093%2Fbioinformatics%2Fbtm404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Clustal W and Clustal X version 2.0</span></div><div class="casAuthors">Larkin, M. A.; Blackshields, G.; Brown, N. P.; Chenna, R.; McGettigan, P. A.; McWilliam, H.; Valentin, F.; Wallace, I. M.; Wilm, A.; Lopez, R.; Thompson, J. D.; Gibson, T. J.; Higgins, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2947-2948</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Clustal W and Clustal X multiple sequence alignment programs have been completely rewritten in C++.  This will facilitate the further development of the alignment algorithms in the future and has allowed proper porting of the programs to the latest versions of Linux, Macintosh and Windows operating systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsv_FPaWsDLVg90H21EOLACvtfcHk0ljyKRgfeOluug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlaqsL%252FM&md5=14c988ecd0b5081ef79149f31a567880</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtm404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtm404%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DM.%2BA.%26aulast%3DBlackshields%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DN.%2BP.%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DMcGettigan%26aufirst%3DP.%2BA.%26aulast%3DMcWilliam%26aufirst%3DH.%26aulast%3DValentin%26aufirst%3DF.%26aulast%3DWallace%26aufirst%3DI.%2BM.%26aulast%3DWilm%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26atitle%3DClustal%2520W%2520and%2520Clustal%2520X%2520version%25202.0%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D2947%26epage%3D2948%26doi%3D10.1093%2Fbioinformatics%2Fbtm404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span> <span> </span><span class="NLM_article-title">Binding space concept: a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1702</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.7b00121</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00121" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWrsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1691-1702&author=G.+Vistoliauthor=A.+Mazzolariauthor=B.+Testaauthor=A.+Pedretti&title=Binding+space+concept%3A+a+new+approach+to+enhance+the+reliability+of+docking+scores+and+its+application+to+predicting+butyrylcholinesterase+hydrolytic+activity&doi=10.1021%2Facs.jcim.7b00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Space Concept: A New Approach To Enhance the Reliability of Docking Scores and Its Application to Predicting Butyrylcholinesterase Hydrolytic Activity</span></div><div class="casAuthors">Vistoli, Giulio; Mazzolari, Angelica; Testa, Bernard; Pedretti, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1691-1702</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking simulations are very popular approaches able to assess the capacity of a given ligand to interact with a target.  Docking simulations are usually focused on a single best complex even though many studies showed that ligands retain a significant mobility within a binding pocket by assuming different binding modes all of which may contribute to the monitored ligand affinity.  The present study describes an innovative concept, the binding space, which allows an exploration of the ligand mobility within the binding pocket by simultaneously considering several ligand poses as generated by docking simulations.  The multiple poses and the relative docking scores can then be analyzed by taking advantage of the same approaches already used in the property space anal.; hence the binding space can be parameterized by (a) mean scores; (b) score ranges and (c) score sensitivity.  The first parameter represents a very simple procedure to account for the contribution of the often neglected alternative binding modes, while the last two descriptors encode the degree of mobility which a given ligand retains within the binding cavity (score ranges) as well as the ease with which a ligand explores such a mobility (score sensitivity).  Here, the binding space concept is applied to the prediction of the hydrolytic activity of BChE by synergistically considering multiple poses and multiple protein structures.  The obtained results shed light on the remarkable potential of the binding space concept, whose parameters allow a significant increase of the predictive power of the docking scores as revealed by extended correlative analyses.  Mean scores are the parameters affording the largest statistical improvement and all here proposed docking-based descriptors show enhancing effects in developing predictive models.  Finally, the study describes a new score function (Contacts score) simply based on the no. of surrounding residues which appears to be particularly productive in the framework of the binding space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmsGdTwEYX37Vg90H21EOLACvtfcHk0lgHbov-yhiMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWrsLrP&md5=77b221d98c16e5af32318cfb8534818e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00121%26sid%3Dliteratum%253Aachs%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DPedretti%26aufirst%3DA.%26atitle%3DBinding%2520space%2520concept%253A%2520a%2520new%2520approach%2520to%2520enhance%2520the%2520reliability%2520of%2520docking%2520scores%2520and%2520its%2520application%2520to%2520predicting%2520butyrylcholinesterase%2520hydrolytic%2520activity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26spage%3D1691%26epage%3D1702%26doi%3D10.1021%2Facs.jcim.7b00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M. M.</span></span> <span> </span><span class="NLM_article-title">A rapid and sensitive method for quantitation of microgram quantities of protein, utilizing the principle of protein–dye binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-253&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+quantitation+of+microgram+quantities+of+protein%2C+utilizing+the+principle+of+protein%E2%80%93dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%252C%2520utilizing%2520the%2520principle%2520of%2520protein%25E2%2580%2593dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D253%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">21995</span>– <span class="NLM_lpage">21998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2FS0021-9258%2818%2941623-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1331042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=21995-21998&author=X.+M.+Guanauthor=T.+S.+Kobilkaauthor=B.+K.+Kobilka&title=Enhancement+of+membrane+insertion+and+function+in+a+type+IIIb+membrane+protein+following+introduction+of+a+cleavable+signal+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide</span></div><div class="casAuthors">Guan, Xiao Ming; Kobilka, Tong Sun; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21995-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The human β2 adrenergic receptor is a type IIIb membrane protein.  It has a putative seven-transmembrane topol. but lacks an amino-terminal cleavable signal sequence.  The mechanism by which the amino terminus of the β2 receptor is translocated across the endoplasmic reticulum membrane is unknown.  Furthermore, it is not known if translocation as a type IIIb protein is essential for the proper folding.  Studies indicate that conversion of β2 receptor from a type IIIb to a type IIIa membrane protein by introducing an NH2-terminal cleavable signal sequence enhances translocation of the receptor into the endoplasmic reticulum membrane, thereby facilitating expression of functional receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwF32oLw6DXLVg90H21EOLACvtfcHk0lgHbov-yhiMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGnsrc%253D&md5=a4fb66665564715147b247c9f69b3ab1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2941623-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252941623-7%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DX.%2BM.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DEnhancement%2520of%2520membrane%2520insertion%2520and%2520function%2520in%2520a%2520type%2520IIIb%2520membrane%2520protein%2520following%2520introduction%2520of%2520a%2520cleavable%2520signal%2520peptide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D21995%26epage%3D21998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martí-Renom, M.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span> <span> </span><span class="NLM_article-title">Comparative protein structure modeling of genes and genomes</span>. <i>Annu. Rev. Biophys. Biomol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1146/annurev.biophys.29.1.291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1146%2Fannurev.biophys.29.1.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10940251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=291-325&author=M.%0AA.+Mart%C3%AD-Renomauthor=A.+Stuartauthor=A.+Fiserauthor=R.+S%C3%A1nchezauthor=F.+Meloauthor=A.+Sali&title=Comparative+protein+structure+modeling+of+genes+and+genomes&doi=10.1146%2Fannurev.biophys.29.1.291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein structure modeling of genes and genomes</span></div><div class="casAuthors">Marti-Renom, Marc A.; Stuart, Ashley C.; Fiser, Andras; Sanchez, Roberto; Melo, Francisco; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-325</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 212 refs.  Comparative modeling predicts the three-dimensional structure of a given protein sequence (target) based primarily on its alignment to one or more proteins of known structure (templates).  The prediction process consists of fold assignment, target-template alignment, model building, and model evaluation.  The no. of protein sequences that can be modeled and the accuracy of the predictions are increasing steadily because of the growth in the no. of known protein structures and because of the improvements in the modeling software.  Further advances are necessary in recognizing weak sequence-structure similarities, aligning sequences with structures, modeling of rigid body shifts, distortions, loops and side chains, as well as detecting errors in a model.  Despite these problems, it is currently possible to model with useful accuracy significant parts of approx. one third of all known protein sequences.  The use of individual comparative models in biol. is already rewarding and increasingly widespread.  A major new challenge for comparative modeling is the integration of it with the torrents of data from genome sequencing projects as well as from functional and structural genomics.  In particular, there is a need to develop an automated, rapid, robust, sensitive, and accurate comparative modeling pipeline applicable to whole genomes.  Such large-scale modeling is likely to encourage new kinds of applications for the many resulting models, based on their large no. and completeness at the level of the family, organism, or functional network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq45B6Amw-zi7Vg90H21EOLACvtfcHk0lgHbov-yhiMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D&md5=d97ffe6c47c4a3bae2bbbf14c045afdd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.29.1.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.29.1.291%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25AD-Renom%26aufirst%3DM.%2BA.%26aulast%3DStuart%26aufirst%3DA.%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DF.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520structure%2520modeling%2520of%2520genes%2520and%2520genomes%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D291%26epage%3D325%26doi%3D10.1146%2Fannurev.biophys.29.1.291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1007/s00894-012-1667-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1007%2Fs00894-012-1667-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=23187683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1-32&author=J.+J.+Stewart&title=Optimization+of+parameters+for+semiempirical+methods+VI%3A+more+modifications+to+the+NDDO+approximations+and+re-optimization+of+parameters&doi=10.1007%2Fs00894-012-1667-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-32</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Modern semiempirical methods are of sufficient accuracy when used in the modeling of mols. of the same type as used as ref. data in the parameterization.  Outside that subset, however, there is an abundance of evidence that these methods are of very limited utility.  In an attempt to expand the range of applicability, a new method called PM7 has been developed.  PM7 was parameterized using exptl. and high-level ab initio ref. data, augmented by a new type of ref. data intended to better define the structure of parameter space.  The resulting method was tested by modeling crystal structures and heats of formation of solids.  Two changes were made to the set of approxns.: a modification was made to improve the description of noncovalent interactions, and two minor errors in the NDDO formalism were rectified.  Av. unsigned errors (AUEs) in geometry and ΔH f for PM7 were reduced relative to PM6; for simple gas-phase org. systems, the AUE in bond lengths decreased by about 5 % and the AUE in ΔH f decreased by about 10 %; for org. solids, the AUE in ΔH f dropped by 60 % and the redn. was 33.3 % for geometries.  A two-step process (PM7-TS) for calcg. the heights of activation barriers has been developed.  Using PM7-TS, the AUE in the barrier heights for simple org. reactions was decreased from values of 12.6 kcal/mol-1 in PM6 and 10.8 kcal/mol-1 in PM7 to 3.8 kcal/mol-1.  The origins of the errors in NDDO methods have been examd., and were found to be attributable to inadequate and inaccurate ref. data.  This conclusion provides insight into how these methods can be improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiyk03_VhyprVg90H21EOLACvtfcHk0ljGcAgcBAtBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVegtA%253D%253D&md5=7177311730da8242d5e05f7f4e045e57</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1667-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1667-x%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%26atitle%3DOptimization%2520of%2520parameters%2520for%2520semiempirical%2520methods%2520VI%253A%2520more%2520modifications%2520to%2520the%2520NDDO%2520approximations%2520and%2520re-optimization%2520of%2520parameters%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D1%26epage%3D32%26doi%3D10.1007%2Fs00894-012-1667-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span> <span> </span><span class="NLM_article-title">Empirical scoring functions for advanced protein-ligand docking with PLANTS</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/ci800298z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800298z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=84-96&author=O.+Korbauthor=T.+St%C3%BCtzleauthor=T.+E.+Exner&title=Empirical+scoring+functions+for+advanced+protein-ligand+docking+with+PLANTS&doi=10.1021%2Fci800298z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS</span></div><div class="casAuthors">Korb, Oliver; Stuetzle, Thomas; Exner, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-96</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we present two empirical scoring functions, PLANTSCHEMPLP and PLANTSPLP, designed for our docking algorithm PLANTS (Protein-Ligand ANT System), which is based on ant colony optimization (ACO).  They are related, regarding their functional form, to parts of already published scoring functions and force fields.  The parametrization procedure described here was able to identify several parameter settings showing an excellent performance for the task of pose prediction on two test sets comprising 298 complexes in total.  Up to 87% of the complexes of the Astex diverse set and 77% of the CCDC/Astex clean listnc (noncovalently bound complexes of the clean list) could be reproduced with root-mean-square deviations of less than 2 Å with respect to the exptl. detd. structures.  A comparison with the state-of-the-art docking tool GOLD clearly shows that this is, esp. for the druglike Astex diverse set, an improvement in pose prediction performance.  Addnl., optimized parameter settings for the search algorithm were identified, which can be used to balance pose prediction reliability and search speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kyR7CGk9mbVg90H21EOLACvtfcHk0ljGcAgcBAtBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D&md5=fce960b75b9f8906354b7c97ff84c092</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fci800298z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800298z%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DEmpirical%2520scoring%2520functions%2520for%2520advanced%2520protein-ligand%2520docking%2520with%2520PLANTS%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D84%26epage%3D96%26doi%3D10.1021%2Fci800298z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span> <span> </span><span class="NLM_article-title">Structural effects of some relevant missense mutations on the MECP2-DNA binding: a MD study analyzed by Rescore+, a versatile rescoring tool of the VEGA ZZ program</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1002/minf.201501030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fminf.201501030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27546046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKkt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=424-433&author=A.+Pedrettiauthor=C.+Granitoauthor=A.+Mazzolariauthor=G.+Vistoli&title=Structural+effects+of+some+relevant+missense+mutations+on+the+MECP2-DNA+binding%3A+a+MD+study+analyzed+by+Rescore%2B%2C+a+versatile+rescoring+tool+of+the+VEGA+ZZ+program&doi=10.1002%2Fminf.201501030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program</span></div><div class="casAuthors">Pedretti, Alessandro; Granito, Cinzia; Mazzolari, Angelica; Vistoli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">424-433</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA methylation plays key roles in mammalian cells and is modulated by a set of proteins which recognize sym. methylated nucleotides.  Among them, the protein MECP2 shows multifunctional roles repressing and/or activating genes by binding to both methylated and unmethylated regions of the genome.  The interest for this protein markedly increased from the observation that its mutations are the primary cause of Rett syndrome, a neurodevelopmental disorder which causes mental retardation in young females.  Thus, the present study is aimed to investigate the effects of some of these known pathogenic missense mutations (i.e. R106Q, R106W, R111G, R133C and R133H) on the MECP2 folding and DNA binding by mol. dynamics simulations.  The effects of the simulated mutations are also parameterized by using a here proposed new tool, named Rescore+, implemented in the VEGA ZZ suite of programs, which calcs. a set of scoring functions on all frames of a trajectory or on all complexes contained in a database thus allowing an easy rescoring of results coming from MD or docking simulations.  The obtained results revealed that the reported loss of the MECP2 function induced by the simulated mutations can be ascribed to both stabilizing and destabilizing effect on DNA binding.  The study confirms that MD simulations are particularly useful to rationalize and predict the mutation effects offering insightful information for diagnostics and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp07FKJ_INy2bVg90H21EOLACvtfcHk0ljGcAgcBAtBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKkt7jM&md5=c90f89eb08c1eddd79945cb1675d59a3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fminf.201501030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201501030%26sid%3Dliteratum%253Aachs%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DGranito%26aufirst%3DC.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26atitle%3DStructural%2520effects%2520of%2520some%2520relevant%2520missense%2520mutations%2520on%2520the%2520MECP2-DNA%2520binding%253A%2520a%2520MD%2520study%2520analyzed%2520by%2520Rescore%252B%252C%2520a%2520versatile%2520rescoring%2520tool%2520of%2520the%2520VEGA%2520ZZ%2520program%26jtitle%3DMol.%2520Inf.%26date%3D2016%26volume%3D35%26spage%3D424%26epage%3D433%26doi%3D10.1002%2Fminf.201501030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Carlo Cifani, Emanuela Micioni Di Bonaventura, Luca Botticelli, Fabio Del Bello, Gianfabio Giorgioni, Pegi Pavletić, Alessandro Piergentili, Wilma Quaglia, Alessandro Bonifazi, Dirk Schepmann, Bernhard Wünsch, Giulio Vistoli, <span class="NLM_string-name hlFld-ContribAuthor">Maria Vittoria Micioni Di Bonaventura</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (19)
                                     , 3107-3116. <a href="https://doi.org/10.1021/acschemneuro.0c00456" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00456%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BHighly%252BPotent%252Band%252BSelective%252BSigma1%252BReceptor%252BAntagonists%252BEffectively%252BBlock%252Bthe%252BBinge%252BEating%252BEpisode%252Bin%252BFemale%252BRats%26aulast%3DCifani%26aufirst%3DCarlo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20072020%26date%3D04092020%26date%3D21092020%26date%3D04092020%26volume%3D11%26issue%3D19%26spage%3D3107%26epage%3D3116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Maria Giovanna Sabbieti, Dimitrios Agas, Marzia Dell’Aera, Rosanna Matucci, Marcin Górecki, Gennaro Pescitelli, Giulio Vistoli, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5763-5782. <a href="https://doi.org/10.1021/acs.jmedchem.9b02100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPotent%252BMuscarinic%252BReceptor%252BAntagonists%25253A%252BInvestigation%252Bon%252Bthe%252BNature%252Bof%252BLipophilic%252BSubstituents%252Bin%252Bthe%252B5-%252Band%25252For%252B6-Positions%252Bof%252Bthe%252B1%25252C4-Dioxane%252BNucleus%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17122019%26date%3D19052020%26date%3D06052020%26volume%3D63%26issue%3D11%26spage%3D5763%26epage%3D5782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Maria Vittoria Micioni Di Bonaventura, Alessandro Bonifazi, Bernhard Wünsch, Dirk Schepmann, JoLynn B. Giancola, Emanuela Micioni Di Bonaventura, Giulio Vistoli, Gianfabio Giorgioni, Wilma Quaglia, Alessandro Piergentili, <span class="NLM_string-name hlFld-ContribAuthor">Carlo Cifani</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 3391-3397. <a href="https://doi.org/10.1021/acschemneuro.9b00261" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DInvestigation%252Bof%252Bthe%252BRole%252Bof%252BChirality%252Bin%252Bthe%252BInteraction%252Bwith%252B%2525CF%252583%252BReceptors%252Band%252BEffect%252Bon%252BBinge%252BEating%252BEpisode%252Bof%252Ba%252BPotent%252B%2525CF%2525831%252BAntagonist%252BAnalogue%252Bof%252BSpipethiane%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02052019%26date%3D12072019%26date%3D23072019%26date%3D12072019%26volume%3D10%26issue%3D8%26spage%3D3391%26epage%3D3397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy H. Newman, Thomas M. Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia, Silvia Franchini, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson’s Disease or Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2222-2228. <a href="https://doi.org/10.1021/acschemneuro.8b00677" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00677%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252B1%25252C4-Dioxane%252BCompounds%252BCombining%252BFavorable%252BD2-like%252Band%252B5-HT1A%252BReceptor%252BInteractions%252Bwith%252BPotential%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bor%252BSchizophrenia%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06122018%26date%3D04012019%26date%3D09012019%26date%3D04012019%26volume%3D10%26issue%3D5%26spage%3D2222%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thomas
M. Keck, R. Benjamin Free, Marilyn M. Day, Sonvia L. Brown, Michele S. Maddaluna, Griffin Fountain, Charles Cooper, Brooke Fallon, Matthew Holmes, Christopher T. Stang, Russell Burkhardt, Alessandro Bonifazi, Michael P. Ellenberger, Amy H. Newman, David R. Sibley, Chun Wu, <span class="NLM_string-name hlFld-ContribAuthor">Comfort A. Boateng</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3722-3740. <a href="https://doi.org/10.1021/acs.jmedchem.9b00231" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00231%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDopamine%252BD4%252BReceptor-Selective%252BCompounds%252BReveal%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bthat%252BEngender%252BAgonist%252BEfficacy%26aulast%3DKeck%26aufirst%3DThomas%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03022019%26date%3D01042019%26date%3D18032019%26volume%3D62%26issue%3D7%26spage%3D3722%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maria
Beatrice Morelli, Consuelo Amantini, Massimo Nabissi, Giorgio Santoni, Bernhard Wünsch, Dirk Schepmann, Cristina Cimarelli, Maura Pellei, Carlo Santini, Stefano Fontana, Valerio Mammoli, Wilma Quaglia, Alessandro Bonifazi, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, <span class="NLM_string-name hlFld-ContribAuthor">Fabio Del Bello</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (4)
                                     , 511-516. <a href="https://doi.org/10.1021/acsmedchemlett.8b00536" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00536%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRole%252Bof%252Bthe%252BNMDA%252BReceptor%252Bin%252Bthe%252BAntitumor%252BActivity%252Bof%252BChiral%252B1%25252C4-Dioxane%252BLigands%252Bin%252BMCF-7%252Band%252BSKBR3%252BBreast%252BCancer%252BCells%26aulast%3DMorelli%26aufirst%3DMaria%2BBeatrice%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D07112018%26date%3D28012019%26date%3D31012019%26date%3D28012019%26volume%3D10%26issue%3D4%26spage%3D511%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Domenico Alberga, Daniela Trisciuzzi, Michele Montaruli, Francesco Leonetti, Giuseppe Felice Mangiatordi, <span class="NLM_string-name hlFld-ContribAuthor">Orazio Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">A New Approach for Drug Target and Bioactivity Prediction: The Multifingerprint Similarity Search Algorithm (MuSSeL). </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 586-596. <a href="https://doi.org/10.1021/acs.jcim.8b00698" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00698%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DA%252BNew%252BApproach%252Bfor%252BDrug%252BTarget%252Band%252BBioactivity%252BPrediction%25253A%252BThe%252BMultifingerprint%252BSimilarity%252BSearch%252BAlgorithm%252B%252528MuSSeL%252529%26aulast%3DAlberga%26aufirst%3DDomenico%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D08102018%26date%3D14122018%26date%3D28112018%26volume%3D59%26issue%3D1%26spage%3D586%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Pegi  Pavletić</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Luca  Botticelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Emanuela  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>. </span><span class="cited-content_cbyCitation_article-title">Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113141. <a href="https://doi.org/10.1016/j.ejmech.2020.113141" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113141%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bfindings%252Bleading%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bdopamine%252BD4%252Breceptor%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252Bwidespread%252Bdiseases%26aulast%3DGiorgioni%26aufirst%3DGianfabio%26date%3D2021%26volume%3D212%26spage%3D113141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Botticelli</span>, <span class="hlFld-ContribAuthor ">Emanuela  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Adele  Romano</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Micioni Di Bonaventura</span>. </span><span class="cited-content_cbyCitation_article-title">Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2288. <a href="https://doi.org/10.3390/nu12082288" title="DOI URL">https://doi.org/10.3390/nu12082288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu12082288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu12082288%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DUnderlying%252BSusceptibility%252Bto%252BEating%252BDisorders%252Band%252BDrug%252BAbuse%25253A%252BGenetic%252Band%252BPharmacological%252BAspects%252Bof%252BDopamine%252BD4%252BReceptors%26aulast%3DBotticelli%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Lopez‐Cuina</span>, <span class="hlFld-ContribAuthor ">Paul A.  Guerin</span>, <span class="hlFld-ContribAuthor ">Marie‐Hélène  Canron</span>, <span class="hlFld-ContribAuthor ">Anna  Delamarre</span>, <span class="hlFld-ContribAuthor ">Benjamin  Dehay</span>, <span class="hlFld-ContribAuthor ">Erwan  Bezard</span>, <span class="hlFld-ContribAuthor ">Wassilios G.  Meissner</span>, <span class="hlFld-ContribAuthor ">Pierre‐Olivier  Fernagut</span>. </span><span class="cited-content_cbyCitation_article-title">Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy. </span><span class="cited-content_cbyCitation_journal-name">Movement Disorders</span><span> <strong>2020,</strong> <em>35 </em>
                                    (7)
                                     , 1163-1172. <a href="https://doi.org/10.1002/mds.28034" title="DOI URL">https://doi.org/10.1002/mds.28034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mds.28034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmds.28034%26sid%3Dliteratum%253Aachs%26jtitle%3DMovement%2520Disorders%26atitle%3DNilotinib%252BFails%252Bto%252BPrevent%252BSynucleinopathy%252Band%252BCell%252BLoss%252Bin%252Ba%252BMouse%252BModel%252Bof%252BMultiple%252BSystem%252BAtrophy%26aulast%3DLopez%25E2%2580%2590Cuina%26aufirst%3DMiguel%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D7%26spage%3D1163%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Yang</span>, <span class="hlFld-ContribAuthor ">Joel S.  Perlmutter</span>, <span class="hlFld-ContribAuthor ">Tammie L.S.  Benzinger</span>, <span class="hlFld-ContribAuthor ">John C.  Morris</span>, <span class="hlFld-ContribAuthor ">Jinbin  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2020,</strong> <em>57 </em>, 100994. <a href="https://doi.org/10.1016/j.arr.2019.100994" title="DOI URL">https://doi.org/10.1016/j.arr.2019.100994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2019.100994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2019.100994%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DDopamine%252BD3%252Breceptor%25253A%252BA%252Bneglected%252Bparticipant%252Bin%252BParkinson%252BDisease%252Bpathogenesis%252Band%252Btreatment%25253F%26aulast%3DYang%26aufirst%3DPengfei%26date%3D2020%26volume%3D57%26spage%3D100994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lídia M.  Lima</span>, <span class="hlFld-ContribAuthor ">Marina A.  Alves</span>, <span class="hlFld-ContribAuthor ">Daniel N.  do Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Homologation: A Versatile Molecular Modification Strategy to Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1734-1750. <a href="https://doi.org/10.2174/1568026619666190808145235" title="DOI URL">https://doi.org/10.2174/1568026619666190808145235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190808145235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190808145235%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DHomologation%25253A%252BA%252BVersatile%252BMolecular%252BModification%252BStrategy%252Bto%252BDrug%252BDiscovery%26aulast%3DLima%26aufirst%3DL%25C3%25ADdia%2BM.%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1734%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Consuelo  Amantini</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Morelli</span>, <span class="hlFld-ContribAuthor ">Giorgio  Santoni</span>, <span class="hlFld-ContribAuthor ">Francisco O.  Battiti</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 461-473. <a href="https://doi.org/10.1016/j.ejmech.2019.02.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252Bmanipulations%252Bon%252Bthe%252B1%25252C4-dioxane%252Bring%252Bof%252B5-HT1A%252Breceptor%252Bagonists%252Blead%252Bto%252Bantagonists%252Bendowed%252Bwith%252Bantitumor%252Bactivity%252Bin%252Bprostate%252Bcancer%252Bcells%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26volume%3D168%26spage%3D461%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Bello</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (4)
                                     , 142. <a href="https://doi.org/10.3390/biom9040142" title="DOI URL">https://doi.org/10.3390/biom9040142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9040142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9040142%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DReceptor%252BLigands%252Bas%252BHelping%252BHands%252Bto%252BL-DOPA%252Bin%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DBello%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D4%26spage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of 77-LH-28-1 and compounds <b>2</b>–<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative selective D<sub>4</sub>R ligands belonging to different chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) General formula of 1,4-disubstituted piperidines and piperazines deduced from classical dopamine D<sub>3</sub>R and D<sub>4</sub>R drugs. (B) Chemical structure of <b>1</b>, fitting all the features of the pharmacophore except for the aromatic terminal, which is replaced by a butyl chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) suitable amine, NaH, DMF.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of mean concentration with standard deviations of <b>12</b> in plasma and brain after subcutaneous administration (3 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Main interactions stabilizing the putative complexes between the D<sub>4</sub>R homology model and <b>1</b> (A), <b>9</b> (B), <b>5</b> (C), and <b>12</b> (D). Panels B–D are focused on the contacts elicited by the apolar tail and underline (B) the extended set of apolar contacts stabilized by the benzyl moiety of <b>9</b>, (C) the detrimental role exerted by polar functions of <b>5</b>, and (D) the involvement of the residues located in ECL2, which contact the phenyl ring of <b>12</b>, whose backbone is colored in lime.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/medium/jm-2018-00265n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Main interactions stabilizing the putative complex for <b>1</b> within the D<sub>4</sub>R homology model, whose residues are colored according to the conservation degree as derived by the sequence alignment of D<sub>4</sub>R with D<sub>2</sub>R and D<sub>3</sub>R (light green = conserved residues; orange = nonconserved residues).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.8b00265/20180420/images/large/jm-2018-00265n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00265&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span> <span> </span><span class="NLM_article-title">Molecular properties of muscarinic acetylcholine receptors</span>. <i>Proc. Jpn. Acad., Ser. B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.2183/pjab.89.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2183%2Fpjab.89.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WisbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=226-256&author=T.+Haga&title=Molecular+properties+of+muscarinic+acetylcholine+receptors&doi=10.2183%2Fpjab.89.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of muscarinic acetylcholine receptors</span></div><div class="casAuthors">Haga, Tatsuya</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Japan Academy, Series B: Physical and Biological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">226-256</span>CODEN:
                <span class="NLM_cas:coden">PJABDW</span>;
        ISSN:<span class="NLM_cas:issn">0386-2208</span>.
    
            (<span class="NLM_cas:orgname">Nippon Gakushiin</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors, which comprise five subtypes (M1-M5 receptors), are expressed in both the CNS and PNS (particularly the target organs of parasympathetic neurons).  M1-M5 receptors are integral membrane proteins with seven trans-membrane segments, bind with acetylcholine (ACh) in the extracellular phase, and thereafter interact with and activate GTP-binding regulatory proteins (G proteins) in the intracellular phase: M1, M3, and M5 receptors interact with Gq-type G proteins, and M2 and M4 receptors with Gi/Go-type G proteins.  Activated G proteins initiate a no. of intracellular signal transduction systems.  Agonist-bound muscarinic receptors are phosphorylated by G protein-coupled receptor kinases, which initiate their desensitization through uncoupling from G proteins, receptor internalization, and receptor breakdown (down regulation).  Recently the crystal structures of M2 and M3 receptors were detd. and are expected to contribute to the development of drugs targeted to muscarinic receptors.  This paper summarizes the mol. properties of muscarinic receptors with ref. to the historical background and bias to studies performed in our labs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNsRsNbN65t7Vg90H21EOLACvtfcHk0lhfXTyzLnEBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WisbnF&md5=a794b04e33ebb4562699767c1776ddc1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2183%2Fpjab.89.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2183%252Fpjab.89.226%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DT.%26atitle%3DMolecular%2520properties%2520of%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DProc.%2520Jpn.%2520Acad.%252C%2520Ser.%2520B%26date%3D2013%26volume%3D89%26spage%3D226%26epage%3D256%26doi%3D10.2183%2Fpjab.89.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonds, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, M. R.</span></span> <span> </span><span class="NLM_article-title">Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3218</span>– <span class="NLM_lpage">3226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1523%2FJNEUROSCI.11-10-03218.1991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1941081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK3MXmsVymu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=3218-3226&author=A.+I.+Leveyauthor=C.+A.+Kittauthor=W.+F.+Simondsauthor=D.+L.+Priceauthor=M.+R.+Brann&title=Identification+and+localization+of+muscarinic+acetylcholine+receptor+proteins+in+brain+with+subtype-specific+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies</span></div><div class="casAuthors">Levey, Allan I.; Kitt, Cheryl A.; Simonds, William F.; Price, Donald L.; Brann, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3218-26</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">The mRNAs encoding 5 genetically distinct muscarinic acetylcholine receptors are present in the central nervous system.  Because of their pharmacol. similarities, it has not been possible to detect the individual encoded proteins; thus, their physiol. functions are not well defined.  To characterize the family of proteins, a panel of subtype-selective antibodies was generated against recombinant muscarinic receptor proteins and shown to bind specifically to each of the cloned receptors.  Using immunopptn., 3 receptor proteins (m1, m2, and m4) accounted for the vast majority of the total solubilized muscarinic binding sites in rat brain.  These receptor subtypes had marked differences in regional and cellular localization as shown by immunocytochem.  The m1-protein was present in cortex and striatum and was localized to cell bodies and neurites, consistent with its role as a major postsynaptic muscarinic receptor.  The m2-receptor protein was abundant in basal forebrain, scattered striatal neurons, mesopontine tegmentum, and cranial motor nuclei; this distribution is similar to that of cholinergic neurons and suggests that m2 is an autoreceptor.  However, m2 was also present in noncholinergic cortical and subcortical structures, providing evidence that this subtype may presynaptically modulate release of other neurotransmitters and/or function postsynaptically.  The m4-receptor was enriched in neostriatum, olfactory tubercle, and islands of Calleja, indicating an important role in extrapyramidal function.  These results clarify the roles of these genetically defined receptor proteins in cholinergic transmission in brain.  Since the nonselective muscarinic drugs used in the treatment of patients with neurol. disease produce many side effects, the characterization of receptor subtypes, including cellular and subcellular localization, will be of great value in defining the targets for the development of more effective and specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGmj58pI1WrVg90H21EOLACvtfcHk0lg8NpzQCq8lWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsVymu7k%253D&md5=88088860361c6ad23d6ff64730997f68</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.11-10-03218.1991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.11-10-03218.1991%26sid%3Dliteratum%253Aachs%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DKitt%26aufirst%3DC.%2BA.%26aulast%3DSimonds%26aufirst%3DW.%2BF.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DIdentification%2520and%2520localization%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520proteins%2520in%2520brain%2520with%2520subtype-specific%2520antibodies%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26spage%3D3218%26epage%3D3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span> <span> </span><span class="NLM_article-title">Activation of M<sub>1</sub> and M<sub>4</sub> muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia</span>. <i>Neuropsychiatr. Dis. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.2147/NDT.S55104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2147%2FNDT.S55104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=24511233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=183-191&author=D.+J.+Fosterauthor=D.+L.+Choiauthor=P.+J.+Connauthor=J.+M.+Rook&title=Activation+of+M1+and+M4+muscarinic+receptors+as+potential+treatments+for+Alzheimer%E2%80%99s+disease+and+schizophrenia&doi=10.2147%2FNDT.S55104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Foster, Daniel J.; Choi, Derrick L.; Conn, P. Jeffrey; Rook, Jerri M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-191, 9</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and schizophrenia (SZ) are neurol. disorders with overlapping symptomatol., including both cognitive deficits and behavioral disturbances.  Current clin. treatments for both disorders have limited efficacy accompanied by dose-limiting side effects, and ultimately fail to adequately address the broad range of symptoms obsd.  Novel therapeutic options for AD and SZ are needed to better manage the spectrum of symptoms with reduced adverse-effect liability.  Substantial evidence suggests that activation of muscarinic acetylcholine receptors (mAChRs) has the potential to treat both cognitive and psychosis-related symptoms assocd. with numerous central nervous system (CNS) disorders.  However, use of nonselective modulators of mAChRs is hampered by dose-limiting peripheral side effects that limit their clin. utility.  In order to maintain the clin. efficacy without the adverse-effect liability, efforts have been focused on the discovery of compds. that selectively modulate the centrally located M1 and M4 mAChR subtypes.  Previous drug discovery attempts have been thwarted by the highly conserved nature of the acetylcholine site across mAChR subtypes.  However, current efforts by our lab. and others have now focused on modulators that bind to allosteric sites on mAChRs, allowing these compds. to display unprecedented subtype selectivity.  Over the past couple of decades, the discovery of small mols. capable of selectively targeting the M1 or M4 mAChR subtypes has allowed researchers to elucidate the roles of these receptors in regulating cognitive and behavioral disturbances in preclin. animal models.  Here, we provide an overview of these promising preclin. and clin. studies, which suggest that M1- and M4-selective modulators represent viable novel targets with the potential to successfully address a broad range of symptoms obsd. in patients with AD and SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1huQLY2kYMrVg90H21EOLACvtfcHk0lg8NpzQCq8lWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL&md5=cb4b539ecd830e56559b11ad18358622</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2147%2FNDT.S55104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S55104%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520as%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520schizophrenia%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2014%26volume%3D10%26spage%3D183%26epage%3D191%26doi%3D10.2147%2FNDT.S55104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">M<sub>1</sub> muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer’s disease</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1039/c2md20025b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1039%2Fc2md20025b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=752-762&author=M.+Deckerauthor=U.+Holzgrabe&title=M1+muscarinic+acetylcholine+receptor+allosteric+modulators+as+potential+therapeutic+opportunities+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc2md20025b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2Fc2md20025b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20025b%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DM1%2520muscarinic%2520acetylcholine%2520receptor%2520allosteric%2520modulators%2520as%2520potential%2520therapeutic%2520opportunities%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D752%26epage%3D762%26doi%3D10.1039%2Fc2md20025b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeggo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kew, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melarange, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roopun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teriakidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M<sub>1</sub> muscarinic receptor agonist, 77-LH-28-1</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28-1&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lhfgEt9HxLLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28-1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of bitopic ligand engagement with the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">23817</span>– <span class="NLM_lpage">23837</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.582874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1074%2Fjbc.M114.582874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=25006252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=23817-23837&author=P.+Keovauthor=L.+L%C3%B3pezauthor=S.+M.+Devineauthor=C.+Valantauthor=J.+R.+Laneauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Molecular+mechanisms+of+bitopic+ligand+engagement+with+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.582874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Keov, Peter; Lopez, Laura; Devine, Shane M.; Valant, Celine; Lane, J. Robert; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">23817-23837</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TBPB and 77-LH-28-1 are selective agonists of the M1 muscarinic acetylcholine receptor (mAChR) that may gain their selectivity through a bitopic mechanism, interacting concomitantly with the orthosteric site and part of an allosteric site.  The current study combined site-directed mutagenesis, anal. pharmacol., and mol. modeling to gain further insights into the structural basis underlying binding and signaling by these agonists.  Mutations within the orthosteric binding site caused similar redns. in affinity and signaling efficacy for both selective and prototypical orthosteric ligands.  In contrast, the mutation of residues within transmembrane helix (TM) 2 and the second extracellular loop (ECL2) discriminated between the different classes of ligand.  In particular, ECL2 appears to be involved in the selective binding of bitopic ligands and in coordinating biased agonism between intracellular calcium mobilization and ERK1/2 phosphorylation.  Mol. modeling of the interaction between TBPB and the M1 mAChR revealed a binding pose predicted to extend from the orthosteric site up toward a putative allosteric site bordered by TM2, TM3, and TM7, thus consistent with a bitopic mode of binding.  Overall, these findings provide valuable structural and mechanistic insights into bitopic ligand actions and receptor activation and support a role for ECL2 in dictating the active states that can be adopted by a G protein-coupled receptor.  This may enable greater selective ligand design and development for mAChRs and facilitate improved identification of bitopic ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK1wgCftEmorVg90H21EOLACvtfcHk0lhfgEt9HxLLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSms7rK&md5=4bd6dfe1cf3d516746e579e97b181f29</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.582874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.582874%26sid%3Dliteratum%253Aachs%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520mechanisms%2520of%2520bitopic%2520ligand%2520engagement%2520with%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D23817%26epage%3D23837%26doi%3D10.1074%2Fjbc.M114.582874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, E. C.</span></span> <span> </span><span class="NLM_article-title">Mutagenic mapping suggests a novel binding mode for selective agonists of M<sub>1</sub> muscarinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1124/mol.108.050963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fmol.108.050963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=331-341&author=G.+Lebonauthor=C.+J.+Langmeadauthor=B.+G.+Tehanauthor=E.+C.+Hulme&title=Mutagenic+mapping+suggests+a+novel+binding+mode+for+selective+agonists+of+M1+muscarinic+acetylcholine+receptors&doi=10.1124%2Fmol.108.050963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.050963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.050963%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DHulme%26aufirst%3DE.%2BC.%26atitle%3DMutagenic%2520mapping%2520suggests%2520a%2520novel%2520binding%2520mode%2520for%2520selective%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D331%26epage%3D341%26doi%3D10.1124%2Fmol.108.050963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M<sub>1</sub>-preferring receptor agonists</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>605</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2008.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejphar.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19168056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=605&publication_year=2009&pages=53-56&author=J.+N.+Heinrichauthor=J.+A.+Buteraauthor=T.+Carrickauthor=A.+Kramerauthor=D.+Kowalauthor=T.+Lockauthor=K.+L.+Marquisauthor=M.+H.+Pauschauthor=M.+Popiolekauthor=S.+C.+Sunauthor=E.+Tsengauthor=A.+J.+Uvegesauthor=S.+C.+Mayer&title=Pharmacological+comparison+of+muscarinic+ligands%3A+historical+versus+more+recent+muscarinic+M1-preferring+receptor+agonists&doi=10.1016%2Fj.ejphar.2008.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists</span></div><div class="casAuthors">Heinrich, Julia N.; Butera, John A.; Carrick, Tikva; Kramer, Angela; Kowal, Dianne; Lock, Tim; Marquis, Karen L.; Pausch, Mark H.; Popiolek, Mike; Sun, Shaiu-Ching; Tseng, Eugene; Uveges, Albert J.; Mayer, Scott C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">605</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">53-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In functional assay assessments using the five muscarinic receptor subtypes, a second generation of muscarinic M1-preferring receptor agonists [AC-42 (1), AC-260584 (2), 77-LH-28-1 (3) and LY-593039 (4)] was shown to have higher selectivity for muscarinic M1 over M3 receptor as compared to historical agonists [talsaclidine (8), sabcomeline (10), xanomeline (11), WAY-132983 (12), cevimeline (9) and NGX-267 (6)].  Another striking difference of these more recent compds. is their affinities for the dopamine D2 and 5-HT2B receptors.  Taken together, these results suggest that the newer compds. may have a greater clin. safety profile, esp. with regard to muscarinic M3 receptor-mediated events, than the historical agonists, but their affinities for other receptors may still compromise their use to validate the therapeutic potential of muscarinic M1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmMFFxEgbLVg90H21EOLACvtfcHk0lh7lZm8jh3EMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D&md5=6654ccca50a1db7447e949f5028093dd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DCarrick%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BC.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26atitle%3DPharmacological%2520comparison%2520of%2520muscarinic%2520ligands%253A%2520historical%2520versus%2520more%2520recent%2520muscarinic%2520M1-preferring%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D605%26spage%3D53%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2008.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lh7lZm8jh3EMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajiness, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, L. V.</span></span> <span> </span><span class="NLM_article-title">Signal transduction pathways modulated by D<sub>2</sub>-like dopamine receptors</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/S1054-3589(08)60786-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2FS1054-3589%2808%2960786-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=454-457&author=R.+M.+Huffauthor=C.+L.+Chioauthor=M.+E.+Lajinessauthor=L.+V.+Goodman&title=Signal+transduction+pathways+modulated+by+D2-like+dopamine+receptors&doi=10.1016%2FS1054-3589%2808%2960786-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1054-3589%2808%2960786-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1054-3589%252808%252960786-3%26sid%3Dliteratum%253Aachs%26aulast%3DHuff%26aufirst%3DR.%2BM.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DLajiness%26aufirst%3DM.%2BE.%26aulast%3DGoodman%26aufirst%3DL.%2BV.%26atitle%3DSignal%2520transduction%2520pathways%2520modulated%2520by%2520D2-like%2520dopamine%2520receptors%26jtitle%3DAdv.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D454%26epage%3D457%26doi%3D10.1016%2FS1054-3589%2808%2960786-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehne, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andree, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, J. N.</span></span> <span> </span><span class="NLM_article-title">D<sub>2</sub> receptor partial agonists: treatment of CNS disorders of dopamine function</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.2174/156802608785161394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.2174%2F156802608785161394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=18691133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1068-1088&author=J.+H.+Kehneauthor=T.+H.+Andreeauthor=J.+N.+Heinrich&title=D2+receptor+partial+agonists%3A+treatment+of+CNS+disorders+of+dopamine+function&doi=10.2174%2F156802608785161394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">D2 receptor partial agonists: treatment of CNS disorders of dopamine function</span></div><div class="casAuthors">Kehne, John H.; Andree, Terrance H.; Heinrich, Julia N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1068-1088</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A remarkable diversity of psychiatric and neurol. disorders have been assocd. with dysfunction of dopamine (DA)-contg. neurons, including schizophrenia, bipolar disorder (BD), Parkinson's disease (PD), and restless legs syndrome (RLS).  In such disorders, transmission in discrete DA pathways may range from hypoactivation to hyperactivation of DA receptors, particularly those of the D2 subtype, providing the rationale for treatment approaches that activate or block D2 receptors, resp.  However, full agonists or pure D2 receptor antagonists may not be optimal therapeutic approaches for their resp. disorders for a no. of reasons, including an inability to restore the aberrant DA pathways to a normal level of basal tone.  D2 receptor partial agonists (D2PAs) are proposed to stabilize activity in DA pathways by dampening excessive (and/or by restoring deficient) D2 receptor stimulation thereby shepherding DA neurons back to a desired level of basal activity.  Stabilizing aberrant DA activity without disrupting non-dysfunctional DA neurons may provide a potentially improved approach for treating DA disorders.  The status of DA D2PAs and their potential application to schizophrenia, BD, PD, and RLS is reviewed.  Preclin. and clin. evidence supports the idea that dysfunctions of D2 receptors contribute to these CNS disorders.  Diseases in which both hyper- and hypofunction of DA pathways are present may be particularly promising, and challenging, targets for D2PAs.  Furthermore, different DA disorders may respond optimally to D2PAs with differing levels of intrinsic activity, with "DA deficiency" diseases responding more effectively to higher intrinsic activity D2PAs than "DA hyperactivation" diseases.  Overall, current evidence supports the conclusion that D2PAs have significant potential as improved CNS therapies relative to classic full agonists and antagonists at D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXnz0ClAI_LVg90H21EOLACvtfcHk0lh7lZm8jh3EMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtbw%253D&md5=e2501665b430e96d34941f0101b98190</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802608785161394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161394%26sid%3Dliteratum%253Aachs%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26atitle%3DD2%2520receptor%2520partial%2520agonists%253A%2520treatment%2520of%2520CNS%2520disorders%2520of%2520dopamine%2520function%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1068%26epage%3D1088%26doi%3D10.2174%2F156802608785161394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. H. F.</span>; <span class="NLM_string-name">Wong, A. H. C.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptor genetics in neuropsychiatric disorders</span>. In  <i>The Dopamine Receptors</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, K. A.</span></span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">632</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1007%2F978-1-60327-333-6_19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=585-632&author=F.+H.+F.+Lee&author=A.+H.+C.+Wongauthor=K.+A.+Neve&title=The+Dopamine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-333-6_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-60327-333-6_19%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DF.%2BH.%2BF.%26atitle%3DDopamine%2520receptor%2520genetics%2520in%2520neuropsychiatric%2520disorders%26btitle%3DThe%2520Dopamine%2520Receptors%26aulast%3DNeve%26aufirst%3DK.%2BA.%26pub%3DHumana%2520Press%26date%3D2010%26spage%3D585%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enna, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Challenges in the search for drugs to treat central nervous system disorders</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.143420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fjpet.108.143420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19182069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Omuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=404-411&author=S.+J.+Ennaauthor=M.+Williams&title=Challenges+in+the+search+for+drugs+to+treat+central+nervous+system+disorders&doi=10.1124%2Fjpet.108.143420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the search for drugs to treat central nervous system disorders</span></div><div class="casAuthors">Enna, S. J.; Williams, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-411</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The history of drug discovery spans approx. 200,000 years.  For much of this time, the identification of therapeutic agents was empirical, with the shift to a more hypothesis-driven approach occurring in the late 19th century.  Since then, the objective has changed from identifying an active drug and its mechanism of action to detg. therapeutic potential only after identifying drug-like compds. that interact with a target site.  Although the emphasis on target identification, or targephilia, has yielded novel drugs, overall it appears to have slowed the drug discovery process, esp. for compds. used in treating central nervous system (CNS) disorders.  This is because the targephilic approach requires a good understanding of target physiol. and its integration with the target organ, with a hierarchical integration from in vitro cellular and functional tissue studies to animal models that reasonably predict human responses.  Because the majority of CNS drugs were discovered empirically, drug discovery in this area appears less amenable to target-based approaches than it seems for other types of therapeutics.  Improving the success rate in CNS drug discovery requires a more pharmacometric-based approach, with a renewed emphasis on defining basic CNS function in intact animals and a more systematic in vivo screening of novel structures.  Efforts must also be directed toward defining the sites of action of existing CNS drugs to aid in the design of second-generation agents with improved efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE5W5Q6hNLP7Vg90H21EOLACvtfcHk0ljT46H_J3jVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Omuro%253D&md5=3b19e9402d08d3e722e6a445b4714d57</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143420%26sid%3Dliteratum%253Aachs%26aulast%3DEnna%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DChallenges%2520in%2520the%2520search%2520for%2520drugs%2520to%2520treat%2520central%2520nervous%2520system%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D404%26epage%3D411%26doi%3D10.1124%2Fjpet.108.143420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Tol, H. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D<sub>4</sub> receptor with high affinity for the antipsychotic clozapine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/350610a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+M.+Van%0ATolauthor=J.+R.+Bunzowauthor=H.-C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine&doi=10.1038%2F350610a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0lggTaGbmD6Lqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614%26doi%3D10.1038%2F350610a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span> <span> </span><span class="NLM_article-title">The return of D<sub>4</sub> dopamine receptor antagonists in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7233</span>– <span class="NLM_lpage">7243</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7233-7243&author=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=The+return+of+D4+dopamine+receptor+antagonists+in+drug+discovery&doi=10.1021%2Facs.jmedchem.7b00151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00151%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DThe%2520return%2520of%2520D4%2520dopamine%2520receptor%2520antagonists%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7233%26epage%3D7243%26doi%3D10.1021%2Facs.jmedchem.7b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the search for D<sub>3</sub>- and D<sub>4</sub>-selective drugs: probes, models and candidates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2eZPYuv_KDM007ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeyer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">PR123</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1021/cr300113a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300113a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR123-178&author=N.+Yeauthor=J.+L.+Neumeyerauthor=R.+J.+Baldessariniauthor=X.+Zhenauthor=A.+Zhang&title=Update+1+of%3A+Recent+progress+in+development+of+dopamine+receptor+subtype-selective+agents%3A+potential+therapeutics+for+neurological+and+psychiatric+disorders&doi=10.1021%2Fcr300113a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300113a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DZhen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DUpdate%25201%2520of%253A%2520Recent%2520progress%2520in%2520development%2520of%2520dopamine%2520receptor%2520subtype-selective%2520agents%253A%2520potential%2520therapeutics%2520for%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR123%26epage%3D178%26doi%3D10.1021%2Fcr300113a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackling, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D<sub>3</sub> receptor ligands</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1002/cbic.200300784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbic.200300784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=15185375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1OmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=508-518&author=U.+R.+Machauthor=A.+E.+Hacklingauthor=S.+Perachonauthor=S.+Ferryauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=P.+Sokoloffauthor=H.+Stark&title=Development+of+novel+1%2C2%2C3%2C4-tetrahydroisoquinoline+derivatives+and+closely+related+compounds+as+potent+and+selective+dopamine+D3+receptor+ligands&doi=10.1002%2Fcbic.200300784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands</span></div><div class="casAuthors">Mach, Ulrich R.; Hackling, Anneke E.; Perachon, Sylvie; Ferry, Sandrine; Wermuth, Camille G.; Schwartz, Jean-Charles; Sokoloff, Pierre; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Based on N-alkylated 1,2,3,4-tetrahydroisoquinoline derivs. which are structurally related to the partial agonist BP 897, a series of novel, selective dopamine D3 receptor antagonists has been synthesized.  Derivatization included changes in the arylamide moiety and the tetrahydroisoquinoline substructure leading to compds. with markedly improved selectivities and affinities in the low nanomolar concn. range.  From the 55 structures presented here, (E)-3-(4-iodophenyl)-N-(4-(1,2,3,4-tetrahydroisoquinolin-2-yl)butyl)acrylamide (51) has high affinity (Ki(hD3) = 12 nM) and a 123-fold preference for the D3 receptor relative to the D2 receptor subtype.  Its pharmacol. profile offers the prospect of a novel radioligand as a tool for various dopamine D3-receptor-related in vitro and in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg7zhWvn6mRLVg90H21EOLACvtfcHk0liFVDP-RvJ7Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1OmtLg%253D&md5=580665e16ce2e75a349d1c301e1916ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300784%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DU.%2BR.%26aulast%3DHackling%26aufirst%3DA.%2BE.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520novel%25201%252C2%252C3%252C4-tetrahydroisoquinoline%2520derivatives%2520and%2520closely%2520related%2520compounds%2520as%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D508%26epage%3D518%26doi%3D10.1002%2Fcbic.200300784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Areias, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D<sub>2</sub> and D<sub>3</sub> receptors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcmdc.201000101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1300-1317&author=L.+L%C3%B3pezauthor=J.+Selentauthor=R.+Ortegaauthor=C.+F.+Masaguerauthor=E.+Dom%C3%ADnguezauthor=F.+Areiasauthor=J.+Breaauthor=M.+I.+Lozaauthor=F.+Sanzauthor=M.+Pastor&title=Synthesis%2C+3D-QSAR%2C+and+structural+modeling+of+benzolactam+derivatives+with+binding+affinity+for+the+D2+and+D3+receptors&doi=10.1002%2Fcmdc.201000101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000101%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DR.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DE.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DPastor%26aufirst%3DM.%26atitle%3DSynthesis%252C%25203D-QSAR%252C%2520and%2520structural%2520modeling%2520of%2520benzolactam%2520derivatives%2520with%2520binding%2520affinity%2520for%2520the%2520D2%2520and%2520D3%2520receptors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1300%26epage%3D1317%26doi%3D10.1002%2Fcmdc.201000101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1–[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9065</span>– <span class="NLM_lpage">9077</span>, <span class="refDoi"> DOI: 10.1021/jm501173q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501173q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9065-9077&author=A.+Bonifaziauthor=H.+Yanoauthor=F.+Del+Belloauthor=A.+Farandeauthor=W.+Quagliaauthor=R.+Petrelliauthor=R.+Matucciauthor=M.+Nesiauthor=G.+Vistoliauthor=S.+Ferr%C3%A9author=A.+Piergentili&title=Synthesis+and+biological+evaluation+of+a+novel+series+of+heterobivalent+muscarinic+ligands+based+on+xanomeline+and+1%E2%80%93%5B3-%284-butylpiperidin-1-yl%29propyl%5D-1%2C2%2C3%2C4-tetrahydroquinolin-2-one+%2877-LH-28-1%29&doi=10.1021%2Fjm501173q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501173q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501173q%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DA.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DPiergentili%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520heterobivalent%2520muscarinic%2520ligands%2520based%2520on%2520xanomeline%2520and%25201%25E2%2580%2593%255B3-%25284-butylpiperidin-1-yl%2529propyl%255D-1%252C2%252C3%252C4-tetrahydroquinolin-2-one%2520%252877-LH-28-1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9065%26epage%3D9077%26doi%3D10.1021%2Fjm501173q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havera, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDyke, J. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancilio, L. F.</span></span> <span> </span><span class="NLM_article-title">Analgetic activity of cyclized basic anilides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm00304a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00304a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=580-583&author=H.+J.+Haveraauthor=J.+W.+VanDykeauthor=T.+M.+Liuauthor=L.+F.+Sancilio&title=Analgetic+activity+of+cyclized+basic+anilides&doi=10.1021%2Fjm00304a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00304a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00304a004%26sid%3Dliteratum%253Aachs%26aulast%3DHavera%26aufirst%3DH.%2BJ.%26aulast%3DVanDyke%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DT.%2BM.%26aulast%3DSancilio%26aufirst%3DL.%2BF.%26atitle%3DAnalgetic%2520activity%2520of%2520cyclized%2520basic%2520anilides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D580%26epage%3D583%26doi%3D10.1021%2Fjm00304a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+T.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lh_SdOaDryhmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sams, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plath, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M<sub>1</sub> receptor agonist with unprecedented selectivity and procognitive potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6386</span>– <span class="NLM_lpage">6397</span>, <span class="refDoi"> DOI: 10.1021/jm100697g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100697g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6386-6397&author=A.+G.+Samsauthor=M.+Hentzerauthor=G.+K.+Mikkelsenauthor=K.+Larsenauthor=C.+Bundgaardauthor=N.+Plathauthor=C.+T.+Christoffersenauthor=B.+Bang-Andersen&title=Discovery+of+N-%7B1-%5B3-%283-oxo-2%2C3-dihydrobenzo%5B1%2C4%5Doxazin-4-yl%29propyl%5Dpiperidin-4-yl%7D-2-phenylacetamide+%28Lu+AE51090%29%3A+an+allosteric+muscarinic+M1+receptor+agonist+with+unprecedented+selectivity+and+procognitive+potential&doi=10.1021%2Fjm100697g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm100697g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100697g%26sid%3Dliteratum%253Aachs%26aulast%3DSams%26aufirst%3DA.%2BG.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DLarsen%26aufirst%3DK.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DPlath%26aufirst%3DN.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520N-%257B1-%255B3-%25283-oxo-2%252C3-dihydrobenzo%255B1%252C4%255Doxazin-4-yl%2529propyl%255Dpiperidin-4-yl%257D-2-phenylacetamide%2520%2528Lu%2520AE51090%2529%253A%2520an%2520allosteric%2520muscarinic%2520M1%2520receptor%2520agonist%2520with%2520unprecedented%2520selectivity%2520and%2520procognitive%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6386%26epage%3D6397%26doi%3D10.1021%2Fjm100697g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micioni Di Bonaventura, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggesi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">The replacement of the 2-methoxy substituent of <i>N</i>-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT<sub>1A</sub> receptor over α<sub>1</sub>-adrenoceptor and D<sub>2</sub>-like receptor subtypes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejmech.2016.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27662034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGrt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=233-244&author=F.+Del%0ABelloauthor=A.+Bonifaziauthor=M.+Giannellaauthor=G.+Giorgioniauthor=A.+Piergentiliauthor=R.+Petrelliauthor=C.+Cifaniauthor=M.+V.+Micioni+Di+Bonaventuraauthor=T.+M.+Keckauthor=A.+Mazzolariauthor=G.+Vistoliauthor=A.+Ciliaauthor=E.+Poggesiauthor=R.+Matucciauthor=W.+Quaglia&title=The+replacement+of+the+2-methoxy+substituent+of+N-%28%286%2C6-diphenyl-1%2C4-dioxan-2-yl%29methyl%29-2-%282-methoxyphenoxy%29ethan-1-amine+improves+the+selectivity+for+5-HT1A+receptor+over+%CE%B11-adrenoceptor+and+D2-like+receptor+subtypes&doi=10.1016%2Fj.ejmech.2016.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes</span></div><div class="casAuthors">Del Bello, Fabio; Bonifazi, Alessandro; Giannella, Mario; Giorgioni, Gianfabio; Piergentili, Alessandro; Petrelli, Riccardo; Cifani, Carlo; Micioni Di Bonaventura, Maria Vittoria; Keck, Thomas M.; Mazzolari, Angelica; Vistoli, Giulio; Cilia, Antonio; Poggesi, Elena; Matucci, Rosanna; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine (I) is a potent 5-HT1A receptor and α1d-adrenoceptor (α1d-AR) ligand.  Analogs II [X = CH, R = Cl, Me, NO2, OH, OCH2OMe; X = N, R = H] were rationally designed and prepd. to evaluate whether electronic and/or lipophilic properties of substituents in the ortho position of its phenoxy moiety exert any favorable effects on the affinity/activity at 5-HT1A receptor and improve selectivity over α1-ARs.  To rationalize the exptl. observations and derive information about receptor-ligand interactions of the reported ligands, docking studies, using 5-HT1A and α1d-AR models generated by homol. techniques, and a retrospective computational study were performed.  The results highlighted that proper substituents in position 2 of the phenoxy moiety of 3 selectively address the ligands toward 5-HT1A receptor with respect to α1-ARs and D2-like receptor subtypes.  Methoxymethylenoxy deriv. II [X = CH, R = OCH2OMe] showed the best 5-HT1A selectivity profile and the highest potency at 5-HT1A receptor, behaving as a partial agonist.  Finally, II [X = CH, R = OCH2OMe], tested in light/dark exploration test in mice, significantly reduced anxiety-linked behaviors.  Therefore, it may be considered a lead for the design of partial agonists potentially useful in the treatment of disorders in which 5-HT1A receptor is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE3SWsDcqoKLVg90H21EOLACvtfcHk0lhB3DkMY8NDaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGrt7jN&md5=d0d0c386b3f910521042565ed32ba839</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMicioni%2BDi%2BBonaventura%26aufirst%3DM.%2BV.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DCilia%26aufirst%3DA.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DThe%2520replacement%2520of%2520the%25202-methoxy%2520substituent%2520of%2520N-%2528%25286%252C6-diphenyl-1%252C4-dioxan-2-yl%2529methyl%2529-2-%25282-methoxyphenoxy%2529ethan-1-amine%2520improves%2520the%2520selectivity%2520for%25205-HT1A%2520receptor%2520over%2520%25CE%25B11-adrenoceptor%2520and%2520D2-like%2520receptor%2520subtypes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D233%26epage%3D244%26doi%3D10.1016%2Fj.ejmech.2016.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Ben, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Soto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span> <span> </span><span class="NLM_article-title">A novel class of dopamine D<sub>4</sub> receptor ligands bearing an imidazoline nucleus</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcmdc.201600022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=26990230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1819-1828&author=V.+Mammoliauthor=A.+Bonifaziauthor=D.+Dal+Benauthor=M.+Giannellaauthor=G.+Giorgioniauthor=A.+Piergentiliauthor=M.+Piginiauthor=W.+Quagliaauthor=A.+Thomasauthor=A.+H.+Newmanauthor=S.+Ferr%C3%A9author=M.+Sanchez-Sotoauthor=T.+M.+Keckauthor=F.+Del+Bello&title=A+novel+class+of+dopamine+D4+receptor+ligands+bearing+an+imidazoline+nucleus&doi=10.1002%2Fcmdc.201600022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus</span></div><div class="casAuthors">Mammoli, Valerio; Bonifazi, Alessandro; Dal Ben, Diego; Giannella, Mario; Giorgioni, Gianfabio; Piergentili, Alessandro; Pigini, Maria; Quaglia, Wilma; Thomas, Ajiroghene; Newman, Amy H.; Ferre, Sergi; Sanchez-Soto, Marta; Keck, Thomas M.; Del Bello, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1819-1828</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Over the years, the 2-substituted imidazoline nucleus has been demonstrated to be a bioversatile structural motif.  In this study, novel imidazoline derivs. bearing a 3- and/or 4-hydroxy- or methoxy-substituted Ph ring, linked by an ethylene bridge to position 2 of an N-benzyl- or N-phenethyl-substituted imidazoline nucleus, were prepd. and studied against D2-like receptor subtypes.  Binding studies highlighted that a set of N-phenethylimidazoline compds. are selective for D4 over D2 and D3 receptors.  In functional assays, the 3-methoxy-substituted deriv., endowed with the highest D4 affinity value, and its 3-hydroxy analog behaved as partial agonists with low intrinsic efficacy and as competitive D4 antagonists when tested in the presence of the D2-like receptor agonist quinpirole.  Mol. docking anal., performed using a homol. model of the human D4 receptor developed using the X-ray crystal structure of the antagonist-bound human D3 receptor as a template, was in accordance with the binding results and provided useful information for the design of novel imidazoline D4 receptor ligands based on this new scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWnSDaWqXh7Vg90H21EOLACvtfcHk0lhB3DkMY8NDaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlKlsLo%253D&md5=ff32a504bf4e28810262bfad7e87a9cb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600022%26sid%3Dliteratum%253Aachs%26aulast%3DMammoli%26aufirst%3DV.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DSanchez-Soto%26aufirst%3DM.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DDel%2BBello%26aufirst%3DF.%26atitle%3DA%2520novel%2520class%2520of%2520dopamine%2520D4%2520receptor%2520ligands%2520bearing%2520an%2520imidazoline%2520nucleus%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1819%26epage%3D1828%26doi%3D10.1002%2Fcmdc.201600022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (I<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhB3DkMY8NDaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcicchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span> <span> </span><span class="NLM_article-title">Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejmech.2017.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=28609709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=327-337&author=F.+Del%0ABelloauthor=A.+Bonifaziauthor=G.+Giorgioniauthor=R.+Petrelliauthor=W.+Quagliaauthor=A.+Altomareauthor=A.+Falcicchioauthor=R.+Matucciauthor=G.+Vistoliauthor=A.+Piergentili&title=Novel+muscarinic+acetylcholine+receptor+hybrid+ligands+embedding+quinuclidine+and+1%2C4-dioxane+fragments&doi=10.1016%2Fj.ejmech.2017.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments</span></div><div class="casAuthors">Del Bello, Fabio; Bonifazi, Alessandro; Giorgioni, Gianfabio; Petrelli, Riccardo; Quaglia, Wilma; Altomare, Angela; Falcicchio, Aurelia; Matucci, Rosanna; Vistoli, Giulio; Piergentili, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-337</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To obtain novel muscarinic acetylcholine receptor (mAChR) antagonists, the enantiomers of the hybrid compds. (I (R = H, Me), II), in which the quinuclidin-3-yloxy fragment of solifenacin and the 6,6-diphenyl-1,4-dioxane-2-yl moiety linked by an ester or ether spacer were embedded in the same chem. entity, were prepd. and evaluated for their affinity at the five mAChR subtypes (M1-M5).  Stereochem. and the nature of the linker between the quinuclidine moiety and the 1,4-dioxane nucleus play an important role on the affinities of the compds.  The presence of an ether bridge confers higher affinities for all mAChR subtypes to the ligand.  Interestingly, the ether enantiomer (R,S)-II shows the highest affinity at all mAChR subtypes with pKi values similar to that of solifenacin at M3 and higher at the other subtypes.  Unlike solifenacin, it shows a preference for M1 mAChR subtype with respect to the other subtypes.  This compd., lacking a permanent pos. charge on the nitrogen atom, can be a useful tool for the pharmacol. study of mAChRs in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOfeZ1yf6kuLVg90H21EOLACvtfcHk0lhnUWWwo50ooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjur3P&md5=31008476052c3ff0a6ac7a01621ae8e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DGiorgioni%26aufirst%3DG.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DFalcicchio%26aufirst%3DA.%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DPiergentili%26aufirst%3DA.%26atitle%3DNovel%2520muscarinic%2520acetylcholine%2520receptor%2520hybrid%2520ligands%2520embedding%2520quinuclidine%2520and%25201%252C4-dioxane%2520fragments%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D137%26spage%3D327%26epage%3D337%26doi%3D10.1016%2Fj.ejmech.2017.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guandalini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanelli, M. N.</span></span> <span> </span><span class="NLM_article-title">Carbachol dimers as homobivalent modulators of muscarinic receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.bcp.2016.03.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=90-101&author=R.+Matucciauthor=M.+Nesiauthor=M.+V.+Martinoauthor=C.+Bellucciauthor=D.+Manettiauthor=E.+Ciutiauthor=A.+Mazzolariauthor=S.+Deiauthor=L.+Guandaliniauthor=E.+Teodoriauthor=G.+Vistoliauthor=M.+N.+Romanelli&title=Carbachol+dimers+as+homobivalent+modulators+of+muscarinic+receptors&doi=10.1016%2Fj.bcp.2016.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatucci%26aufirst%3DR.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DMartino%26aufirst%3DM.%2BV.%26aulast%3DBellucci%26aufirst%3DC.%26aulast%3DManetti%26aufirst%3DD.%26aulast%3DCiuti%26aufirst%3DE.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26atitle%3DCarbachol%2520dimers%2520as%2520homobivalent%2520modulators%2520of%2520muscarinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D108%26spage%3D90%26epage%3D101%26doi%3D10.1016%2Fj.bcp.2016.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farfariello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggesi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships in 1,4-benzodioxan-related compounds. 11. Reversed enantioselectivity of 1,4-dioxane derivatives in α<sub>1</sub>-adrenergic and 5-HT<sub>1A</sub> receptor binding sites recognition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1021/jm301525w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301525w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKhurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=584-588&author=A.+Bonifaziauthor=A.+Piergentiliauthor=F.+Del+Belloauthor=Y.+Farandeauthor=M.+Giannellaauthor=M.+Piginiauthor=C.+Amantiniauthor=M.+Nabissiauthor=V.+Farfarielloauthor=G.+Santoniauthor=E.+Poggesiauthor=A.+Leonardiauthor=S.+Menegonauthor=W.+Quaglia&title=Structure%E2%80%93activity+relationships+in+1%2C4-benzodioxan-related+compounds.+11.+Reversed+enantioselectivity+of+1%2C4-dioxane+derivatives+in+%CE%B11-adrenergic+and+5-HT1A+receptor+binding+sites+recognition&doi=10.1021%2Fjm301525w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11. Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1-Adrenergic and 5-HT1A Receptor Binding Sites Recognition</span></div><div class="casAuthors">Bonifazi, Alessandro; Piergentili, Alessandro; Del Bello, Fabio; Farande, Yogita; Giannella, Mario; Pigini, Maria; Amantini, Consuelo; Nabissi, Massimo; Farfariello, Valerio; Santoni, Giorgio; Poggesi, Elena; Leonardi, Amedeo; Menegon, Sergio; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">584-588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-HT1A receptor and α1-adrenoreceptor (α1-AR) binding sites recognized by the 1,4-dioxanes 2-4 display reversed stereochem. requirements. (S)-2 proved to be a potent 5-HT1A receptor agonist highly selective over α1-AR subtypes.  Chirality influenced the anticancer activity of 3 and 4 in human prostate cancer cells (PC-3): (R)-4, eutomer at the α1d-AR subtype, was the most potent.  The decreased effect of 4 and (R)-4 in α1d-AR silenced PC-3 cells confirmed that their anticancer activity was α1d-AR-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Q-LN9OxlA7Vg90H21EOLACvtfcHk0lhnUWWwo50ooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKhurjJ&md5=1ddde77a863997976e8b1f1380c3afc0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301525w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301525w%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DY.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DFarfariello%26aufirst%3DV.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%25201%252C4-benzodioxan-related%2520compounds.%252011.%2520Reversed%2520enantioselectivity%2520of%25201%252C4-dioxane%2520derivatives%2520in%2520%25CE%25B11-adrenergic%2520and%25205-HT1A%2520receptor%2520binding%2520sites%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D584%26epage%3D588%26doi%3D10.1021%2Fjm301525w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barocelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flammini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Novel potent <i>N</i>-methyl-D-aspartate (NMDA) receptor antagonists or σ<sub>1</sub> receptor ligands based on properly substituted 1,4-dioxane ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8601</span>– <span class="NLM_lpage">8615</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01214</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01214" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8601-8615&author=A.+Bonifaziauthor=F.+Del+Belloauthor=V.+Mammoliauthor=A.+Piergentiliauthor=R.+Petrelliauthor=C.+Cimarelliauthor=M.+Pelleiauthor=D.+Schepmannauthor=B.+W%C3%BCnschauthor=E.+Barocelliauthor=S.+Bertoniauthor=L.+Flamminiauthor=C.+Amantiniauthor=M.+Nabissiauthor=G.+Santoniauthor=G.+Vistoliauthor=W.+Quaglia&title=Novel+potent+N-methyl-D-aspartate+%28NMDA%29+receptor+antagonists+or+%CF%831+receptor+ligands+based+on+properly+substituted+1%2C4-dioxane+ring&doi=10.1021%2Facs.jmedchem.5b01214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Potent N-Methyl-D-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring</span></div><div class="casAuthors">Bonifazi, Alessandro; Del Bello, Fabio; Mammoli, Valerio; Piergentili, Alessandro; Petrelli, Riccardo; Cimarelli, Cristina; Pellei, Maura; Schepmann, Dirk; Wunsch, Bernhard; Barocelli, Elisabetta; Bertoni, Simona; Flammini, Lisa; Amantini, Consuelo; Nabissi, Massimo; Santoni, Giorgio; Vistoli, Giulio; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8601-8615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepd. to interact either with the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA) receptor or with σ1 receptors, resp.  The biol. profiles of the novel compds. were assessed using radioligand binding assays, and the compds. with the highest affinities were investigated for their functional activity.  The results were in line with the available pharmacophore models and highlighted that the 1,4-dioxane scaffold is compatible with potent antagonist activity at NMDA receptor or high affinity for σ1 receptors.  The primary amines I [R = C6H11, trans] and I [R = Ph] bearing a cyclohexyl and a Ph ring or two Ph rings in position 6, resp., were the most potent noncompetitive antagonists at the NMDA receptor with IC50 values similar to those of the dissociative anesthetic (S)-(+)-ketamine.  The 5,5-di-Ph substitution assocd. with a benzylaminomethyl moiety in position 2, as in II, favored the interaction with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom9Lw-lUtPSLVg90H21EOLACvtfcHk0ljub2bfRea1SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slsb%252FN&md5=0c053c67bc8f4f3449c1af2a3470df2e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01214%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DMammoli%26aufirst%3DV.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DCimarelli%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26aulast%3DBarocelli%26aufirst%3DE.%26aulast%3DBertoni%26aufirst%3DS.%26aulast%3DFlammini%26aufirst%3DL.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DNovel%2520potent%2520N-methyl-D-aspartate%2520%2528NMDA%2529%2520receptor%2520antagonists%2520or%2520%25CF%25831%2520receptor%2520ligands%2520based%2520on%2520properly%2520substituted%25201%252C4-dioxane%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8601%26epage%3D8615%26doi%3D10.1021%2Facs.jmedchem.5b01214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and high affinity 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10676</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10676-10691&author=J.+Caoauthor=R.+D.+Slackauthor=O.+M.+Bakareauthor=C.+Burzynskiauthor=R.+Raisauthor=B.+S.+Slusherauthor=T.+Kopajticauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=H.+Yanoauthor=Y.+Heauthor=G.-H.+Biauthor=Z.-X.+Xiauthor=C.+J.+Lolandauthor=A.+H.+Newman&title=Novel+and+high+affinity+2-%5B%28diphenylmethyl%29sulfinyl%5Dacetamide+%28modafinil%29+analogues+as+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.6b01373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Cao, Jianjing; Slack, Rachel D.; Bakare, Oluyomi M.; Burzynski, Caitlin; Rais, Rana; Slusher, Barbara S.; Kopajtic, Theresa; Bonifazi, Alessandro; Ellenberger, Michael P.; Yano, Hideaki; He, Yi; Bi, Guo-Hua; Xi, Zheng-Xiong; Loland, Claus J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10676-10691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT).  The atypical DAT inhibitors have received attention due to their promising pharmacol. profiles in animal models of cocaine and methamphetamine abuse.  Herein the authors report a series of modafinil analogs that have an atypical DAT inhibitor profile.  The authors extended SAR by chem. manipulating the oxidn. states of the sulfoxide and the amide functional groups, halogenating the Ph rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 1-(4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (compd. 11b), which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine.  These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimulant abuse medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0BwESHNuRbVg90H21EOLACvtfcHk0ljub2bfRea1SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP&md5=e912f256c764249ad606d83ac9c570fb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520high%2520affinity%25202-%255B%2528diphenylmethyl%2529sulfinyl%255Dacetamide%2520%2528modafinil%2529%2520analogues%2520as%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10676%26epage%3D10691%26doi%3D10.1021%2Facs.jmedchem.6b01373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.173948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling&doi=10.1124%2Fjpet.110.173948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0ljub2bfRea1SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302%26doi%3D10.1124%2Fjpet.110.173948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farande, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benicchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signalling pathway</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5725</span>– <span class="NLM_lpage">5733</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.bmc.2015.07.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5725-5733&author=F.+Del%0ABelloauthor=A.+Farandeauthor=M.+Giannellaauthor=A.+Piergentiliauthor=W.+Quagliaauthor=T.+Benicchiauthor=F.+Cappelliauthor=A.+Nenciniauthor=M.+Salernoauthor=R.+J.+Thomasauthor=M.+Travagliauthor=M.+Varrone&title=Identification+of+2-aminopyrimidine+derivatives+as+inhibitors+of+the+canonical+Wnt+signalling+pathway&doi=10.1016%2Fj.bmc.2015.07.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DA.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DBenicchi%26aufirst%3DT.%26aulast%3DCappelli%26aufirst%3DF.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DSalerno%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26atitle%3DIdentification%2520of%25202-aminopyrimidine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520canonical%2520Wnt%2520signalling%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5725%26epage%3D5733%26doi%3D10.1016%2Fj.bmc.2015.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">In vitro prediction of brain penetration – a case for free thinking?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1517/17460441.1.6.595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1517%2F17460441.1.6.595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=595-560&author=S.+G.+Summerfieldauthor=P.+Jeffrey&title=In+vitro+prediction+of+brain+penetration+%E2%80%93+a+case+for+free+thinking%3F&doi=10.1517%2F17460441.1.6.595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17460441.1.6.595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.1.6.595%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520prediction%2520of%2520brain%2520penetration%2520%25E2%2580%2593%2520a%2520case%2520for%2520free%2520thinking%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2006%26volume%3D6%26spage%3D595%26epage%3D560%26doi%3D10.1517%2F17460441.1.6.595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelletti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Cin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehanne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajbaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchió, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliosi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdonà, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomelleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolyl 5-azaspiro[2.4]heptanes: lead identification and early lead optimization of a new series of potent and selective dopamine D3 receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8576</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8549-8576&author=F.+Micheliauthor=A.+Bacchiauthor=S.+Braggioauthor=L.+Castellettiauthor=P.+Cavalliniauthor=P.+Cavanniauthor=S.+Cremonesiauthor=M.+Dal+Cinauthor=A.+Ferianiauthor=S.+Gehanneauthor=M.+Kajbafauthor=L.+Marchi%C3%B3author=S.+Nolaauthor=B.+Oliosiauthor=A.+Pellacaniauthor=E.+Perdon%C3%A0author=A.+Savaauthor=T.+Semeraroauthor=L.+Tarsiauthor=S.+Tomelleriauthor=A.+Wongauthor=F.+Visentiniauthor=L.+Zonziniauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+5-azaspiro%5B2.4%5Dheptanes%3A+lead+identification+and+early+lead+optimization+of+a+new+series+of+potent+and+selective+dopamine+D3+receptor+antagonists&doi=10.1021%2Facs.jmedchem.6b00972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio, Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdona, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8549-8576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described.  Some of these compds. also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases.  A few derivs. with overall favorable developability characteristics were selected for further late lead optimization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKMOaVTpugrVg90H21EOLACvtfcHk0ljcg08tNDvwRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN&md5=9588db3bf4e320c6d082b4318a8143a4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCastelletti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDal%2BCin%26aufirst%3DM.%26aulast%3DFeriani%26aufirst%3DA.%26aulast%3DGehanne%26aufirst%3DS.%26aulast%3DKajbaf%26aufirst%3DM.%26aulast%3DMarchi%25C3%25B3%26aufirst%3DL.%26aulast%3DNola%26aufirst%3DS.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DPerdon%25C3%25A0%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTomelleri%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%25205-azaspiro%255B2.4%255Dheptanes%253A%2520lead%2520identification%2520and%2520early%2520lead%2520optimization%2520of%2520a%2520new%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8549%26epage%3D8576%26doi%3D10.1021%2Facs.jmedchem.6b00972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laydbak, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span> <span> </span><span class="NLM_article-title">Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6342</span>– <span class="NLM_lpage">6451</span>, <span class="refDoi"> DOI: 10.1021/jm300303e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6342-6451&author=S.+Shibataauthor=J.+R.+Gillespieauthor=R.+M.+Ranadeauthor=C.+Y.+Kohauthor=J.+E.+Kimauthor=J.+U.+Laydbakauthor=F.+H.+Zuckerauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=F.+S.+Bucknerauthor=E.+Fan&title=Urea-based+inhibitors+of+Trypanosoma+brucei+methionyl-tRNA+synthetase%3A+selectivity+and+in+vivo+characterization&doi=10.1021%2Fjm300303e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Based Inhibitors of Trypanosoma brucei Methionyl-tRNA Synthetase: Selectivity and in Vivo Characterization</span></div><div class="casAuthors">Shibata, Sayaka; Gillespie, J. Robert; Ranade, Ranae M.; Koh, Cho Yeow; Kim, Jessica E.; Laydbak, Joy U.; Zucker, Frank H.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Fan, Erkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6342-6351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based methionyl-tRNA synthetase inhibitors were designed, synthesized, and evaluated for their potential toward treating human African trypanosomiasis (HAT).  With the aid of a homol. model and a structure-activity-relationship approach, low nM inhibitors were discovered that show high selectivity toward the parasite enzyme over the closest human homolog.  These compds. inhibit parasite growth with EC50 values as low as 0.15 μM while having low toxicity to mammalian cells.  Two compds. (2 and 26) showed excellent membrane permeation in the MDR1-MDCKII model and encouraging oral pharmacokinetic properties in mice.  Compd. 2 (I) was confirmed to enter the CNS in mice.  Compd. 26 had modest suppressive activity against Trpanosoma brucei rhodesiense in the mouse model, suggesting that more potent analogs or compds. with higher exposures need to be developed.  The urea-based inhibitors are thus a promising starting point for further optimization toward the discovery of orally available and CNS active drugs to treat HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobDMlz2d57bLVg90H21EOLACvtfcHk0lhmHJxNjSHKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D&md5=a7029357bdc79d52992a4b6eeff53e80</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300303e%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DKoh%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLaydbak%26aufirst%3DJ.%2BU.%26aulast%3DZucker%26aufirst%3DF.%2BH.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DFan%26aufirst%3DE.%26atitle%3DUrea-based%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520methionyl-tRNA%2520synthetase%253A%2520selectivity%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6342%26epage%3D6451%26doi%3D10.1021%2Fjm300303e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piergentili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Bello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perfumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span> <span> </span><span class="NLM_article-title">Novel highly potent and selective σ<sub>1</sub> receptor antagonists related to spipethiane</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1021/jm901542q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901542q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Wktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1261-1269&author=A.+Piergentiliauthor=C.+Amantiniauthor=F.+Del+Belloauthor=M.+Giannellaauthor=L.+Mattioliauthor=M.+Palmeryauthor=M.+Perfumiauthor=M.+Piginiauthor=G.+Santoniauthor=P.+Tucciauthor=M.+Zottiauthor=W.+Quaglia&title=Novel+highly+potent+and+selective+%CF%831+receptor+antagonists+related+to+spipethiane&doi=10.1021%2Fjm901542q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane</span></div><div class="casAuthors">Piergentili, Alessandro; Amantini, Consuelo; Del Bello, Fabio; Giannella, Mario; Mattioli, Laura; Palmery, Maura; Perfumi, Marina; Pigini, Maria; Santoni, Giorgio; Tucci, Paolo; Zotti, Margherita; Quaglia, Wilma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conservative chem. modifications of the core structure of the lead spipethiane (1) afforded novel potent σ1 ligands. σ1 affinity and σ1/σ2 selectivity proved to be favored by the introduction of polar functions (oxygen atom or carbonyl group) in position 3 or 4 (4-6) or by the elongation of the distance between the two hydrophobic portions of the mol. with the simultaneous presence of a carbonyl group in position 4 (8 and 9).  The obsd. cytostatic effect against the human breast cancer cell line MCF-7/ADR, highly expressing σ1 receptors, and not against MCF-7, as well as the enhancement of morphine analgesia highlighted the σ1 antagonist profile of this series of compds.  In particular, due to its high σ1 affinity (pKi = 10.28) and σ1/σ2 selectivity ratio (29510), compd. 9 (I) might be a novel valuable tool for σ receptor characterization and a suitable template for the rational design of potential therapeutically useful σ1 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JWhD2T1LHrVg90H21EOLACvtfcHk0lhmHJxNjSHKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Wktg%253D%253D&md5=ab40c7eaaf8f259f9796d38d48af96a8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901542q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901542q%26sid%3Dliteratum%253Aachs%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DMattioli%26aufirst%3DL.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DPerfumi%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DTucci%26aufirst%3DP.%26aulast%3DZotti%26aufirst%3DM.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DNovel%2520highly%2520potent%2520and%2520selective%2520%25CF%25831%2520receptor%2520antagonists%2520related%2520to%2520spipethiane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1261%26epage%3D1269%26doi%3D10.1021%2Fjm901542q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schetz, J. A.</span></span> <span> </span><span class="NLM_article-title">An unambiguous assay for the cloned human sigma<sub>1</sub> receptor reveals high affinity interactions with dopamine D<sub>4</sub> receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>578</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2007.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.ejphar.2007.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=17961544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=578&publication_year=2008&pages=123-136&author=I.+T.+Leeauthor=S.+Chenauthor=J.+A.+Schetz&title=An+unambiguous+assay+for+the+cloned+human+sigma1+receptor+reveals+high+affinity+interactions+with+dopamine+D4+receptor+selective+compounds+and+a+distinct+structure-affinity+relationship+for+butyrophenones&doi=10.1016%2Fj.ejphar.2007.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span></div><div class="casAuthors">Lee, Ivan T.; Chen, Shiuhwei; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">578</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of the sigma1 receptor to interact with a huge range of drug structural classes coupled with its wide distribution in the body has contributed to it being implicated as a possible therapeutic target for a broad array of disorders ranging from substance abuse to depression to Alzheimer's disease.  Surprisingly, the reported affinity values for some sigma1 receptor ligands vary more than 50-fold.  The potential of the sigma1 receptor as a pharmacotherapeutic target prompted us to develop an unambiguous assay system for measuring the affinity of ligands to the cloned human sigma1 receptor.  In the course of characterizing this system and detg. the true affinity values for almost three dozen compds., it was discovered that some dopamine D4 receptor selective compds. bind sigma1 receptors with high affinity.  A systematic anal. of haloperidol-like compds. revealed a clear structure-affinity relationship amongst clin. relevant butyrophenones.  The antidepressant fluvoxamine, the drug of abuse methamphetamine, and the neurosteroid progesterone were amongst the many ligands whose interactions with the sigma1 receptor were confirmed with the screening assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6V71Qpygx17Vg90H21EOLACvtfcHk0lhmHJxNjSHKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D&md5=a5f025cd9d7c3f130544afb4e3140f56</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BT.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520unambiguous%2520assay%2520for%2520the%2520cloned%2520human%2520sigma1%2520receptor%2520reveals%2520high%2520affinity%2520interactions%2520with%2520dopamine%2520D4%2520receptor%2520selective%2520compounds%2520and%2520a%2520distinct%2520structure-affinity%2520relationship%2520for%2520butyrophenones%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D578%26spage%3D123%26epage%3D136%26doi%3D10.1016%2Fj.ejphar.2007.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span> <span> </span><span class="NLM_article-title">Assessing brain free fraction in early drug discovery</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1517/17425250903559873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1517%2F17425250903559873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=20102287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=337-344&author=K.+D.+Readauthor=S.+Braggio&title=Assessing+brain+free+fraction+in+early+drug+discovery&doi=10.1517%2F17425250903559873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing brain free fraction in early drug discovery</span></div><div class="casAuthors">Read, Kevin D.; Braggio, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The incorporation of brain tissue binding routinely in CNS drug discovery screening strategies has markedly changed the way CNS drug discovery is performed and is proving to be a valuable tool in identifying new therapies for CNS diseases.  For many years emphasis has been placed on the magnitude of the brain to blood ratio, the bigger the better, even though, in many cases, brain total concn. (Cbrain) has no or, at best, poor correlation with receptor occupancy/pharmacodynamic readout.  Today, Cbrain values measured during in vivo expts. are cor. for the fraction unbound measured through in vitro expts. using brain tissue homogenate or brain tissue slice to obtain an est. of the brain unbound concn. (Cu,brain), and this has been demonstrated across a range of CNS targets to give a much better correlation with receptor occupancy/pharmacodynamic readout.  This apparently simple change in CNS lead optimization strategy has de facto revolutionized the vision of the brain penetration concepts.Areas covered in this review: This review will provide an overview of the use and applications of assessing brain free fraction to det. Cu,brain.Take home message: Assessing brain free fraction to det. Cu,brain in CNS lead optimization strategies is the surrogate of choice for rapidly assessing biophase concn. for the majority of CNS targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9c99W0CmXPbVg90H21EOLACvtfcHk0ljzClMMRrtAcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D&md5=f989ca92c918d40fc01ba01835942ded</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1517%2F17425250903559873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903559873%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DBraggio%26aufirst%3DS.%26atitle%3DAssessing%2520brain%2520free%2520fraction%2520in%2520early%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D337%26epage%3D344%26doi%3D10.1517%2F17425250903559873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, A.</span></span> <span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2030</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200900103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbdv.200900103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=19937839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+basics+and+implications+of+the+evolving+new+concept&doi=10.1002%2Fcbdv.200900103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept</span></div><div class="casAuthors">Reichel, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2030-2049</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A review.  Despite enormous efforts, achieving a safe and efficacious concn. profile in the brain remains one of the big challenges in central nervous system (CNS) drug discovery and development.  Although there are multiple reasons, many failures are due to underestimating the complexity of the brain, also in terms of pharmacokinetics (PK).  To this day, PK support of CNS drug discovery heavily relies on improving the blood-brain barrier (BBB) permeability in vitro and/or the brain/plasma ratio (Kp) in vivo, even though neither parameter can be reliably linked to pharmacodynamic (PD) and efficacy readouts.  While increasing BBB permeability may shorten the onset of drug action, an increase in the total amt. in brain may not necessarily increase the relevant drug concn. at the pharmacol. target.  Since the traditional Kp ratio is based on a crude homogenization of brain tissue, it ignores the compartmentalization of the brain and an increase favors non-specific binding to brain lipids rather than free drug levels.  To better link exposure/PK to efficacy/PD and to delineate key parameters, an integrated approach to CNS drug discovery is emerging which distinguishes total from unbound brain concns.  As the complex nature of the brain requires different compartments to be considered when trying to understand and improve new compds., several complementary parameters need to be measured in vitro and in vivo, and integrated into a coherent model of brain penetration and distribution.  The new paradigm thus concs. on finding drug candidates with the right balance between free fraction in plasma and brain, and between rate and extent of CNS penetration.  Integrating this data into a coherent model of CNS distribution which can be linked to efficacy will allow it to design compds. with an optimal mix in physicochem., pharmacol., and pharmacokinetic properties, ultimately mitigating the risk for failures in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprtDCziki1f7Vg90H21EOLACvtfcHk0ljzClMMRrtAcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSrtL3F&md5=d1b7b08605319178cfececbfa59da39a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200900103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200900103%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049%26doi%3D10.1002%2Fcbdv.200900103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span> <span> </span><span class="NLM_article-title">MetaQSAR: an integrated database engine to manage and analyze metabolic data</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01473</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01473" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1019-1030&author=A.+Pedrettiauthor=A.+Mazzolariauthor=G.+Vistoliauthor=B.+Testa&title=MetaQSAR%3A+an+integrated+database+engine+to+manage+and+analyze+metabolic+data&doi=10.1021%2Facs.jmedchem.7b01473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data</span></div><div class="casAuthors">Pedretti, Alessandro; Mazzolari, Angelica; Vistoli, Giulio; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-1030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The study describes the MetaQSAR tool, a new database engine specifically tailored to collect and analyze metabolic data.  This is a plug-in embedded in the VEGA suite of programs (freely downloadable at www.vegazz.net) and takes advantage from all cheminformatics features implemented in the software with addnl. tools aimed to perform statistical analyses, similarity searches and physicochem. profiling of the stored mols.  MetaQSAR also implements a novel metab. classification, which groups the metabolic reactions in 101 classes and can find numerous applications in metabolic analyses.  The potentials of MetaQSAR are here assessed by using it to store and analyze an extended database focused on metab. of xenobiotics, which was collected by manually curated meta-anal. of the recent literature.  The database includes 1890 substrates taken from about 1500 original papers in the years 2004-2015.  The database was utilized in both physicochem. analyses and similarity searches, so evidencing the notable potentialities of MetaQSAR, which can find particularly fruitful applications in developing targeted predictive approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5F-P_xq-qbbVg90H21EOLACvtfcHk0ljzClMMRrtAcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gs7fI&md5=945cc6a583728bf0c192b760f1a2a8d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01473%26sid%3Dliteratum%253Aachs%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMetaQSAR%253A%2520an%2520integrated%2520database%2520engine%2520to%2520manage%2520and%2520analyze%2520metabolic%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1019%26epage%3D1030%26doi%3D10.1021%2Facs.jmedchem.7b01473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, S. D.</span></span> <span> </span><span class="NLM_article-title">The biochemistry of drug metabolism - an introduction: part 3. Reactions of hydrolysis and their enzymes</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2031</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200790169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fcbdv.200790169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=2031-2122&author=B.+Testaauthor=S.+D.+Kr%C3%A4mer&title=The+biochemistry+of+drug+metabolism+-+an+introduction%3A+part+3.+Reactions+of+hydrolysis+and+their+enzymes&doi=10.1002%2Fcbdv.200790169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790169%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DS.%2BD.%26atitle%3DThe%2520biochemistry%2520of%2520drug%2520metabolism%2520-%2520an%2520introduction%253A%2520part%25203.%2520Reactions%2520of%2520hydrolysis%2520and%2520their%2520enzymes%26jtitle%3DChem.%2520Biodiversity%26date%3D2007%26volume%3D4%26spage%3D2031%26epage%3D2122%26doi%3D10.1002%2Fcbdv.200790169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0libFBTVEGxzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conner, A. C.</span></span> <span> </span><span class="NLM_article-title">Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2Fj.mce.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27899324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2017&pages=3-11&author=M.+J.+Woolleyauthor=A.+C.+Conner&title=Understanding+the+common+themes+and+diverse+roles+of+the+second+extracellular+loop+%28ECL2%29+of+the+GPCR+super-family&doi=10.1016%2Fj.mce.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family</span></div><div class="casAuthors">Woolley, Michael J.; Conner, Alex C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular loops (ECLs) of G protein-coupled receptors (GPCRs) can bind directly to docked orthosteric or allosteric ligands, they can contain transient contact points for ligand entry into the transmembrane (TM) bundle and they can regulate the activation of the receptor signalling pathways.  Of the three ECLs, ECL2 is the largest and most structurally diverse reflecting its functional importance.  This has been shown through biochem. techniques and has been supported by the many subsequent crystal structures of GPCRs bound to both agonists and antagonists.  ECL2 shares common structural features between (and sometimes across) receptor sub-families and can facilitate ligand entry to the TM core or act directly as a surface of the ligand-binding pocket.  Structural similarities seem to underpin common binding mechanisms; however, where these exist, variations in primary sequence ensure ligand-binding specificity.  This review will compare current understanding of the structural themes and main functional roles of ECL2 in ligand binding, activation and regulation of the major families of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uQpFUSHnlLVg90H21EOLACvtfcHk0libFBTVEGxzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnt7vM&md5=072c61b1b81aff3ee686e9820e99fedc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BJ.%26aulast%3DConner%26aufirst%3DA.%2BC.%26atitle%3DUnderstanding%2520the%2520common%2520themes%2520and%2520diverse%2520roles%2520of%2520the%2520second%2520extracellular%2520loop%2520%2528ECL2%2529%2520of%2520the%2520GPCR%2520super-family%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2017%26volume%3D449%26spage%3D3%26epage%3D11%26doi%3D10.1016%2Fj.mce.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackshields, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettigan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWilliam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, D. G.</span></span> <span> </span><span class="NLM_article-title">Clustal W and Clustal X version 2.0</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2947</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btm404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1093%2Fbioinformatics%2Fbtm404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=17846036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlaqsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=2947-2948&author=M.+A.+Larkinauthor=G.+Blackshieldsauthor=N.+P.+Brownauthor=R.+Chennaauthor=P.+A.+McGettiganauthor=H.+McWilliamauthor=F.+Valentinauthor=I.+M.+Wallaceauthor=A.+Wilmauthor=R.+Lopezauthor=J.+D.+Thompsonauthor=T.+J.+Gibsonauthor=D.+G.+Higgins&title=Clustal+W+and+Clustal+X+version+2.0&doi=10.1093%2Fbioinformatics%2Fbtm404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Clustal W and Clustal X version 2.0</span></div><div class="casAuthors">Larkin, M. A.; Blackshields, G.; Brown, N. P.; Chenna, R.; McGettigan, P. A.; McWilliam, H.; Valentin, F.; Wallace, I. M.; Wilm, A.; Lopez, R.; Thompson, J. D.; Gibson, T. J.; Higgins, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2947-2948</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Clustal W and Clustal X multiple sequence alignment programs have been completely rewritten in C++.  This will facilitate the further development of the alignment algorithms in the future and has allowed proper porting of the programs to the latest versions of Linux, Macintosh and Windows operating systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsv_FPaWsDLVg90H21EOLACvtfcHk0libFBTVEGxzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlaqsL%252FM&md5=14c988ecd0b5081ef79149f31a567880</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtm404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtm404%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DM.%2BA.%26aulast%3DBlackshields%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DN.%2BP.%26aulast%3DChenna%26aufirst%3DR.%26aulast%3DMcGettigan%26aufirst%3DP.%2BA.%26aulast%3DMcWilliam%26aufirst%3DH.%26aulast%3DValentin%26aufirst%3DF.%26aulast%3DWallace%26aufirst%3DI.%2BM.%26aulast%3DWilm%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26atitle%3DClustal%2520W%2520and%2520Clustal%2520X%2520version%25202.0%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D2947%26epage%3D2948%26doi%3D10.1093%2Fbioinformatics%2Fbtm404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span> <span> </span><span class="NLM_article-title">Binding space concept: a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1702</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.7b00121</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00121" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWrsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1691-1702&author=G.+Vistoliauthor=A.+Mazzolariauthor=B.+Testaauthor=A.+Pedretti&title=Binding+space+concept%3A+a+new+approach+to+enhance+the+reliability+of+docking+scores+and+its+application+to+predicting+butyrylcholinesterase+hydrolytic+activity&doi=10.1021%2Facs.jcim.7b00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Space Concept: A New Approach To Enhance the Reliability of Docking Scores and Its Application to Predicting Butyrylcholinesterase Hydrolytic Activity</span></div><div class="casAuthors">Vistoli, Giulio; Mazzolari, Angelica; Testa, Bernard; Pedretti, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1691-1702</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking simulations are very popular approaches able to assess the capacity of a given ligand to interact with a target.  Docking simulations are usually focused on a single best complex even though many studies showed that ligands retain a significant mobility within a binding pocket by assuming different binding modes all of which may contribute to the monitored ligand affinity.  The present study describes an innovative concept, the binding space, which allows an exploration of the ligand mobility within the binding pocket by simultaneously considering several ligand poses as generated by docking simulations.  The multiple poses and the relative docking scores can then be analyzed by taking advantage of the same approaches already used in the property space anal.; hence the binding space can be parameterized by (a) mean scores; (b) score ranges and (c) score sensitivity.  The first parameter represents a very simple procedure to account for the contribution of the often neglected alternative binding modes, while the last two descriptors encode the degree of mobility which a given ligand retains within the binding cavity (score ranges) as well as the ease with which a ligand explores such a mobility (score sensitivity).  Here, the binding space concept is applied to the prediction of the hydrolytic activity of BChE by synergistically considering multiple poses and multiple protein structures.  The obtained results shed light on the remarkable potential of the binding space concept, whose parameters allow a significant increase of the predictive power of the docking scores as revealed by extended correlative analyses.  Mean scores are the parameters affording the largest statistical improvement and all here proposed docking-based descriptors show enhancing effects in developing predictive models.  Finally, the study describes a new score function (Contacts score) simply based on the no. of surrounding residues which appears to be particularly productive in the framework of the binding space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmsGdTwEYX37Vg90H21EOLACvtfcHk0libFBTVEGxzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWrsLrP&md5=77b221d98c16e5af32318cfb8534818e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00121%26sid%3Dliteratum%253Aachs%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DPedretti%26aufirst%3DA.%26atitle%3DBinding%2520space%2520concept%253A%2520a%2520new%2520approach%2520to%2520enhance%2520the%2520reliability%2520of%2520docking%2520scores%2520and%2520its%2520application%2520to%2520predicting%2520butyrylcholinesterase%2520hydrolytic%2520activity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26spage%3D1691%26epage%3D1702%26doi%3D10.1021%2Facs.jcim.7b00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M. M.</span></span> <span> </span><span class="NLM_article-title">A rapid and sensitive method for quantitation of microgram quantities of protein, utilizing the principle of protein–dye binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-253&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+quantitation+of+microgram+quantities+of+protein%2C+utilizing+the+principle+of+protein%E2%80%93dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%252C%2520utilizing%2520the%2520principle%2520of%2520protein%25E2%2580%2593dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D253%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">21995</span>– <span class="NLM_lpage">21998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1016%2FS0021-9258%2818%2941623-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1331042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=21995-21998&author=X.+M.+Guanauthor=T.+S.+Kobilkaauthor=B.+K.+Kobilka&title=Enhancement+of+membrane+insertion+and+function+in+a+type+IIIb+membrane+protein+following+introduction+of+a+cleavable+signal+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide</span></div><div class="casAuthors">Guan, Xiao Ming; Kobilka, Tong Sun; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21995-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The human β2 adrenergic receptor is a type IIIb membrane protein.  It has a putative seven-transmembrane topol. but lacks an amino-terminal cleavable signal sequence.  The mechanism by which the amino terminus of the β2 receptor is translocated across the endoplasmic reticulum membrane is unknown.  Furthermore, it is not known if translocation as a type IIIb protein is essential for the proper folding.  Studies indicate that conversion of β2 receptor from a type IIIb to a type IIIa membrane protein by introducing an NH2-terminal cleavable signal sequence enhances translocation of the receptor into the endoplasmic reticulum membrane, thereby facilitating expression of functional receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwF32oLw6DXLVg90H21EOLACvtfcHk0lgUY43kpa3mcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGnsrc%253D&md5=a4fb66665564715147b247c9f69b3ab1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2941623-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252941623-7%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DX.%2BM.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DEnhancement%2520of%2520membrane%2520insertion%2520and%2520function%2520in%2520a%2520type%2520IIIb%2520membrane%2520protein%2520following%2520introduction%2520of%2520a%2520cleavable%2520signal%2520peptide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D21995%26epage%3D21998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martí-Renom, M.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span> <span> </span><span class="NLM_article-title">Comparative protein structure modeling of genes and genomes</span>. <i>Annu. Rev. Biophys. Biomol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1146/annurev.biophys.29.1.291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1146%2Fannurev.biophys.29.1.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10940251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=291-325&author=M.%0AA.+Mart%C3%AD-Renomauthor=A.+Stuartauthor=A.+Fiserauthor=R.+S%C3%A1nchezauthor=F.+Meloauthor=A.+Sali&title=Comparative+protein+structure+modeling+of+genes+and+genomes&doi=10.1146%2Fannurev.biophys.29.1.291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein structure modeling of genes and genomes</span></div><div class="casAuthors">Marti-Renom, Marc A.; Stuart, Ashley C.; Fiser, Andras; Sanchez, Roberto; Melo, Francisco; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-325</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 212 refs.  Comparative modeling predicts the three-dimensional structure of a given protein sequence (target) based primarily on its alignment to one or more proteins of known structure (templates).  The prediction process consists of fold assignment, target-template alignment, model building, and model evaluation.  The no. of protein sequences that can be modeled and the accuracy of the predictions are increasing steadily because of the growth in the no. of known protein structures and because of the improvements in the modeling software.  Further advances are necessary in recognizing weak sequence-structure similarities, aligning sequences with structures, modeling of rigid body shifts, distortions, loops and side chains, as well as detecting errors in a model.  Despite these problems, it is currently possible to model with useful accuracy significant parts of approx. one third of all known protein sequences.  The use of individual comparative models in biol. is already rewarding and increasingly widespread.  A major new challenge for comparative modeling is the integration of it with the torrents of data from genome sequencing projects as well as from functional and structural genomics.  In particular, there is a need to develop an automated, rapid, robust, sensitive, and accurate comparative modeling pipeline applicable to whole genomes.  Such large-scale modeling is likely to encourage new kinds of applications for the many resulting models, based on their large no. and completeness at the level of the family, organism, or functional network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq45B6Amw-zi7Vg90H21EOLACvtfcHk0lgUY43kpa3mcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D&md5=d97ffe6c47c4a3bae2bbbf14c045afdd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.29.1.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.29.1.291%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25AD-Renom%26aufirst%3DM.%2BA.%26aulast%3DStuart%26aufirst%3DA.%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DF.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520structure%2520modeling%2520of%2520genes%2520and%2520genomes%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D291%26epage%3D325%26doi%3D10.1146%2Fannurev.biophys.29.1.291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1007/s00894-012-1667-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1007%2Fs00894-012-1667-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=23187683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1-32&author=J.+J.+Stewart&title=Optimization+of+parameters+for+semiempirical+methods+VI%3A+more+modifications+to+the+NDDO+approximations+and+re-optimization+of+parameters&doi=10.1007%2Fs00894-012-1667-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-32</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Modern semiempirical methods are of sufficient accuracy when used in the modeling of mols. of the same type as used as ref. data in the parameterization.  Outside that subset, however, there is an abundance of evidence that these methods are of very limited utility.  In an attempt to expand the range of applicability, a new method called PM7 has been developed.  PM7 was parameterized using exptl. and high-level ab initio ref. data, augmented by a new type of ref. data intended to better define the structure of parameter space.  The resulting method was tested by modeling crystal structures and heats of formation of solids.  Two changes were made to the set of approxns.: a modification was made to improve the description of noncovalent interactions, and two minor errors in the NDDO formalism were rectified.  Av. unsigned errors (AUEs) in geometry and ΔH f for PM7 were reduced relative to PM6; for simple gas-phase org. systems, the AUE in bond lengths decreased by about 5 % and the AUE in ΔH f decreased by about 10 %; for org. solids, the AUE in ΔH f dropped by 60 % and the redn. was 33.3 % for geometries.  A two-step process (PM7-TS) for calcg. the heights of activation barriers has been developed.  Using PM7-TS, the AUE in the barrier heights for simple org. reactions was decreased from values of 12.6 kcal/mol-1 in PM6 and 10.8 kcal/mol-1 in PM7 to 3.8 kcal/mol-1.  The origins of the errors in NDDO methods have been examd., and were found to be attributable to inadequate and inaccurate ref. data.  This conclusion provides insight into how these methods can be improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiyk03_VhyprVg90H21EOLACvtfcHk0lgUY43kpa3mcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVegtA%253D%253D&md5=7177311730da8242d5e05f7f4e045e57</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1667-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1667-x%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%26atitle%3DOptimization%2520of%2520parameters%2520for%2520semiempirical%2520methods%2520VI%253A%2520more%2520modifications%2520to%2520the%2520NDDO%2520approximations%2520and%2520re-optimization%2520of%2520parameters%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D1%26epage%3D32%26doi%3D10.1007%2Fs00894-012-1667-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span> <span> </span><span class="NLM_article-title">Empirical scoring functions for advanced protein-ligand docking with PLANTS</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/ci800298z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800298z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=84-96&author=O.+Korbauthor=T.+St%C3%BCtzleauthor=T.+E.+Exner&title=Empirical+scoring+functions+for+advanced+protein-ligand+docking+with+PLANTS&doi=10.1021%2Fci800298z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS</span></div><div class="casAuthors">Korb, Oliver; Stuetzle, Thomas; Exner, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-96</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we present two empirical scoring functions, PLANTSCHEMPLP and PLANTSPLP, designed for our docking algorithm PLANTS (Protein-Ligand ANT System), which is based on ant colony optimization (ACO).  They are related, regarding their functional form, to parts of already published scoring functions and force fields.  The parametrization procedure described here was able to identify several parameter settings showing an excellent performance for the task of pose prediction on two test sets comprising 298 complexes in total.  Up to 87% of the complexes of the Astex diverse set and 77% of the CCDC/Astex clean listnc (noncovalently bound complexes of the clean list) could be reproduced with root-mean-square deviations of less than 2 Å with respect to the exptl. detd. structures.  A comparison with the state-of-the-art docking tool GOLD clearly shows that this is, esp. for the druglike Astex diverse set, an improvement in pose prediction performance.  Addnl., optimized parameter settings for the search algorithm were identified, which can be used to balance pose prediction reliability and search speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kyR7CGk9mbVg90H21EOLACvtfcHk0lhx0Vp1cvte8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D&md5=fce960b75b9f8906354b7c97ff84c092</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fci800298z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800298z%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DEmpirical%2520scoring%2520functions%2520for%2520advanced%2520protein-ligand%2520docking%2520with%2520PLANTS%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D84%26epage%3D96%26doi%3D10.1021%2Fci800298z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzolari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span> <span> </span><span class="NLM_article-title">Structural effects of some relevant missense mutations on the MECP2-DNA binding: a MD study analyzed by Rescore+, a versatile rescoring tool of the VEGA ZZ program</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1002/minf.201501030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=10.1002%2Fminf.201501030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=27546046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKkt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=424-433&author=A.+Pedrettiauthor=C.+Granitoauthor=A.+Mazzolariauthor=G.+Vistoli&title=Structural+effects+of+some+relevant+missense+mutations+on+the+MECP2-DNA+binding%3A+a+MD+study+analyzed+by+Rescore%2B%2C+a+versatile+rescoring+tool+of+the+VEGA+ZZ+program&doi=10.1002%2Fminf.201501030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program</span></div><div class="casAuthors">Pedretti, Alessandro; Granito, Cinzia; Mazzolari, Angelica; Vistoli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">424-433</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA methylation plays key roles in mammalian cells and is modulated by a set of proteins which recognize sym. methylated nucleotides.  Among them, the protein MECP2 shows multifunctional roles repressing and/or activating genes by binding to both methylated and unmethylated regions of the genome.  The interest for this protein markedly increased from the observation that its mutations are the primary cause of Rett syndrome, a neurodevelopmental disorder which causes mental retardation in young females.  Thus, the present study is aimed to investigate the effects of some of these known pathogenic missense mutations (i.e. R106Q, R106W, R111G, R133C and R133H) on the MECP2 folding and DNA binding by mol. dynamics simulations.  The effects of the simulated mutations are also parameterized by using a here proposed new tool, named Rescore+, implemented in the VEGA ZZ suite of programs, which calcs. a set of scoring functions on all frames of a trajectory or on all complexes contained in a database thus allowing an easy rescoring of results coming from MD or docking simulations.  The obtained results revealed that the reported loss of the MECP2 function induced by the simulated mutations can be ascribed to both stabilizing and destabilizing effect on DNA binding.  The study confirms that MD simulations are particularly useful to rationalize and predict the mutation effects offering insightful information for diagnostics and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp07FKJ_INy2bVg90H21EOLACvtfcHk0lhx0Vp1cvte8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKkt7jM&md5=c90f89eb08c1eddd79945cb1675d59a3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fminf.201501030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201501030%26sid%3Dliteratum%253Aachs%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DGranito%26aufirst%3DC.%26aulast%3DMazzolari%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26atitle%3DStructural%2520effects%2520of%2520some%2520relevant%2520missense%2520mutations%2520on%2520the%2520MECP2-DNA%2520binding%253A%2520a%2520MD%2520study%2520analyzed%2520by%2520Rescore%252B%252C%2520a%2520versatile%2520rescoring%2520tool%2520of%2520the%2520VEGA%2520ZZ%2520program%26jtitle%3DMol.%2520Inf.%26date%3D2016%26volume%3D35%26spage%3D424%26epage%3D433%26doi%3D10.1002%2Fminf.201501030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL','PDB','3PBL'); return false;">PDB: 3PBL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6c38" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6c38','PDB','6c38'); return false;">PDB: 6c38</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00265">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18651"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00265">10.1021/acs.jmedchem.8b00265</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Elemental analysis results for compounds <b>2</b>–<b>4</b> and <b>8</b>–<b>14</b>. Experimental details of radioligand binding assays at α<sub>1a</sub>-, α<sub>1b</sub>-, and α<sub>1d</sub>-AR, β<sub>1</sub>- and β<sub>2</sub>-AR, σ<sub>1</sub> receptor, DAT, and SERT. Calibration standard and quality control report for <b>12</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_001.pdf">jm8b00265_si_001.pdf (2.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00265/suppl_file/jm8b00265_si_002.csv">jm8b00265_si_002.csv (3.52 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00265&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-8%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00265" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00265" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992d12b9823da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
